
<html lang="en"     class="pb-page"  data-request-id="3a1b0bf1-8ccc-4af4-9311-6f07a329ae23"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2014.57.issue-6;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm401767k;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Selective and Potent Morpholinone Inhibitors of the MDM2–p53 Protein–Protein Interaction" /></meta><meta name="dc.Creator" content="Ana Z.  Gonzalez" /></meta><meta name="dc.Creator" content="John  Eksterowicz" /></meta><meta name="dc.Creator" content="Michael D.  Bartberger" /></meta><meta name="dc.Creator" content="Hilary P.  Beck" /></meta><meta name="dc.Creator" content="Jude  Canon" /></meta><meta name="dc.Creator" content="Ada  Chen" /></meta><meta name="dc.Creator" content="David  Chow" /></meta><meta name="dc.Creator" content="Jason  Duquette" /></meta><meta name="dc.Creator" content="Brian M.  Fox" /></meta><meta name="dc.Creator" content="Jiasheng  Fu" /></meta><meta name="dc.Creator" content="Xin  Huang" /></meta><meta name="dc.Creator" content="Jonathan B.  Houze" /></meta><meta name="dc.Creator" content="Lixia  Jin" /></meta><meta name="dc.Creator" content="Yihong  Li" /></meta><meta name="dc.Creator" content="Zhihong  Li" /></meta><meta name="dc.Creator" content="Yun  Ling" /></meta><meta name="dc.Creator" content="Mei-Chu  Lo" /></meta><meta name="dc.Creator" content="Alexander M.  Long" /></meta><meta name="dc.Creator" content="Lawrence R.  McGee" /></meta><meta name="dc.Creator" content="Joel  McIntosh" /></meta><meta name="dc.Creator" content="Dustin L.  McMinn" /></meta><meta name="dc.Creator" content="Jonathan D.  Oliner" /></meta><meta name="dc.Creator" content="Tao  Osgood" /></meta><meta name="dc.Creator" content="Yosup  Rew" /></meta><meta name="dc.Creator" content="Anne Y.  Saiki" /></meta><meta name="dc.Creator" content="Paul  Shaffer" /></meta><meta name="dc.Creator" content="Sarah  Wortman" /></meta><meta name="dc.Creator" content="Peter  Yakowec" /></meta><meta name="dc.Creator" content="Xuelei  Yan" /></meta><meta name="dc.Creator" content="Qiuping  Ye" /></meta><meta name="dc.Creator" content="Dongyin  Yu" /></meta><meta name="dc.Creator" content="Xiaoning  Zhao" /></meta><meta name="dc.Creator" content="Jing  Zhou" /></meta><meta name="dc.Creator" content="Steven H.  Olson" /></meta><meta name="dc.Creator" content="Julio C.  Medina" /></meta><meta name="dc.Creator" content="Daqing  Sun" /></meta><meta name="dc.Description" content="We previously reported the discovery of AMG 232, a highly potent and selective piperidinone inhibitor of the MDM2–p53 interaction. Our continued search for potent and diverse analogues led to the d..." /></meta><meta name="Description" content="We previously reported the discovery of AMG 232, a highly potent and selective piperidinone inhibitor of the MDM2–p53 interaction. Our continued search for potent and diverse analogues led to the d..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 4, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401767k" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401767k" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401767k" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401767k" /></link>
        
    
    

<title>Selective and Potent Morpholinone Inhibitors of the MDM2–p53 Protein–Protein Interaction | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401767k" /></meta><meta property="og:title" content="Selective and Potent Morpholinone Inhibitors of the MDM2–p53 Protein–Protein Interaction" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0022.jpeg" /></meta><meta property="og:description" content="We previously reported the discovery of AMG 232, a highly potent and selective piperidinone inhibitor of the MDM2–p53 interaction. Our continued search for potent and diverse analogues led to the discovery of novel morpholinone MDM2 inhibitors. This change to a morpholinone core has a significant impact on both potency and metabolic stability compared to the piperidinone series. Within this morpholinone series, AM-8735 emerged as an inhibitor with remarkable biochemical potency (HTRF IC50 = 0.4 nM) and cellular potency (SJSA-1 EdU IC50 = 25 nM), as well as pharmacokinetic properties. Compound 4 also shows excellent antitumor activity in the SJSA-1 osteosarcoma xenograft model with an ED50 of 41 mg/kg. Lead optimization toward the discovery of this inhibitor as well as key differences between the morpholinone and the piperidinone series will be described herein." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401767k"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401767k">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401767k&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401767k&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401767k&amp;href=/doi/10.1021/jm401767k" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2472-2488</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401625b" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401774f" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Selective and Potent Morpholinone Inhibitors of the MDM2–p53 Protein–Protein Interaction</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ana+Z.++Gonzalez">Ana Z. Gonzalez</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Eksterowicz">John Eksterowicz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+D.++Bartberger">Michael D. Bartberger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hilary+P.++Beck">Hilary P. Beck</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jude++Canon">Jude Canon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ada++Chen">Ada Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Chow">David Chow</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason++Duquette">Jason Duquette</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+M.++Fox">Brian M. Fox</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiasheng++Fu">Jiasheng Fu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Huang">Xin Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan+B.++Houze">Jonathan B. Houze</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lixia++Jin">Lixia Jin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yihong++Li">Yihong Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhihong++Li">Zhihong Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yun++Ling">Yun Ling</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mei-Chu++Lo">Mei-Chu Lo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander+M.++Long">Alexander M. Long</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lawrence+R.++McGee">Lawrence R. McGee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel++McIntosh">Joel McIntosh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dustin+L.++McMinn">Dustin L. McMinn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan+D.++Oliner">Jonathan D. Oliner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tao++Osgood">Tao Osgood</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yosup++Rew">Yosup Rew</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne+Y.++Saiki">Anne Y. Saiki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Shaffer">Paul Shaffer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sarah++Wortman">Sarah Wortman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Yakowec">Peter Yakowec</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xuelei++Yan">Xuelei Yan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qiuping++Ye">Qiuping Ye</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dongyin++Yu">Dongyin Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoning++Zhao">Xiaoning Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jing++Zhou">Jing Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+H.++Olson">Steven H. Olson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julio+C.++Medina">Julio C. Medina</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daqing++Sun">Daqing Sun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Departments of <sup>†</sup>Therapeutic Discovery, <sup>‡</sup>Pharmaceutics, and <sup>§</sup>Pharmacokinetics and Drug Metabolism, Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span></div><div class="aff-info" id="aff2"><span class="aff-text">Departments of <sup>∥</sup>Therapeutic Discovery and <sup>⊥</sup>Oncology Research, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">#</span> <span class="aff-text">Department of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div><div class="corresp-info"><strong>*</strong>Telephone: 650-244-2654. Fax: 650-837-9369. E-mail: <a href="/cdn-cgi/l/email-protection#a9c8c7c8cec6c7d3c8e9c8c4ceccc787cac6c4"><span class="__cf_email__" data-cfemail="c4a5aaa5a3abaabea584a5a9a3a1aaeaa7aba9">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401767k&amp;href=/doi/10.1021%2Fjm401767k" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2472–2488</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 18, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 November 2013</li><li><span class="item_label"><b>Published</b> online</span>4 March 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 March 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401767k" title="DOI URL">https://doi.org/10.1021/jm401767k</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2472%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAna%2BZ.%2BGonzalez%252C%2BJohn%2BEksterowicz%252C%2BMichael%2BD.%2BBartberger%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D6%26contentID%3Djm401767k%26title%3DSelective%2Band%2BPotent%2BMorpholinone%2BInhibitors%2Bof%2Bthe%2BMDM2%25E2%2580%2593p53%2BProtein%25E2%2580%2593Protein%2BInteraction%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2488%26publicationDate%3DMarch%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401767k"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3049</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">41</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401767k" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Selective and Potent Morpholinone Inhibitors of the MDM2–p53 Protein–Protein Interaction&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Z. Gonzalez&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Eksterowicz&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;D. Bartberger&quot;},{&quot;first_name&quot;:&quot;Hilary&quot;,&quot;last_name&quot;:&quot;P. Beck&quot;},{&quot;first_name&quot;:&quot;Jude&quot;,&quot;last_name&quot;:&quot;Canon&quot;},{&quot;first_name&quot;:&quot;Ada&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Chow&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;Duquette&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;M. Fox&quot;},{&quot;first_name&quot;:&quot;Jiasheng&quot;,&quot;last_name&quot;:&quot;Fu&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;B. Houze&quot;},{&quot;first_name&quot;:&quot;Lixia&quot;,&quot;last_name&quot;:&quot;Jin&quot;},{&quot;first_name&quot;:&quot;Yihong&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Zhihong&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yun&quot;,&quot;last_name&quot;:&quot;Ling&quot;},{&quot;first_name&quot;:&quot;Mei-Chu&quot;,&quot;last_name&quot;:&quot;Lo&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;M. Long&quot;},{&quot;first_name&quot;:&quot;Lawrence&quot;,&quot;last_name&quot;:&quot;R. McGee&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;McIntosh&quot;},{&quot;first_name&quot;:&quot;Dustin&quot;,&quot;last_name&quot;:&quot;L. McMinn&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;D. Oliner&quot;},{&quot;first_name&quot;:&quot;Tao&quot;,&quot;last_name&quot;:&quot;Osgood&quot;},{&quot;first_name&quot;:&quot;Yosup&quot;,&quot;last_name&quot;:&quot;Rew&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;Y. Saiki&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Shaffer&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;Wortman&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Yakowec&quot;},{&quot;first_name&quot;:&quot;Xuelei&quot;,&quot;last_name&quot;:&quot;Yan&quot;},{&quot;first_name&quot;:&quot;Qiuping&quot;,&quot;last_name&quot;:&quot;Ye&quot;},{&quot;first_name&quot;:&quot;Dongyin&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Xiaoning&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Jing&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;H. Olson&quot;},{&quot;first_name&quot;:&quot;Julio&quot;,&quot;last_name&quot;:&quot;C. Medina&quot;},{&quot;first_name&quot;:&quot;Daqing&quot;,&quot;last_name&quot;:&quot;Sun&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;2472-2488&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401767k&quot;},&quot;abstract&quot;:&quot;We previously reported the discovery of AMG 232, a highly potent and selective piperidinone inhibitor of the MDM2–p53 interaction. Our continued search for potent and diverse analogues led to the discovery of novel morpholinone MDM2 inhibitors. This change to a morpholinone core has a significant impact on both potency and metabolic stability compared to the piperidinone series. Within this morpholinone series, AM-8735 emerged as an inhibitor with remarkable biochemical potency (HTRF IC50 = 0.4 nM) and cellular potency (SJSA-1 EdU IC50 = 25 nM), as well as pharmacokinetic properties. Compound 4 also shows excellent antitumor activity in the SJSA-1 osteosarcoma xenograft model with an ED50 of 41 mg/kg. Lead optimization toward the discovery of this inhibitor as well as key differences between the morpholinone and the piperidinone series will be described herein.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401767k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401767k" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401767k&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401767k" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401767k&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401767k" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401767k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401767k&amp;href=/doi/10.1021/jm401767k" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401767k" /></input><a href="/doi/pdf/10.1021/jm401767k" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401767k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401767k%26sid%3Dliteratum%253Aachs%26pmid%3D24548297%26genre%3Darticle%26aulast%3DGonzalez%26date%3D2014%26atitle%3DSelective%2Band%2BPotent%2BMorpholinone%2BInhibitors%2Bof%2Bthe%2BMDM2%25E2%2580%2593p53%2BProtein%25E2%2580%2593Protein%2BInteraction%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D6%26spage%3D2472%26epage%3D2488%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a>,</li><li><a href="/action/doSearch?ConceptID=292317" title="Ethyl groups">Ethyl groups</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jmcmar.2014.57.issue-6/production/jmcmar.2014.57.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0022.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We previously reported the discovery of AMG 232, a highly potent and selective piperidinone inhibitor of the MDM2–p53 interaction. Our continued search for potent and diverse analogues led to the discovery of novel morpholinone MDM2 inhibitors. This change to a morpholinone core has a significant impact on both potency and metabolic stability compared to the piperidinone series. Within this morpholinone series, AM-8735 emerged as an inhibitor with remarkable biochemical potency (HTRF IC<sub>50</sub> = 0.4 nM) and cellular potency (SJSA-1 EdU IC<sub>50</sub> = 25 nM), as well as pharmacokinetic properties. Compound <b>4</b> also shows excellent antitumor activity in the SJSA-1 osteosarcoma xenograft model with an ED<sub>50</sub> of 41 mg/kg. Lead optimization toward the discovery of this inhibitor as well as key differences between the morpholinone and the piperidinone series will be described herein.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span></span> Accession Codes</h4><p class="last">The coordinates of <b>4</b> with MDM2 have been deposited in the PDB with accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OBA">4OBA</a>.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38634" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38634" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Recognized as the “guardian of the genome” the transcription factor p53 is the cell’s main tumor suppressor and one of the most frequently inactivated genes in human cancers.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Over 30 years of research has shown that upon cellular stress, p53 response triggers the expression of multiple genes that control cell cycle arrest, apoptosis, senescence, and DNA repair.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In about 50% of cancer cells p53 inactivation takes place through mutations within the p53 gene (<i>TP53</i>) or by translational modifications of its gene product.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In those tumors that retain wild-type p53 function, loss of activity occurs by other means, such as direct inhibition by its natural inhibitors.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Discovered in 1987, the oncogene MDM2 has been identified as p53’s main inhibitor and is found to be amplified in many tumor tissues.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> Research has shown that overexpression of MDM2 blocks p53-mediated cell cycle arrest and apoptosis.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> As a result, disruption of MDM2 binding to p53 has emerged as an attractive strategy for the reactivation of the p53 pathway.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Despite the inherent challenges associated with this task, the relatively small hydrophobic interface between MDM2 and p53 suggested the possibility of designing a small molecule inhibitor that could bind to MDM2 in the p53 binding region.<a onclick="showRef(event, 'ref5 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref5 ref11 ref12 ref13 ref14">(5, 11-14)</a> Several small molecule inhibitors of the MDM2–p53 interaction are now being tested in the clinic.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15-18)</a></div><div class="NLM_p">We recently described the structure-based design of a novel class of potent and selective piperidinone inhibitors of the MDM2–p53 interaction exemplified by AM-8553 (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) and AMG 232 (<b>2</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22">(19-22)</a> While <b>1</b> is a potent inhibitor (SJSA-1 EdU IC<sub>50</sub> = 72 nM),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> continued investigation of the <i>N</i>-alkyl substituent in <b>1</b> resulted in a substantial improvement in the biochemical and cellular potency of our inhibitors.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Potent morpholinone and piperidinone inhibitors of the MDM2–p53 interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cocrystal structure of <b>3</b> bound to human MDM2 (17–111) at 1.7 Å resolution. White labels indicate positions normally occupied by key p53 residues. MDM2 residues His96 and Gly58 are labeled in yellow. The coordinates of <b>3</b> with MDM2 have been deposited in the PDB with accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OAS">4OAS</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These efforts led to the discovery of AMG 232 (<b>2</b>), an exquisitely potent and selective piperidinone inhibitor.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Compound <b>2</b> demonstrated significant inhibition in both biochemical (HTRF) and cellular (SJSA-1, EdU) assays with an IC<sub>50</sub> of 0.6 and 9.2 nM, respectively.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Furthermore, <b>2</b> has an outstanding pharmacokinetic profile and shows robust in vivo antitumor activity inhibiting tumor growth in an SJSA-1 osteosarcoma xenograft model with an ED<sub>50</sub> of 9.2 mg/kg.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">The exceptional potency of <b>2</b> can be understood by the cocrystal structure of analogue <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Compound <b>3</b> occupies three critical binding sites on MDM2, namely, the Leu26<sub>(p53)</sub>, Trp23<sub>(p53)</sub>, and Phe19<sub>(p53)</sub> pockets. The carboxylate of <b>3</b> presumably engages in a salt bridge with the imidazole moiety on His96. The C3-Me points directly toward solvent, supporting our hypothesis that the improvement in potency observed with this substitution in the piperidinone series is due to the stabilization of the gauche conformation rather than from an additional contact with the MDM2 protein.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Additionally, the sulfone moiety plays an important role in directing the small lipophilic ethyl group on <b>3</b> toward the Phe19<sub>(p53)</sub> binding pocket while placing the <i>tert</i>-butyl moiety in close contact with the protein, in a shelf region located above Gly58. Direct comparison of the single X-ray crystal structure of <b>2</b> with the structure of analogue <b>3</b> bound to MDM2 shows a nearly perfect overlap between the two, suggesting that <b>2</b> binds to MDM2 in a low energy conformation that contributes to its high potency.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p last">Initial efforts on morpholinone compounds indicated that this scaffold could be a template for the design of very potent MDM2–p53 inhibitors.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In this article, we report how our continued quest to find molecules with diverse structures that maintain the favorable efficacy of <b>2</b> led to the discovery of novel morpholinone-derived inhibitors of the MDM2–p53 interaction. Among these, AM-8735 (<b>4</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), a potent and selective MDM2 inhibitor (SJSA-1 EdU IC<sub>50</sub> = 25 nM), shows remarkable pharmacokinetic properties and in vivo efficacy in a SJSA-1 osteosarcoma xenograft model (ED<sub>50</sub> = 41 mg/kg). In addition, we will discuss the significant differences in metabolic stability observed between the morpholinone inhibitors and their piperidinone counterparts.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86256" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86256" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We commenced our research in this area by synthesizing morpholinone compounds using knowledge gained from the piperidinone series. From this effort, two findings became evident that are best exemplified by comparing morpholinone <b>5</b> and the aforementioned piperidinone <b>3</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>): whereas morpholinone inhibitors are 5- to 10-fold less potent than their piperidinone counterparts, most morpholinones are more stable in hepatocytes, a finding that is consistent across preclinical species and human.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Given that the observed metabolism of most analogues is driven by glucuronidation of the parent acid (<10% turnover in human microsomes), we hoped that the morpholinone series could provide a pharmacokinetic advantage over the piperidinones that would compensate for the observed loss in potency. Besides this core change, there is another key difference between inhibitors <b>3</b> and <b>5</b>. Piperidinone inhibitor <b>3</b> requires the C3-methyl substituent to enforce a conformational equilibrium in favor of the gauche binding conformation (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>; C3-monosubstituted, Δ<i>E</i><sub>anti-gauche</sub> = −0.5 kcal/mol, 3:1 anti/gauche; C3-disubstituted, Δ<i>E</i><sub>anti-gauche</sub> = 2.8 kcal/mol, 1:46 anti/gauche), resulting in a 2- to 3-fold improvement in potency.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Conversely, analogous quantum mechanical calculations on the morpholinone core predict that the MDM2-binding gauche conformer is preferred, even in the absence of a stabilizing methyl substituent (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). These calculations are in agreement with the observed in vitro data showing that the C2-Me-substituted morpholinone <b>6</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) exhibits similar potency (HTRF ± HS IC<sub>50</sub> = 0.6/2.3 nM, EdU IC<sub>50</sub> = 32 nM) to its <i>des</i>-Me counterpart <b>5</b> (HTRF ± HS IC<sub>50</sub> = 0.5/2.0 nM, EdU IC<sub>50</sub> = 37 nM).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. B3LYP/6-31G* structures and relative energies (kcal/mol) for model mono- and disubstituted piperidinone and morpholinone inhibitors of the MDM2–p53 interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Comparison between Piperidinone <b>3</b> and Morpholinone <b>5</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0017.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Biochemical Potency</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>D</sub> (SPR, nM)</td><td class="colsep0 rowsep0" align="left">0.036</td><td class="colsep0 rowsep0" align="left">0.392</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Potency in SJSA-1 Cells</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p21 IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">18.4 ± 0.6</td><td class="colsep0 rowsep0" align="left">240 ± 90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EdU IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">3.2 ± 1.2</td><td class="colsep0 rowsep0" align="left">37 ± 19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Hepatocyte Intrinsic Clearance (mL/min per 10<sup>6</sup> cells)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">15.0</td><td class="colsep0 rowsep0" align="left">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">6.7</td><td class="colsep0 rowsep0" align="left">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">18.0</td><td class="colsep0 rowsep0" align="left">12.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">68.0</td><td class="colsep0 rowsep0" align="left">15.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Assay conducted in the absence of human serum.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Assay conducted in the presence of 10% human serum.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Mean and standard deviation of at least two runs.</p></div></div></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. C2-Me-substituted morpholinone <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With these data in hand, we began our research efforts by exploring modifications around the <i>N</i>-alkyl substituent. Thus, a series of sulfonamides, reverse sulfonamides, and sulfones were synthesized (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). From these, incorporation of <i>N</i>-arylsulfonamide substituents provided some of our most potent morpholinone inhibitors (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, entries 2–7). Introducing a fluorine at the ortho position of the arene moiety resulted in increased potency and decreased PXR activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, entry 3). The para-fluoro substitution also resulted in decreased PXR activation (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, entry 4 vs entry 2). With the potent ortho-phenyl substituent in place, the size of the <i>S</i>-alkyl substituent proved to be inconsequential to potency but did affect stability in human hepatocytes (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, entries 6 and 7 vs entry 3). In the case of the sulfone substituent, increasing the size of the group from ethyl to <i>tert</i>-butyl resulted in a significant improvement in both biochemical and cellular potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, entries 8–10). Nonetheless, further increasing the size of this small lipophilic group did not lead to more potent analogues and in most cases was also detrimental to the hepatocyte stability (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, entries 11–13). Finally, substituents such as sulfonamide <b>19</b> and oxetanesulfone <b>20</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, entries 14–15) provided inhibitors with reduced cellular potency when compared to <b>5</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Optimization of the <i>N</i>-Alkyl Group: Sulfonamides, Reverse Sulfonamides, and Sulfones</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0018.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0019.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> in biochemical assay using serum free buffer.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> in biochemical assay using buffer containing 15% human serum.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Cellular potency in SJSA-1 in the presence of 10% human serum.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Human PXR activation, % of control, rafampin, at 2 μM.</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">Human hepatocyte stability.</p></div><div class="footnote" id="t2fn6"><sup>Table f</sup><p class="last">Mean and standard deviation of at least two runs.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Modification to the R Group that Occupies the MDM2 Phe19<sub>p53</sub> Pocket</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0020.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Entry</th><th class="colsep0 rowsep0" align="center">Compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">HTRF<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t3fn6" aria-label="f">f</a> Serum Free IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">HTRF<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> 15% HS IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">SJSA-1 EdU<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a> IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">hPXR (%)<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a><sup>,</sup><a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">hHep CL (μL/min per 10<sup>6</sup> cells)<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">Rat PK<a class="ref internalNav" href="#t3fn7" aria-label="g">g</a> CL (L h<sup>–1</sup> kg<sup>–1</sup>)/<i>t</i><sub>1/2</sub> (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">1.1 ± 0.1</td><td class="colsep0 rowsep0" align="left">6.9 ± 2.1</td><td class="colsep0 rowsep0" align="left">129 ± 54</td><td class="colsep0 rowsep0" align="left">22 ± 11</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">0.5 ± 0.3</td><td class="colsep0 rowsep0" align="left">2.0 ± 0.1</td><td class="colsep0 rowsep0" align="left">37 ± 19</td><td class="colsep0 rowsep0" align="left">50 ± 21</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">0.23/4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.4 ± 0.2</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.6</td><td class="colsep0 rowsep0" align="left">33 ± 8</td><td class="colsep0 rowsep0" align="left">12 ± 2</td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left">0.43/4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">67 ± 14</td><td class="colsep0 rowsep0" align="left">42 ± 5</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">0.11/6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="left">0.5 ± 0.1</td><td class="colsep0 rowsep0" align="left">5.1 ± 1.6</td><td class="colsep0 rowsep0" align="left">120 ± 16</td><td class="colsep0 rowsep0" align="left">49 ± 9</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pr</td><td class="colsep0 rowsep0" align="left">0.4 ± 0.1</td><td class="colsep0 rowsep0" align="left">1.8 ± 0.9</td><td class="colsep0 rowsep0" align="left">25 ± 9</td><td class="colsep0 rowsep0" align="left">19.2</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">0.35/5.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">IC<sub>50</sub> in biochemical assay using serum free buffer.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">IC<sub>50</sub> in biochemical assay using buffer containing 15% human serum.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Cellular potency in SJSA-1 in the presence of 10% human serum.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Human PXR activation, % of control, rafampin, at 2 μM.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">Human hepatocyte stability.</p></div><div class="footnote" id="t3fn6"><sup>f</sup><p class="last">Mean and standard deviation of at least two runs.</p></div><div class="footnote" id="t3fn7"><sup>g</sup><p class="last">Rat PK, iv, 0.5 mg/kg.</p></div></div></div><div class="NLM_p">Representative sulfonamides and sulfones in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> were evaluated for their potential to cause drug–drug interactions by inhibition of the CYP enzymes. Whereas a majority of sulfones show minimal liabilities in these assays, many sulfonamides demonstrate considerable time dependent inhibition of CYP3A4 (e.g., <b>9</b>, 70%; <b>13</b>, 74%; <b>14</b>, 0.4%; <b>15</b>, 3%; <b>5</b>, 23%).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">With the potent <i>tert</i>-butyl sulfone in place we studied the interaction of the small alkyl group with the Phe19<sub>(p53)</sub> pocket in the MDM2 protein. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, increasing the group size from methyl to ethyl resulted in a 3-fold improvement in cellular potency (entries 1 and 2). However, attempts to further improve potency by increasing the size of this substituent to isopropyl or <i>tert</i>-butyl were not successful (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, entries 3–5). Gratifyingly, the cyclopropyl functionality provided a good balance for this position, yielding the most potent analogue with an IC<sub>50</sub> of 25 nM in the SJSA-1 EdU assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, entry 6) and a decrease in PXR activity. Importantly, all analogues studied within this series maintained favorable stability in human hepatocytes. The majority of inhibitors within this group exhibit low clearance in rats. On the basis of its good potency and stability in human hepatocytes, <b>4</b> was selected for further evaluation.</div><div class="NLM_p">First, we evaluated the selectivity of <b>4</b> by examining its ability to inhibit the proliferation of HCT116 p53<sup>wt</sup> and p53<sup>–/–</sup> tumor cells in vitro (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Compound <b>4</b> displayed substantial growth inhibition of wild-type p53 cells (BrdU, 10% HS, IC<sub>50</sub> = 63 nM) and no growth inhibition of p53-deficient cells (IC<sub>50</sub> > 25 μM). Similarly, <b>4</b> exhibited a dose-dependent increase of p21 mRNA, a direct transcriptional readout of p53 activity, in HCT116 p53<sup>wt</sup> cells (p21, 10% HS, IC<sub>50</sub> = 160 nM). No induction of p21 was observed in HTC116 p53<sup>–/–</sup> tumor cells treated with <b>4</b> at concentrations up to 10 μM. Compound <b>4</b> also demonstrated significant time and concentration dependent p21 mRNA induction in vivo in a pharmacodynamic assay in SJSA-1 osteosarcoma tumors (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref19 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref21">(19, 21)</a> A maximum p21 induction of 8-fold was observed 2 h after dosing on day 4 at 25 mg/kg. These data indicate in vivo p53-mediated activity displayed by <b>4</b> and provided dose-selection guidance for a xenograft efficacy study.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cell activity of <b>4</b> is p53 dependent. (a) In HCT116 p53<sup>wt</sup> and p53<sup>–/–</sup> cells, the percentage of BrdU positive cells was measured 16 h after compound treatment by flow cytometry. DMSO control was designated as 0% inhibition. (b) In HCT116 p53<sup>wt</sup> and p53 −/– cells, total RNA was extracted 7 h after compound treatment and p21 mRNA was measured by quantitative RT-PCR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. PD study results of <b>4</b> in SJSA-1 tumor xenograft: (∗) <i>p</i> < 0.05. Female athymic nude mice (<i>n</i> = 5/group) were implanted subcutaneously with 5 × 10<sup>6</sup> SJSA-1 cells. When tumors reached ∼175 mm<sup>3</sup>, 25 mg/kg <b>4</b> or vehicle was administered orally once daily (q.d.) for 4 days. Mice were sacrificed on day 4 at 1, 2, 4, 8, and 24 h postdose. Tumors were immediately removed and snap-frozen. p21 mRNA levels were measured by quantitative RT-PCR. Tumors treated with vehicle served as a negative control and indicated the baseline p21 mRNA level. Data are represented as mean p21 fold induction over vehicle (blue bars) + SEM of data from five mice. Concentrations in plasma were analyzed by LC/MS/MS and plotted as red dots against the right <i>y</i>-axis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. SJSA-1 cells (5 × 10<sup>6</sup>) were implanted subcutaneously into female athymic nude mice. Treatment with vehicle or <b>4</b> at 5, 25, 50, or 100 mg/kg q.d. by oral gavage began on day 9 when tumors had reached ∼200 mm<sup>3</sup> (<i>n</i> = 10/group). Tumor sizes and body weights were measured twice per week. Data are represented as mean tumor volumes, and the error bars represent SEM of data from 10 mice. No significant (>5%) body weight loss was observed in any of the groups: (∗) <i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Thus, we tested the ability of <b>4</b> to inhibit tumor growth in a mouse xenograft model bearing the same SJSA-1 osteosarcoma tumor used in the pharmacodynamic assay (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In this study, SJSA-1 tumor cells were implanted subcutaneously and grown in mice for 9 days to an average volume of 200 mm<sup>3</sup>. After this period, <b>4</b> was administered by oral gavage (as a solution in 15% HPβCD, 1% Pluronic F68, pH 8) at 5, 25, 50, and 100 mg/kg q.d. for a period of 2 weeks, and tumor volume was quantified. This compound caused robust dose-dependent tumor growth inhibition with the highest dose of 100 mg/kg resulting in tumor stasis. The calculated ED<sub>50</sub> was 41 mg/kg (95% confidence interval of 34.11–50.25).</div><div class="NLM_p">Potency and hepatocyte stability comparisons between piperidinone <b>25</b> and morpholinone <b>4</b> are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. The most significant advantage morpholinone <b>4</b> has over piperidinone <b>25</b> is its improved stability in hepatocytes across all tested species. This observation supports what was observed with compounds <b>3</b> and <b>5</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">In order to better understand their metabolic pathways, analogues <b>4</b> and <b>25</b> were incubated separately in hepatocytes (10<sup>6</sup> cells/mL) from five different species and their degradation products evaluated by LC–MS/MS (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). In the case of <b>25</b>, the chromatograms show that both the oxidative metabolite <b>M1</b> and acylglucuronide <b>M2</b> are generated across species, including human hepatocytes (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>b).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Formation of the acylglucuronide of <b>25</b> in dog and human hepatocytes was qualitatively more significant than that in hepatocytes of other species.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Comparison between Morpholinone <b>4</b> and Piperidinone <b>25</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0021.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Biochemical Potency</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (HTRF, nM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.4 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.10 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (HTRF, 15% HS, nM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.8 ± 0.9</td><td class="colsep0 rowsep0" align="left">1.1 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Rat PK (iv, 0.5 mg/kg)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (L h<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">0.35</td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Hepatocyte Stability (μL/min per 10<sup>6</sup> cells)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">24</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">IC<sub>50</sub> in biochemical assay using serum free buffer.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Mean and standard deviation of at least two runs.</p></div></div></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Metabolite profiles of <b>4</b> (a) and <b>25</b> (b) from hepatocyte incubation at 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Cocrystal structure of <b>4</b> bound to human MDM2 (17–111). White labels indicate positions normally occupied by key p53 residues. MDM2 residues His96 and Gly58 are labeled in yellow. The coordinates of <b>4</b> with MDM2 have been deposited in the PDB with accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OBA">4OBA</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In contrast, the oxidative metabolite of <b>4</b> was the major metabolite in mouse and rat hepatocytes. Although both the oxidative metabolite and acylglucuronide of <b>4</b> were detected in other species, they were barely detected in dog and human hepatocytes (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>a). It appeared that this seemingly simple core substitution is enough to change the formation rates of metabolites. Moreover it impacted their intrinsic clearances across species, especially in human hepatocytes.</div><div class="NLM_p last">In an X-ray cocrystal with human MDM2 (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), compound <b>4</b> binds to the MDM2 protein in a similar fashion to several piperidinone inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The C6-<i>m</i>-Cl-phenyl, C5-<i>p</i>-Cl-phenyl, and cyclopropyl moieties occupy the Leu26<sub>(p53)</sub>, Trp23<sub>(p53)</sub>, and Phe19<sub>(p53)</sub> pockets, respectively. The carboxylate appears to engage in a salt bridge with the imidazole moiety on His96, a residue that also engages in a face-to-face, π-stacking interaction with the C6-arene. The <i>tert-</i>butyl moiety on the sulfone projects onto the glycine shelf region maximizing the hydrophobic contact with the MDM2 protein.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synthesis of amino alcohol <b>32</b> commenced with commercially available amino acid <b>27</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Reduction of <b>27</b> with lithium aluminum hydride followed by Boc protection gave carbamate <b>29</b>. Dess–Martin periodinane-mediated oxidation of the alcohol produced aldehyde <b>30</b>. Addition of 3-chlorophenylmagnesium bromide at room temperature to <b>30</b> yielded <i>trans</i>-amino alcohol <b>31</b> which could be subsequently hydrolyzed to amino alcohol <b>32</b> hydrochloride.</div><div class="NLM_p">Alternatively, amino alcohol <b>32</b> was also synthesized through a Henry reaction between nitroalkane <b>34</b> and 3-chlorobenzaldehyde followed by in situ protection of the secondary carbinol to its corresponding silyl ether <b>35</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Reduction of the nitro group in <b>35</b> followed by chiral resolution of <b>32</b> provided the desired amino alcohol <b>36</b> in 97% ee.</div><figure id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LiAlH<sub>4</sub>, THF, reflux, 3 h, quant; (b) Boc<sub>2</sub>O, TEA, DCM, 12 h, 73%; (c) DMP, DCM, rt, 2 h, 95%; (d) 3-chlorophenylmagnesium bromide, THF, rt, 12 h, 47%; (e) HCl/dioxane, 2 h, quant.</p></p></figure><figure id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) AgNO<sub>2</sub>, Et<sub>2</sub>O, 0 °C, 62%; (b) 3-chlorobenzaldehyde, pyridine, alumina, TESCl, 55 °C, 12 h; (c) Zn/HCl, 40 °C, 2 h, 20% over two steps; (d) (+)-di-<i>p</i>-toluoyl-<span class="smallcaps smallerCapital">d</span>-tartaric acid, EtOH/water, 38% (97% ee).</p></p></figure><div class="NLM_p">With the desired amino alcohol at hand, the secondary alcohol was converted to the TBS ether <b>37</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). This transformation can be accomplished in good yields starting from either the free-base amino alcohol <b>36</b> or its hydrochloride salt <b>32</b>. Ytterbium-catalyzed addition of the free amine on the least hindered side of a chosen epoxide generated intermediates <b>38a</b>–<b>e</b>. This transformation proved to be tolerant to a wide variety of monosubstituted epoxides. Moreover, starting from the corresponding enantiomerically enriched epoxide allowed for diastereoselective formation of <b>38</b> with retention of configuration at the carbinol center. Aziridines <b>39a</b>–<b>d</b> could be formed under standard Mitsunobu conditions in good yields. However, for <b>38e</b>, the <i>tert</i>-butyl moiety proved to be too hindered for these conditions, and thus, mesylate formation followed by an intramolecular displacement of the mesylate yielded aziridine <b>39e</b> albeit in low yields.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><figure id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TBSCl, imidazole, DCM 25 °C, 90%; (b) Yb(OTf)<sub>3,</sub> CH<sub>3</sub>CN, 6 h, 130 °C, 79–93%; (c) DEAD, PPh<sub>3</sub>, THF, 40 °C, 12 h, 69–82% (d) <i>t</i>-BuSH, InCl<sub>3</sub>, DCM, 25 °C, 12 h, 88–98%; (e) MsCl, TEA, DCM, −78 °C to rt, 12 h, 31%; (f) TBAF, THF, 15 min, 25 °C, 73–95%; (g) bromoacetic acid, NaH, THF, 25 °C, 12 h, 100% conversion; (h) HATU, DMF, DIPEA, 25 °C, 1 h, 61–90% (last two steps); (i) LiHMDS, allyl bromide, −78 °C, 1 h, 85%, 2:1 mixture of isomers; (j) NaIO<sub>4</sub>, RuCl<sub>3</sub>, CH<sub>3</sub>CN/CCl<sub>4</sub>/H<sub>2</sub>O, 32–75% combined yield for both isomers.</p></p></figure><div class="NLM_p">Indium-catalyzed aziridine opening with the appropriate thiol occurred smoothly.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Alkylation of the free alcohol with bromoacetic acid produced acids <b>41</b> that could then undergo an intramolecular amide coupling reaction to form morpholinones <b>42</b>. Interestingly, attempts to produce this amide bond in an intermolecular fashion with either acid chlorides or carboxylic acids failed with a variety of reagents. Thus, proceeding in an intramolecular fashion was pivotal for the success of this synthetic route. Finally, allylation at C2 followed by oxidation of both the thioether and the terminal alkene to their corresponding sulfones and carboxylic acids, respectively, afforded the desired inhibitors as a nearly 1.5:1 mixture of diastereoisomers in favor of the desired C2-<i>R</i>-isomer.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><figure id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) chloroacetyl chloride, TEA, 0 °C, THF, 2 h; then NaH, rt, 12 h, 86%; (b) ethyl 2-bromo-2-cyclopropylacetate, NaH, DMF, rt, 12 h, 82%; (c) NaOEt/EtOH, rt, 4 h, 57%; (d) LiEt<sub>3</sub>BH, THF, rt, 30 min, 90%; (e) <i>t</i>-BuSH, cyanomethyltributylphosphorane, toluene, 110 °C, 12 h, 43%. (f) LiHMDS, allyl bromide, −78 °C, 1 h, 85%, 2:1 mixture of isomers; (g) NaIO<sub>4</sub>, RuCl<sub>3</sub>, CH<sub>3</sub>CN/CCl<sub>4</sub>/H<sub>2</sub>O, 32–75% combined yield for both isomers.</p></p></figure><div class="NLM_p">Since reaction of <b>37</b> with 1-cyclopropyloxirane gave a complex mixture of products under the ytterbium-catalyzed reaction conditions depicted in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, an alternative synthetic route was devised to access the cyclopropyl-substituted analogues (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). First, formation of the morpholinone core was achieved by addition of chloroacetyl chloride to <b>36</b> under basic conditions.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> From <b>43</b>, N-alkylation proceeded smoothly to <b>44</b>, yielding a 45:55 mixture of isomers favoring <b>44b</b>.</div><div class="NLM_p">However, after isolation of the desired isomer <b>44a</b>, <b>44b</b> could be easily re-equilibrated to a 45:55 mixture of <b>44a</b>/<b>44b</b> that could subsequently be separated to give more of the desired isomer. Compound <b>44a</b> could then be reduced to the primary alcohol with superhydride. Alcohol <b>45</b> could easily be transformed to a thioether under Mitsunobu conditions and then to inhibitor <b>4</b> following a similar alkylation/oxidation sequence as that depicted previously in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><figure id="sch5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3,4-dimethoxybenzyl alcohol, NaH, DMF, 60 °C, 2 h, 44%; (b) 4-bromobenzenesulfonyl chloride, DMAP, DCM, rt, 78%; (c) <b>47</b>, NaO<sup>t</sup>Bu, DMF, 85 °C, 12 h, 66%; (d) DDQ, CH<sub>2</sub>Cl<sub>2</sub>/H<sub>2</sub>O, 0 °C, 2 h, 87%; (e) cyanomethyltributylphosphorane, toluene, 110 °C, 12 h, 10–85%; (f) LiHMDS, allyl bromide, −78 °C, 1 h, 85%, 2:1 mixture of isomers; (g) NaIO<sub>4</sub>, RuCl<sub>3</sub>, CH<sub>3</sub>CN/CCl<sub>4</sub>/H<sub>2</sub>O, 32–75% combined yield for both isomers.</p></p></figure><div class="NLM_p">Given the versatility of the Mitsunobu reaction, intermediate <b>49</b> was synthesized to quickly access a variety of sulfone- and sulfonamide-substituted inhibitors (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). To this end, enantiomerically pure brosylate <b>47</b> was synthesized from <i>R</i>-2-ethoxyoxirane and 3,4-dimethoxybenzyl alcohol. N-Alkylation of <b>43</b> with <b>47</b> formed isomerically pure <b>48</b>. Subsequently, DDQ effected the formation of the desired primary carbinol <b>49</b> that served as a common intermediate toward the synthesis of both sulfonamide- and sulfone-containing analogues.</div><figure id="sch6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LHMDS, allyl bromide, −78 °C, 1 h, 85%, 2:1 mixture of isomers; (b) DDQ, CH<sub>2</sub>Cl<sub>2</sub>/H<sub>2</sub>O, 0 °C, 2 h, 87%; (c) DMP, DCM, 1 h, rt, quant; (d) MeNH<sub>2</sub>, Na(OEt)<sub>3</sub>BH, DCE, 12 h, 83%; (e) cyclopropanesulfonyl chloride, TEA, DCM, rt, 24 h, 38% (three steps); (f) NaIO<sub>4</sub>, RuCl<sub>3</sub>, CH<sub>3</sub>CN/CCl<sub>4</sub>/H<sub>2</sub>O, 65%, combined yield for both isomers.</p></p></figure><figure id="sch7" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LiHMDS, MeI, −78 °C, 1 h, 85%, ∼1.5:1 mixture of isomers; (b) LiHMDS, allyl bromide, −30 °C, 12 h, 45%, ∼1.5:1 mixture of isomers; (c) NaIO<sub>4</sub>, RuCl<sub>3</sub>, CH<sub>3</sub>CN/CCl<sub>4</sub>/H<sub>2</sub>O, 49%, combined yield for both isomers.</p></p></figure><div class="NLM_p">Cyclopropylsulfonamide inhibitor <b>7</b> could be prepared from intermediate <b>48</b> by alkylation at C2 followed by deprotection of the 3,4-dimethoxybenzyl ether to yield <b>52</b> (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). Dess–Martin periodinane oxidation of <b>52</b> produced aldehyde <b>53</b> which, after a quick workup, was converted to methylamine <b>54</b> through a reductive amination. Addition of cyclopropanesulfonyl chloride to <b>54</b> rendered sulfonamide <b>55</b> that could be easily converted to inhibitor <b>7</b> utilizing our standard oxidation conditions.</div><div class="NLM_p last">Finally, tetrasubstituted inhibitor <b>6</b> was synthesized from <b>42b</b> by two subsequent alkylation reactions followed by our standard oxidative conditions (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80770" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80770" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Novel, potent, and selective morpholinone inhibitors of the MDM2–p53 interaction were described. The morpholinone inhibitors are less efficacious but have improved hepatocyte stability relative to piperidinone inhibitors. Among these, compound <b>4</b> shows excellent biochemical potency (HTRF IC<sub>50</sub> = 0.4 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), MDM2 selectivity over MDMX (MDMX HTRF IC<sub>50</sub> > 100 μM), cellular potency (SJSA-1 EdU IC<sub>50</sub> = 25 nM), as well as good pharmacokinetic properties (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Importantly, compound <b>4</b> shows a marked improvement in hepatocyte stability compared to piperidinone inhibitor <b>25</b>. Oxidation is the main metabolic pathway for the morpholinone series and the morpholinone inhibitors have significantly less formation of the acylglucuronide metabolite than the piperidinones across preclinical species. This molecule also demonstrates robust antitumor activity in the SJSA-1 osteosarcoma xenograft study with a calculated ED<sub>50</sub> of 41 mg/kg.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64488" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64488" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Chemistry</h3><div class="NLM_p last">Reactions, unless otherwise stated, were conducted under an inert gas atmosphere (nitrogen or argon) at the temperature indicated. Commercial reagents and anhydrous solvents were used without further purification. Analytical thin layer chromatography (TLC) was performed on Analtech silica gel with organic binder 250 μm TLC plates. Removal of solvents was conducted by using a rotary evaporator, and residual solvent was removed from nonvolatile compounds using a vacuum manifold maintained at approximately 1 Torr. All yields reported are isolated yields. Preparative reversed-phase high pressure liquid chromatography (RP-HPLC) was performed using an Agilent 1100 series HPLC and Phenomenex Gemini C18 column (5 μm, 100 mm × 30 mm i.d.), eluting with a binary solvent system A and B using a gradient elusion [A, H<sub>2</sub>O with 0.1% trifluoroacetic acid (TFA); B, CH<sub>3</sub>CN with 0.1% TFA] with UV detection at 220 nm. All final compounds were purified to ≥95% purity as determined by a Agilent 1100 series HPLC with UV detection at 220 nm using the following method: Zorbax SB-C8 column (3.5 μm, 150 mm × 4.6 mm i.d.); mobile phase, A = H<sub>2</sub>O with 0.1% TFA, B = CH<sub>3</sub>CN with 0.1% TFA; gradient 5–95% B (0–15 min); flow rate, 1.5 mL/min. Low-resolution mass spectrometry (MS) data were determined on an Agilent 1100 series LCMS with UV detection at 254 nm and a low resolution electrospray mode (ESI). High-resolution mass spectra were obtained on an Agilent 6510 Q-TOF MS instrument with an Agilent 1200 LC on the front end. <sup>1</sup>H NMR spectra were obtained on a Bruker Avance III 500 (500 MHz) or Bruker Avance II 400 (400 MHz) spectrometer. Chemical shifts (δ) are reported in parts per million (ppm) relative to residual undeuterated solvent as an internal reference. The following abbreviations were used to explain the multiplicities: s = single, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, dt = doublet of triplets, m = multiplet, br = broad. Optical rotations ([α]<sub>D</sub>) were measured on a JASCO P-1020 polarimeter. Specific rotations are given as deg/dm, and the concentrations are reported as g/100 mL of the specific solvent and were recorded at the temperature indicated. Absolute stereochemistry of inhibitors <b>1</b>–<b>5</b> was unambiguously determined through crystallographic analysis; for the rest of the inhibitors stereochemistry at C2 was assigned as <i>R</i> in agreement with that observed from inhibitors <b>1</b>–<b>5</b>.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> (<i>R</i>)-2-Amino-2-(4-chlorophenyl)ethanol (<b>28</b>)</h3><div class="NLM_p last">A solution of 1 M LiAlH<sub>4</sub> in THF was diluted with 460 mL of anhydrous THF and was heated to 75 °C under a nitrogen atmosphere. (<i>R</i>)-2-Amino-2-(4-chlorophenyl)acetic acid (<b>27</b>) (25.0 g, 135 mmol; Asta Tech, Inc., Bristol, PA) was added in several portions. The reaction mixture was heated to reflux for about 3 h, cooled to room temperature, and quenched by adding water (8.0 mL), aqueous 15% NaOH (8.0 mL), and water (25.6 mL), successively. The mixture was stirred vigorously for 30 min. The solids were filtered off, rinsed with THF and the combined organics were concentrated in vacuo to provide <b>28</b> as a yellow solid (>98% yield, 23 g). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.31–7.35 (m, 2H), 7.29 (m, 2 H), 4.05 (br s, 1H), 3.69–3.78 (m, 1H), 3.53 (dd, <i>J</i> = 10.56, 8.02 Hz, 1H), 2.48 (br s, 1H), 1.59 (br s, 2 H). MS (ESI) <i>m</i>/<i>z</i> = 172.0 [M + H]<sup>+</sup> .</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> (<i>R</i>)-<i>tert</i>-Butyl 1-(4-Chlorophenyl)-2-hydroxyethylcarbamate (<b>29</b>)</h3><div class="NLM_p last">A solution of di-<i>tert</i>-butyl dicarbonate (36.6 g, 168 mmol) in DCM (50 mL) was added dropwise to a solution of <b>28</b> (23 g, 135 mmol) in DCM (200 mL) at 0 °C. After the addition was completed, the ice bath was removed and the reaction mixture was stirred at room temperature for 1.5 h. The reaction mixture was concentrated in vacuo and the crude material was triturated with 10% DCM/hexane (850 mL) to provide <b>29</b> as a white powder (73% yield, 27 g). <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 7.33–7.39 (m, 2 H), 7.27–7.32 (m, 2 H), 7.24 (d, <i>J</i> = 8.02 Hz, 1 H), 4.75–4.84 (m, 1 H), 4.43–4.56 (m, 1 H), 3.41–3.52 (m, 2 H), 1.36 (s, 9 H). MS (CI+) <i>m</i>/<i>z</i> = 565.0 [2M + Na]<sup>+</sup>.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (<i>R</i>)-<i>tert</i>-Butyl 1-(4-Chlorophenyl)-2-oxoethylcarbamate (<b>30</b>)</h3><div class="NLM_p last">1,1,1-Tris(acetoxy)-1,1-dihydro-1,2-benziodoxol-3-(1<i>H</i>)-one (“Dess–Martin periodinane”) (17.4 g, 41.1 mmol) was added in several portions to a stirred suspension of <b>29</b> (5.5 g, 20.5 mmol) in wet DCM (40 mL of DCM/40 μL of water) at room temperature. The mixture was stirred for 2 h, diluted with diethyl ether (40 mL), and quenched by adding a solution of Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (10 equiv) in saturated aqueous NaHCO<sub>3</sub> solution (80 mL) at room temperature. The mixture was stirred vigorously for 10 min, and the layers were separated. The aqueous layer was extracted with diethyl ether (40 mL). The organics were pooled, washed with saturated aqueous NaHCO<sub>3</sub> solution and brine, dried over MgSO<sub>4</sub>, filtered, and the filtrate was concentrated. The crude material was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.46 (br s, 1H), 7.31–7.37 (m, 2H), 7.17–7.24 (m, 2H), 5.58–5.92 (m, 1H), 5.25 (d, <i>J</i> = 3.72 Hz, 1H), 5.14–5.34 (m, 1H), 1.27–1.45 (m, 9H).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>tert</i>-Butyl (1<i>R</i>,2<i>R</i>)-2-(3-Chlorophenyl)-1-(4-chlorophenyl)-2-hydroxyethylcarbamate (<b>31</b>)</h3><div class="NLM_p last">A 500 mL three-neck flask was charged with a magnetic stir bar, magnesium (2.163 g, 89 mmol), a crystal of iodine, and anhydrous diethyl ether (100 mL). The flask was equipped with an addition funnel and a reflux condensor. The addition funnel was charged with a solution of 1-bromo-3-chlorobenzene (89 mmol) in anhydrous ether. An amount of 15 mL of this solution was added dropwise into the flask under vigorous stirring. Then the reaction mixture was heated to reflux for about 5 min until the color of the iodine was no longer visible. The heating source was removed, and the remainder of the 1-bromo-3-chlorobenzene solution was added dropwise at a rate to maintain gentle reflux. After the addition was completed, the reaction mixture was maintained at reflux temperature for another 30 min. The reaction mixture turned light brown during the heating. The oil bath was removed, and without cooling, a solution of <b>30</b> (4.80 g, 17.80 mmol) in anhydrous diethyl ethyl ether (66 mL) was added over a period of 30 min. The mixture was stirred for an additional 2 h at room temperature. The reaction mixture was poured into 200 mL of a cold saturated aqueous NH<sub>4</sub>Cl solution. The two layers were separated, and the aqueous layer was extracted with ethyl acetate (2 × 100 mL). The combined organic layers were washed with water and then brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated. The residue was washed with 100 mL of hexanes, filtered, and dried to provide the title compound as a mixture of two diastereomers (anti/syn = 9:1 by NMR). The crude material was used in the next step without further purification (49% combined yield, 3.2 g). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.16–7.32 (8H, m), 5.38 (1H, d, <i>J</i> = 4.4 Hz), 4.85 (1H, d, <i>J</i> = 5.0 Hz), 1.32 (9H, s). MS (ESI) <i>m</i>/<i>z</i> = 404.0 [M + Na]<sup>+</sup>.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (1<i>R</i>,2<i>R</i>)-2-Amino-1-(3-chlorophenyl)-2-(4-chlorophenyl)ethanol Hydrochloride (<b>32</b>)</h3><div class="NLM_p last">Compound <b>31</b> (3.0 g, 7.49 mmol) was treated with 20 mL of 4 N HCl in dioxane at room temperature for 2 h. The solvent was evaporated. The residue was triturated with diethyl ether, filtered, washed with diethyl ether, and dried under vacuum to give <b>32</b> (>98% yield, 2.4 g). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.36 (2H, d, <i>J =</i> 12 Hz), 7.27 (5H, m), 7.07 (1H, d, <i>J</i> = 8 Hz), 4.90 (1H, d, <i>J</i> = 8 Hz), 4.36 (1H, d, <i>J</i> = 12 Hz). MS (ESI) <i>m</i>/<i>z</i> = 282.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 1-Chloro-4-(nitromethyl)benzene (<b>34</b>)</h3><div class="NLM_p last">A suspension of AgNO<sub>2</sub> (392 g) in diethyl ether (1.6 L) was cooled to 0 °C, and a solution of 4-chlorobenzyl bromide (395 g, 1.92 mol) in diethyl ether (1.6 L) was added dropwise over 1 h (temperature maintained below 3 °C during addition). The reaction mixture was stirred for 16 h at 0 °C in the dark. Then the mixture was filtered and the solids were washed with diethyl ether (3×). The combined filtrates were concentrated under reduced pressure. The residue was purified by column chromatography on silica gel (eluent, 0–10% EtOAc in heptane; gradient elution) to give <b>34</b> (62% yield, 205 g). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.41 (s, 4H), 5.42 (s, 2H). MS (ESI) <i>m</i>/<i>z</i> = 172.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (±)-2-Amino-1-(3-chlorophenyl)-2-(4-chlorophenyl)ethanol ((±)-<b>32</b>)</h3><div class="NLM_p last">To a flask containing 3-chlorobenzaldehyde (135 mL, 168 g, 1.19 mol) were added <b>34</b> (205 g, 1.19 mol), alumina (135 g), pyridine (96 mL, 1.19 mol), and chlorotriethylsilane (200 mL, 180 g, 1.19 mol). The flask was covered in aluminum foil and spun for 16 h in the dark at room temperature on a rotary evaporator. The resulting thick paste was then filtered and washed with isopropanol. The filtrate was divided into two equal portions. The procedure for each portion is as follows: To each solution was added 1 M HCl (7 L, 7 mol), and then Zn powder (800 g, 12.3 mol) was added in several portions. The reaction mixture was stirred until the observed exothermic reaction (to 35 °C) was complete (90 min). Then the mixture was cooled to 0 °C and basified with 30% NaOH to approximately pH 10. The suspension was filtered through a pad of Celite and washed with DCM. The filtrate was transferred to a separatory funnel, and the layers were separated. The aqueous layer was extracted with DCM. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated under reduced pressure. The residue was dissolved in MTBE (1.5 L) and cooled to 0 °C. Then 4 N HCl in dioxane (375 mL, 1.5 mol) was added dropwise. The solid was collected by filtration. The solid was purified by crystallization from dioxane/ethanol to give a racemic mixture of <b>32</b> (20% overall yield, 76 g). MS (ESI) <i>m</i>/<i>z</i> = 281.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (<i>R</i>,<i>R</i>)-2-Amino-1-(3-chlorophenyl)-2-(4-chlorophenyl)ethanol ((<i>R</i>,<i>R</i>-)<b>36</b>)</h3><div class="NLM_p last"><i>trans</i>-<b>32</b> (900 g, 2.8 mols) (>99.5% purity) was basified with 1 M NaOH (8 L) and extracted with EtOAc (6 L x 2). The EtOAc layers were combined, washed with water and brine, dried and concentrated, affording 800 g of free amine. The free amine was taken in EtOH (32 L) and (+)-di-<i>p</i>-toluoyl-D-tartaric acid (1095 g) was added. The mixture was heated to reflux and water was added until the solution became clear (2.4 L). The solution was allowed to cool overnight. The solid was filtered, washed with EtOH, and dried, affording 1.2 kg of wet salt (74% ee). The salt was taken in EtOH (24 L) and water (1.8 L), heated to reflux, and cooled overnight. The solid was filtered, washed with EtOH, and dried, affording 900 g of wet salt (92% ee). The salt was taken in EtOH (18 L) and water (1.2 L), heated to reflux, and cooled overnight. The solid was filtered, washed with EtOH, and dried, affording 600 g of wet salt (>97% ee). The salt was basified with 2 M NaOH (8 L) and extracted with EtOAc (4 L x 2). The EtOAc layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. <b>36</b> (>95% purity, > 97%ee) was obtained as a white solid (38% yield, 302 g). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.11–7.21 (m, 7H), 6.96–6.98 (m, 1H), 4.67 (d, <i>J</i> = 7.8 Hz, 1H), 3.92 (d, <i>J</i> = 7.8 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> = 282.0 [M + H]<sup>+</sup>. Enantiomeric excess determined via chiral HPLC (OD-H, 250 × 4.6 mm, hexane:IPA = 90:10, 215, and 230 nm, 20 min method) 11.3 min (major, 99.8%) and 15.9 min (minor, 0.2%). Optical rotation for major isomer: [α]<sub>D</sub><sup>23.5</sup> = +92.7° (c = 0.385, in MeOH).</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (1<i>R</i>,2<i>R</i>)-2-((<i>tert</i>-Butyldimethylsilyl)oxy)-2-(3-chlorophenyl)-1-(4-chlorophenyl)ethanamine (<b>37</b>)</h3><div class="NLM_p last">To a solution of (1<i>R</i>,2<i>R</i>)-2-amino-1-(3-chlorophenyl)-2-(4-chlorophenyl)ethanol (<b>36</b>) (1.0 g, 3.54 mmol) and imidazole (0.483 g, 7.09 mmol) in DCM (3.54 mL) was added <i>tert</i>-butyldimethylchlorosilane (0.588 g, 3.90 mmol) at room temperature. The mixture was stirred overnight at room temperature. After this period the reaction mixture was diluted with water (10 mL) and extracted with DCM (3 × 20 mL). The organic extract was dried over MgSO<sub>4</sub>. The solution was filtered and concentrated under vacuum to give the crude material as a light-yellow oil. The crude material was adsorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column (120 g), eluting with isocratic 70/25/5 DCM/acetone/MeOH with 0.1% of triethylamine to provide <b>37</b> (90% yield, 1.26 g) as a light-yellow oil. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.12–7.30 (m, 7H), 7.07 (dt, <i>J</i> = 1.76, 4.11 Hz, 1H), 4.71 (d, <i>J</i> = 5.87 Hz, 1H), 3.97 (d, <i>J</i> = 5.67 Hz, 1H), 0.86–0.90 (m, 9H), −0.13 to −0.06 (m, 3H), −0.31 to −0.21 (m, 3H). MS (ESI) <i>m</i>/<i>z</i> = 396.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (<i>R</i>)-1-(((1<i>R</i>,2<i>R</i>)-2-((<i>tert</i>-Butyldimethylsilyl)oxy)-2-(3-chlorophenyl)-1-(4-chlorophenyl)ethyl)amino)butan-2-ol (<b>38b</b>)</h3><div class="NLM_p last">A solution of (1<i>R</i>,2<i>R</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-2-(3-chlorophenyl)-1-(4-chlorophenyl)ethanamine (<b>37</b>) (1.22 g, 3.08 mmol), (<i>R</i>)-(+)-1,2-epoxybutane (0.288 mL, 4.00 mmol), and ytterbium(III) trifluoromethanesulfonate (0.345 mL, 0.462 mmol) in acetonitrile (10 mL) was heated at 130 °C for 3 h in a microwave. This was diluted with water and extracted with ethyl acetate (3×). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to provide <b>38b</b> (1.39 g, 96% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.19 (d, <i>J</i> = 8.61 Hz, 4H), 7.14–7.22 (m, 1H), 7.06–7.13 (m, 2H), 7.01 (d, <i>J</i> = 8.41 Hz, 2H), 6.80 (d, <i>J</i> = 7.63 Hz, 1H), 4.55 (d, <i>J</i> = 7.24 Hz, 1H), 3.73 (d, <i>J</i> = 7.24 Hz, 1H), 3.42–3.54 (m, 1H), 2.56 (d, <i>J</i> = 11.93 Hz, 1H), 1.31–1.49 (m, 3H), 0.91 (s, 9H), −0.04 (s, 3H), −0.23 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 468.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>S</i>)-1-((1<i>R</i>,2<i>R</i>)-2-((<i>tert</i>-Butyldimethylsilyl)oxy)-2-(3-chlorophenyl)-1-(4-chlorophenyl)ethyl)-2-ethylaziridine (<b>39b</b>)</h3><div class="NLM_p last">To a solution of triphenylphosphine (2.55 g, 9.72 mmol) and <b>38b</b> (4.14 g, 8.84 mmol) dissolved in THF (15 mL) was added diethyl azodicarboxylate, 40 wt % solution in toluene (3.83 mL, 9.72 mmol). The mixture was stirred at 40 °C overnight. The crude mixture was concentrated, adsorbed onto a plug of silica gel, and purified by chromatography through a Redi-Sep prepacked silica gel column (120 g), eluting with isocratic 5–10% EtOAc in hexanes to provide <b>39b</b> (69% yield, 3.0 g) as a light-yellow oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.29–7.38 (m, 3H), 7.12 (d, <i>J</i> = 7.83 Hz, 2H), 7.03 (d, <i>J</i> = 16.38 Hz, 1H), 6.96 (d, <i>J</i> = 8.31 Hz, 1H), 6.73–6.78 (m, 1H), 4.84 (d, <i>J</i> = 6.36 Hz, 1H), 3.72–3.87 (m, 1H), 3.49–3.66 (m, 1H), 2.50 (d, <i>J</i> = 6.36 Hz, 1H), 1.79 (d, <i>J</i> = 3.42 Hz, 1H), 1.64 (d, <i>J</i> = 6.36 Hz, 1H), 1.26–1.30 (m, 2H), 0.85–0.90 (m, 9H), 0.68 (t, <i>J</i> = 7.34 Hz, 3H), 0.10 (s, 3H), −0.18 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 450.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>R</i>)-2-((<i>tert</i>-Butyldimethylsilyl)oxy)-2-(3-chlorophenyl)-1-(4-chlorophenyl)ethyl)-1-(<i>tert</i>-butylthio)butan-2-amine (<b>40b</b>)</h3><div class="NLM_p last">To a solution of (<i>S</i>)-1-((1<i>R</i>,2<i>R</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-2-(3-chlorophenyl)-1-(4-chlorophenyl)ethyl)-2-ethylaziridine (<b>39b</b>) (170 mg, 0.377 mmol) in DCM (1.9 mL) at room temperature were added 2-methyl-2-propanethiol (85 μL, 0.755 mmol) and indium(III) chloride (0.835 mg, 3.77 μmol). The light yellow slurry mixture was stirred at room temperature overnight. The mixture was concentrated to give quantitatively <b>40b</b> (>98% yield, 206 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.04 (br s, 7H), 6.57–6.81 (m, 1H), 4.34–4.57 (m, 1H), 3.69–3.98 (m, 1H), 2.46–2.68 (m, 2H), 2.21–2.44 (m, 2H), 1.45 (bs, 2H), 1.32 (br s, 9H), 0.94 (s, 9H), 0.89 (t, <i>J</i> = 7.35 Hz, 3H), 0.05 (br s, 3H), −0.21 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 540.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-1-(<i>tert</i>-Butylthio)butan-2-yl)-6-(3-chlorophenyl)-5-(4-chlorophenyl)morpholin-3-one (<b>42b</b>)</h3><div class="NLM_p"><i>Step A.</i> To a 250 mL round-bottomed flask were added (<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>R</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-2-(3-chlorophenyl)-1-(4-chlorophenyl)ethyl)-1-(<i>tert</i>-butylthio)butan-2-amine <b>40b</b> (3.07 g, 5.68 mmol) and tetrabutylammonium fluoride, 1.0 M in tetrahydrofuran (14.19 mL, 14.19 mmol) in THF (10 mL), at room temperature. The mixture was stirred for 1 h at this temperature. The reaction was quenched with water (10 mL). The mixture was extracted with diethyl ether (3 × 10 mL), and the organic extracts were dried over MgSO<sub>4</sub>. The solution was filtered and concentrated under vacuum to give the crude material as a light-yellow oil.</div><div class="NLM_p">The crude material was adsorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column (40 g), eluting with three-step isocratic 8–20% acetone in hexanes to provide (1<i>R</i>,2<i>R</i>)-2-(((<i>S</i>)-1-(<i>tert</i>-butylthio)butan-2-yl)amino)-1-(3-chlorophenyl)-2-(4-chlorophenyl)ethanol (73.1% yield, 1.8 g). MS (ESI) <i>m</i>/<i>z</i> = 426.2 [M + H]<sup>+</sup>.</div><div class="NLM_p"><i>Step B.</i> To a 100 mL round-bottomed flask were added (1<i>R</i>,2<i>R</i>)-2-(((<i>S</i>)-1-(<i>tert</i>-butylthio)butan-2-yl)amino)-1-(3-chlorophenyl)-2-(4-chlorophenyl)ethanol (1.74 g, 4.08 mmol) and bromoacetic acid (0.680 g, 4.90 mmol) in THF (13.60 mL). To this solution sodium hydride, 60% in oil (0.408 g, 10.20 mmol), was added in portions over a period of 10 min. The mixture was allowed to stir at room temperature overnight. After this period the crude mixture was diluted in water (10 mL) and extracted with diethyl ether (3 × 20 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was used in the next step without further purification. MS (ESI) <i>m</i>/<i>z</i> = 484.2 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><i>Step C.</i> To a solution of 2-((1<i>R</i>,2<i>R</i>)-2-(((<i>S</i>)-1-(<i>tert</i>-butylthio)butan-2-yl)amino)-1-(3-chlorophenyl)-2-(4-chlorophenyl)ethoxy)acetic acid (1.98 g, 4.09 mmol) and <i>N</i>,<i>N</i>-diethylpropan-2-amine (1.273 mL, 8.17 mmol) in DMF (13.62 mL) was added HATU (1.865 g, 4.90 mmol). The mixture was stirred overnight at room temperature. After this period, the crude mixture was quenched with water and extracted with diethyl ether (3 × 30 mL). The organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude material was adsorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column (40 g), eluting with three-step isocratic 5–15% acetone in hexanes to provide <b>42b</b> (70% yield over the last two steps, 1.34 g) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.30 (d, <i>J</i> = 8.41 Hz, 2H), 7.23–7.27 (m, 1H), 7.12–7.20 (m, 2H), 7.08 (d, <i>J</i> = 8.41 Hz, 2H), 6.83 (d, <i>J</i> = 6.65 Hz, 1H), 4.82 (d, <i>J</i> = 8.80 Hz, 1H), 4.56 (d, <i>J</i> = 9.00 Hz, 1H), 4.43 (q, <i>J</i> = 16.43 Hz, 2H), 3.27 (dd, <i>J</i> = 9.98, 12.52 Hz, 1H), 2.87–3.03 (m, 1H), 2.58 (dd, <i>J</i> = 4.50, 12.52 Hz, 1H), 1.94–2.22 (m, 1H), 1.55–1.61 (m, 1H), 1.31–1.37 (m, 9H), 0.64 (t, <i>J</i> = 7.53 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 466.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-1-(<i>tert</i>-Butylsulfonyl)butan-2-yl)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholin-2-yl)acetic Acid (<b>5</b>)</h3><div class="NLM_p last">Compound <b>5</b> was prepared from <b>42b</b> as an amorphous solid through a procedure similar to that described elsewhere.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.18–7.27 (m, 5H), 7.11–7.17 (m, 1H), 7.07 (t, <i>J</i> = 7.82 Hz, 1H), 6.97 (d, <i>J</i> = 7.63 Hz, 1H), 5.06 (d, <i>J</i> = 6.46 Hz, 1H), 4.86 (d, <i>J</i> = 6.65 Hz, 1H), 4.63 (t, <i>J</i> = 5.97 Hz, 1H), 3.85 (dd, <i>J</i> = 9.00, 13.69 Hz, 1H), 3.23–3.39 (m, 1H), 3.00 (s, 2H), 2.87 (d, <i>J</i> = 13.69 Hz, 1H), 1.97–2.17 (m, 1H), 1.45–1.64 (m, 1H), 1.31–1.40 (m, 9H), 0.45 (t, <i>J</i> = 7.53 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 556.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 556.1334 [M + H]<sup>+</sup>, calcd for C<sub>26</sub>H<sub>32</sub>Cl<sub>2</sub>NO<sub>6</sub>S 556.1322.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-((2<i>R,</i>5<i>R,</i>6<i>R</i>)-4-((<i>S</i>)-1-(<i>tert</i>-Butylsulfonyl)propan-2-yl)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholin-2-yl)acetic Acid (<b>21</b>)</h3><div class="NLM_p last">Compound <b>21</b> was prepared as a single isomer from <b>37</b> (11% overall yield for the last eight steps) through similar procedures to those described for the synthesis of <b>5</b> in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.31 (d, <i>J</i> = 8.41 Hz, 2H), 7.20–7.22 (m, 1H), 7.04–7.16 (m, 4H), 6.81 (d, <i>J</i> = 7.82 Hz, 1H), 5.02 (d, <i>J</i> = 9.59 Hz, 1H), 4.73 (dd, <i>J</i> = 7.04, 4.69 Hz, 1H), 4.64 (d, <i>J</i> = 9.78 Hz, 1H), 4.15 (dd, <i>J</i> = 13.40, 9.68 Hz, 1H), 3.57–3.71 (m, 1H), 3.26 (dd, <i>J</i> = 16.24, 7.24 Hz, 1H), 2.97 (dd, <i>J</i> = 16.24, 4.70 Hz, 1H), 2.85 (dd, <i>J</i> = 13.40, 3.42 Hz, 1H), 1.44 (br s, 9 H), 1.37 (d, <i>J</i> = 6.85 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 542 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 542.1177 [M + H]<sup>+</sup>, calcd for C<sub>25</sub>H<sub>30</sub>Cl<sub>2</sub>NO<sub>6</sub>S 542.1165.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-1-(<i>tert</i>-Butylsulfonyl)-4,4,4-trifluorobutan-2-yl)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholin-2-yl)acetic Acid (<b>22</b>)</h3><div class="NLM_p last">Compound <b>22</b> was prepared as a single isomer from <b>37</b> (2% overall yield for the last eight steps) through procedures similar to those described for the synthesis of <b>5</b> in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.31–7.36 (m, 2H), 7.25–7.30 (m, 2H), 7.20–7.24 (m, 2H), 7.13 (t, <i>J</i> = 8.12 Hz, 1H), 6.88–7.04 (m, 1H), 5.18 (d, <i>J</i> = 7.83 Hz, 1H), 5.04 (d, <i>J</i> = 7.83 Hz, 1H), 4.82 (dd, <i>J</i> = 6.85, 4.11 Hz, 1H), 4.05–4.19 (m, 1H), 3.81–3.94 (m, 1H), 3.22 (dd, <i>J</i> = 16.92, 6.94 Hz, 2H), 2.92–3.14 (m, 2H), 2.26–2.42 (m, 1H), 1.36–1.51 (m, 9H). MS (ESI) <i>m</i>/<i>z</i> = 610 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 610.1050 [M + H]<sup>+</sup>, calcd for C<sub>26</sub>H<sub>29</sub>Cl<sub>2</sub>NO<sub>6</sub>S 610.1039.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-1-(<i>tert</i>-Butylsulfonyl)-3-methylbutan-2-yl)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholin-2-yl)acetic Acid (<b>23</b>)</h3><div class="NLM_p last">Compound <b>23</b> was prepared as a single isomer from <b>37</b> (3% overall yield for the last eight steps) through procedures similar to those described for the synthesis of <b>5</b> in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.49 (d, <i>J</i> = 8.22 Hz, 2H), 7.33–7.42 (m, 3H), 7.22 (d, <i>J</i> = 0.98 Hz, 3H), 5.28–5.39 (m, 1H), 5.16 (s, 1H), 4.66 (t, <i>J</i> = 6.16 Hz, 1H), 3.77 (dd, <i>J</i> = 7.43, 14.09 Hz, 1H), 3.30 (t, <i>J</i> = 7.53 Hz, 1H), 3.09–3.22 (m, <i>J</i> = 3.23, 6.16 Hz, 3H), 2.33–2.49 (m, 1H), 1.49 (s, 9H), 0.78 (d, <i>J</i> = 6.65 Hz, 3H), 0.53 (d, <i>J</i> = 6.85 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 570.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 570.1490 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>34</sub>Cl<sub>2</sub>NO<sub>6</sub>S 570.1478.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-1-(<i>tert</i>-Butylsulfonyl)-3,3-dimethylbutan-2-yl)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholin-2-yl)acetic Acid (<b>24</b>)</h3><div class="NLM_p last">Compound <b>24</b> was prepared as a single isomer from <b>37</b> (2% overall yield for the last eight steps) through procedures similar to those described for the synthesis of <b>5</b> in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.33 (d, <i>J</i> = 8.41 Hz, 2H), 7.27–7.30 (m, 3H), 7.08–7.23 (m, 3H), 5.34 (d, <i>J</i> = 7.24 Hz, 1H), 5.20 (d, <i>J</i> = 7.43 Hz, 1H), 4.76 (t, <i>J</i> = 6.26 Hz, 1H), 3.95 (dd, <i>J</i> = 9.59, 13.69 Hz, 1H), 3.60 (d, <i>J</i> = 2.35 Hz, 1H), 3.51 (s, 1H), 3.12 (d, <i>J</i> = 6.26 Hz, 1H), 2.99 (dd, <i>J</i> = 2.35, 13.69 Hz, 1H), 1.48 (s, 9H), 0.78 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> = 584.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 584.1642 [M + H]<sup>+</sup>, calcd for C<sub>28</sub>H<sub>36</sub>Cl<sub>2</sub>NO<sub>6</sub>S 584.1635.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)morpholin-3-one (<b>43</b>)</h3><div class="NLM_p">To a solution of (1<i>R</i>,2<i>R</i>)-2-amino-1-(3-chlorophenyl)-2-(4-chlorophenyl)ethanol (<b>36</b>) (0.47 g, 1.7 mmol) and triethylamine (0.349 mL, 2.5 mmol) in THF at 0 °C was added chloroacetyl chloride (0.16 mL, 2.0 mmol). The reaction mixture was stirred at 0 °C for 1 h. After this time, saturated aqueous NH<sub>4</sub>Cl solution and ethyl acetate were added. The layers were separated and the combined organic layers were washed with water (3 × 10 mL), dried over MgSO<sub>4</sub>, filtered and the filtrate was concentrated in vacuum to give 2-chloro-<i>N</i>-((1<i>R</i>,2<i>R</i>)-2-(3-chlorophenyl)-1-(4-chlorophenyl)-2-hydroxyethyl)acetamide as a light yellow oil which was taken to the next step without further purification. MS (ESI) <i>m</i>/<i>z</i> 380.0 [M + Na]<sup>+</sup>.</div><div class="NLM_p last">The product above was dissolved in THF (15 mL) and treated with several portions of sodium hydride (60% dispersion in mineral oil, 0.167 g, 4.16 mmol) over a period of 5 min. The mixture was stirred at room temperature for 5 h. After this time, saturated aqueous NH<sub>4</sub>Cl solution and ethyl acetate were added. The organic extracts were separated and the combined organic layers were washed with water (3 × 10 mL), dried over MgSO<sub>4</sub>, filtered and the filtrate was concentrated in vacuo to give the crude material as a yellow oil. The crude was absorbed onto a plug of silica gel and purified by silica gel column chromatography, eluting with a gradient of 0–30% acetone in hexanes to provide <b>43</b> (86% yield, 0.49 g). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.47–7.54 (m, 1H), 7.46–7.54 (m, 1H), 7.34 −7.42 (m, 2H), 7.29–7.32 (m, 2H), 7.26–7.29 (m, 1H), 7.13–7.25 (m, 1H), 6.98 (d, <i>J</i> = 8.41 Hz, 1H), 4.57–4.65 (m, 1H), 4.45 (d, <i>J</i> = 9.98 Hz, 1H), 4.00 (d, <i>J</i> = 5.67 Hz, 2H). MS (ESI) <i>m</i>/<i>z</i> = 322.2 [M]<sup>+</sup>.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Ethyl 2-((2<i>R</i>,3<i>R</i>)-2-(3-Chlorophenyl)-3-(4-chlorophenyl)-5-oxomorpholino)-2-cyclopropylacetate (<b>44</b>)</h3><div class="NLM_p last">To a solution of (5<i>R</i>,6<i>R</i>)-6-(3-chlorophenyl)-5-(4-chlorophenyl)morpholin-3-one (<b>43</b>) (4.3 g, 13.35 mmol) in DMF (26.7 mL) was added sodium hydride (1.068 g, 26.7 mmol) at 0 °C, and the mixture was stirred at this temperature for 30 min. To the mixture was added racemic ethyl 2-bromo-2-cyclopropylacetate (3.71 mL, 26.7 mmol) in DMF (40 mL) dropwise and was stirred at room temperature for 2 h. The reaction was quenched with saturated aqueous NH<sub>4</sub>Cl (10 mL) and diluted with diethyl ether (10 mL). The solution was washed with 10% citric acid (10 mL), 5% NaHCO<sub>3</sub> (10 mL), water (10 mL), brine (10 mL). The combined organic extracts were dried with MgSO<sub>4</sub>. The solvent was evaporated under reduced pressure, and the residue (a 45:55 <b>44a</b>/<b>44b</b> mixture of epimers) was purified by flash chromatography on silica gel (120 g), eluting with 5% ethyl acetate in DCM to give first <b>44a</b> (40% yield, 2.4 g) and then <b>44b</b> (48% yield, 2.9 g).</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Characterization of (<i>S</i>)-Ethyl 2-((2<i>R</i>,3<i>R</i>)-2-(3-Chlorophenyl)-3-(4-chlorophenyl)-5-oxomorpholino)-2-cyclopropylacetate (<b>44a</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.28–7.31 (m, 2H), 7.21–7.27 (m, 2H), 7.12–7.20 (m, 3H), 6.90 (d, <i>J</i> = 7.83 Hz, 1H), 4.88 (d, <i>J</i> = 7.34 Hz, 1H), 4.73 (d, <i>J</i> = 7.34 Hz, 1H), 4.35–4.54 (m, 2H), 4.13 (q, <i>J</i> = 7.09 Hz, 1H), 3.95–4.09 (m, 1H), 3.53 (d, <i>J</i> = 10.51 Hz, 1H), 1.30–1.42 (m, 1H), 1.23 (t, <i>J</i> = 7.09 Hz, 3H), 0.65–0.77 (m, 1H), 0.56 (dd, <i>J</i> = 4.89, 7.83 Hz, 1H), 0.33 (dd, <i>J</i> = 5.26, 9.90 Hz, 1H), −0.05 (dd, <i>J</i> = 5.87, 9.54 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> = 448.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Characterization of (<i>R</i>)-Ethyl 2-((2<i>R</i>,3<i>R</i>)-2-(3-Chlorophenyl)-3-(4-chlorophenyl)-5-oxomorpholino)-2-cyclopropylacetate (<b>44b</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) d 7.28 (s, 1H), 7.24–7.27 (m, 2H), 7.21 (t, <i>J</i> = 1.83 Hz, 1H), 7.09–7.18 (m, 3H), 6.83 (d, <i>J</i> = 7.83 Hz, 1H), 4.83 (d, <i>J</i> = 8.07 Hz, 1H), 4.65 (d, <i>J</i> = 8.07 Hz, 1H), 4.46 (d, <i>J</i> = 3.42 Hz, 2H), 4.09–4.28 (m, 2H), 2.85 (d, <i>J</i> = 10.03 Hz, 1H), 1.36–1.48 (m, 1H), 1.28–1.32 (m, 3H), 0.68 (d, <i>J</i> = 8.56 Hz, 1H), 0.53 (d, <i>J</i> = 7.82 Hz, 1H), 0.10–0.20 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> = 448.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>S</i>)-Ethyl 2-((2<i>R</i>,3<i>R</i>)-2-(3-Chlorophenyl)-3-(4-chlorophenyl)-5-oxomorpholino)-2-cyclopropylacetate (<b>44a</b>) from (<i>R</i>)-Ethyl 2-((2<i>R</i>,3<i>R</i>)-2-(3-Chlorophenyl)-3-(4-chlorophenyl)-5-oxomorpholino)-2-cyclopropylacetate (<b>44b</b>)</h3><div class="NLM_p last">Sodium ethoxide (0.144 mL, 0.386 mmol) was added to a solution of (<i>R</i>)-ethyl 2-((2<i>R</i>,3<i>R</i>)-2-(3-chlorophenyl)-3-(4-chlorophenyl)-5-oxomorpholino)-2-cyclopropylacetate (0.346 g, 0.772 mmol) in anhydrous ethanol (1.543 mL) at room temperature. After 4 h, the reaction mixture was neutralized with 3 M HCl (0.13 mL). The mixture was partitioned between water and EtOAc, and the layers were separated. The aqueous layer was extracted with EtOAc twice, and the organics were pooled and washed with brine. The combined organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to provide a crude that was subsequently purified by flash chromatography on silica gel, eluting with 5% ethyl acetate in DCM to provide <b>44b</b> (57% yield, 0.2 g) (see experimental above for characterization of <b>44b</b>).</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-cyclopropyl-2-hydroxyethyl)morpholin-3-one (<b>45</b>)</h3><div class="NLM_p last">To a solution of <b>44a</b> (3.6 g, 8.29 mmol) in THF (8.29 mL) was added superhydride (lithium triethylborohydride, 1.0 M solution in THF) (17.4 mL, 17.4 mmol) at 0 °C. After 15 min, LCMS showed complete conversion to the desired product. MeOH (3 mL) was added dropwise over a period of 1 min. Then potassium peroxymonosulfate (Oxone) (15.29 g, 24.87 mmol) in water (60 mL) was added dropwise over a period of 10 min. After 1 h, saturated aqueous NaHSO<sub>3</sub> (9 mL) was added at room temperature. Extraction was with diethyl ether (2 × 60 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated under a vacuum. The crude material was adsorbed onto a plug of silica gel and purified by flash chromatography through a silica gel column (330 g), eluting with isocratic 20% acetone in hexanes to provide <b>45</b> as an off-white solid (90% yield, 3.0 g). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.04–7.25 (m, 7H), 6.79 (d, <i>J</i> = 7.63 Hz, 1H), 4.87 (d, <i>J</i> = 7.43 Hz, 1H), 4.52 (d, <i>J</i> = 7.43 Hz, 1H), 4.26–4.42 (m, 2H), 3.50–3.59 (m, 1H), 3.13–3.36 (m, 2H), 2.88 (br s, 1H), 0.79 (ddd, <i>J</i> = 3.03, 4.94, 7.87 Hz, 1H), 0.40–0.57 (m, 2H), 0.11–0.23 (m, 1H), −0.10 to 0.06 (m, 1H). MS (ESI) <i>m</i>/<i>z</i> = 405.4 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholin-2-yl)acetic Acid (<b>4</b>)</h3><div class="NLM_p last">Compound <b>4</b> was prepared as a single isomer from <b>45</b> (24% yield, last three steps) through a procedure similar to that described for the synthesis of <b>5</b> (for Mitsunobu reaction conditions see synthesis of <b>50a</b> below and ref  <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">34</a>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.28 (s, 5H), 7.06–7.17 (m, 3H), 5.10 (d, <i>J</i> = 4.70 Hz, 1H), 4.86 (d, <i>J</i> = 4.70 Hz, 1H), 4.50 (t, <i>J</i> = 6.16 Hz, 1H), 3.74–3.98 (m, 1H), 2.90–3.16 (m, <i>J</i> = 5.67 Hz, 2H), 2.01–2.08 (m, 1H), 1.35 (s, 9H), 1.09–1.28 (m, 1H), 0.22–0.43 (m, 2H), −0.13 to 0.07 (m, 1H), −0.69 to −0.66 (bs, 1H). MS (ESI) <i>m</i>/<i>z</i> = 568.1 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 568.1331 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>32</sub>Cl<sub>2</sub>NO<sub>6</sub>S 568.1322.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>R</i>)-1-((3,4-Dimethoxybenzyl)oxy)butan-2-ol (<b>46</b>)</h3><div class="NLM_p last">To a suspension of sodium hydride (60% dispersion in mineral oil, 8.91 g, 223 mmol) in DMF (300 mL) at 60 °C was added dropwise a solution of 3,4-dimethoxybenzyl alcohol (29.4 mL, 202 mmol) in DMF (100 mL) over a period of 30 min. The mixture was stirred at 60 °C for 0.5 h until H<sub>2</sub> evolution ceased. The mixture was cooled to 45 °C, and then (<i>R</i>)-2-ethyloxirane (17.61 mL, 202 mmol) was added dropwise. The mixture was allowed to stir at 45 °C overnight. The reaction mixture was diluted with saturated aqueous NaHCO<sub>3</sub> solution (300 mL) and extracted with diethyl ether (3 × 300 mL). The organic extract was washed with water (3 × 300 mL) and dried over MgSO<sub>4</sub>. The solution was filtered and concentrated under reduced pressure. The residue was adsorbed onto a plug of silica gel and purified by chromatography through a silica gel column (330 g, RediSep Rf, Teledyne Isco, Lincoln, NE), eluting with a gradient of 10–40% acetone in hexanes to provide <b>46</b> as an off-white oil (44% yield, 21.4 g). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.81–6.93 (m, 3H), 4.51 (s, 2H), 3.91 (d, <i>J</i> = 1.00 Hz, 6H), 3.69–3.82 (m, 1H), 3.52 (dd, <i>J</i> = 3.03, 9.49 Hz, 1H), 3.33 (dd, <i>J</i> = 8.02, 9.39 Hz, 1H), 1.44–1.58 (m, 2H), 0.98 (t, <i>J</i> = 7.53 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 263.2 [M + Na]<sup>+</sup>.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>R</i>)-1-((3,4-Dimethoxybenzyl)oxy)butan-2-yl 4-Bromobenzenesulfonate (<b>47</b>)</h3><div class="NLM_p last">To DMAP (14.54 g, 119 mmol) and (<i>R</i>)-1-((3,4-dimethoxybenzyl)oxy)butan-2-ol (<b>46</b>) (13.0 g, 54.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (180 mL) was added 4-bromobenzene-1-sulfonyl chloride (20.74 g, 81 mmol). The mixture was stirred at room temperature overnight. The crude material was partitioned between ethyl acetate (50 mL) and saturated aqueous sodium bicarbonate (100 mL). The organics were sequestered, and the aqueous portion was extracted further with ethyl acetate (50 mL). The organics were combined and washed with 0.1 M HCl (2 × 50 mL). The organics were then washed with brine (50 mL), dried over MgSO<sub>4</sub>, filtered, and the filtrate was concentrated under vacuum. The residue was adsorbed onto a plug of silica gel and purified by chromatography through a silica gel column (330 g, RediSep Rf, Teledyne Isco, Lincoln, NE), eluting with a three-step gradient of 10–30% acetone in hexanes which afforded <b>47</b> (78% yield, 19 g). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.75 (d, <i>J</i> = 8.56 Hz, 2H), 7.59 (d, <i>J</i> = 8.31 Hz, 2H), 6.66–6.89 (m, 3H), 4.67 (quin, <i>J</i> = 5.62 Hz, 1H), 4.25–4.45 (m, 2H), 3.90 (s, 3H), 3.89 (s, 3H), 3.42–3.58 (m, 2H), 1.64–1.82 (m, 2H), 0.88 (t, <i>J</i> = 7.46 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 481.0 [M + Na]<sup>+</sup>.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-((3,4-dimethoxybenzyl)oxy)butan-2-yl)morpholin-3-one (<b>48</b>)</h3><div class="NLM_p last">A solution of <b>43</b> (260 mg, 0.807 mmol), (<i>R</i>)-1-((3,4-dimethoxybenzyl)oxy)butan-2-yl 4-bromobenzenesulfonate (<b>47</b>) (556 mg, 1.210 mmol), and sodium <i>tert</i>-butoxide (116 mg, 1.210 mmol) in 1,4-dioxane (2 mL) was stirred at 85 °C overnight. After this period the reaction mixture was poured into saturated aqueous NaHCO<sub>3</sub> solution (10 mL) and brine (10 mL) and extracted with 2.5% MeOH in CH<sub>2</sub>Cl<sub>2</sub> (3 × 30 mL). The combined organics were dried over sodium sulfate, filtered, and the filtrate was concentrated under vacuum. Silica gel chromatography (gradient elution with 10–40% acetone in hexanes) afforded <b>48</b> (66% yield, 289 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.29 (s, 4H), 7.21–7.25 (m, 1H), 7.18 (t, <i>J</i> = 1.66 Hz, 1H), 7.11 (t, <i>J</i> = 7.92 Hz, 1H), 7.06 (d, <i>J</i> = 8.41 Hz, 1H), 6.78–6.92 (m, 3H), 4.77 (d, <i>J</i> = 7.83 Hz, 1H), 4.58 (d, <i>J</i> = 7.83 Hz, 1H), 4.45 (s, 2H), 4.37–4.40 (m, 2H), 3.96 (t, <i>J</i> = 9.49 Hz, 1H), 3.91 (s, 3H), 3.89 (s, 3H), 1.80–1.95 (m, <i>J</i> = 7.14, 14.77 Hz, 1H), 1.61 (bs, 2H), 1.64–1.72 (m, 1H), 0.63 (t, <i>J</i> = 7.53 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 566.2 [M + Na]<sup>+</sup>.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-hydroxybutan-2-yl)morpholin-3-one (<b>49</b>)</h3><div class="NLM_p last">To a 0 °C solution of <b>48</b> (140 mg, 0.257 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2.4 mL) and water (129 μL) was added DDQ (70.0 mg, 0.309 mmol). The mixture was stirred at 0 °C. After 2 h the reaction contents were poured into saturated aqueous NaHCO<sub>3</sub> solution (50 mL) and CH<sub>2</sub>Cl<sub>2</sub> (30 mL). The layers were separated, and the aqueous layer was extracted further with CH<sub>2</sub>Cl<sub>2</sub> (2 × 20 mL). The combined organics were dried over sodium sulfate, filtered, and the filtrate was concentrated under vacuum. Silica gel chromatography (gradient elution 10–40% acetone in hexanes) afforded <b>49</b> (87% yield, 89 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.22–7.26 (m, 2H), 7.17–7.21 (m, 1H), 7.01–7.13 (m, 4H), 6.75 (d, <i>J</i> = 7.83 Hz, 1H), 4.54 (d, <i>J</i> = 4.70 Hz, 2H), 4.35 (d, <i>J</i> = 2.74 Hz, 2H), 3.53–3.62 (m, 2H), 3.41 (q, <i>J</i> = 7.04 Hz, 1H), 3.26–3.37 (m, 1H), 1.76–1.92 (m, 1H), 1.41 (ddd, <i>J</i> = 6.06, 7.53, 13.79 Hz, 1H), 1.14 (t, <i>J</i> = 6.94 Hz, 1H), 0.62–0.70 (m, 3H). MS (ESI) <i>m</i>/<i>z</i> = 394.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(ethylthio)butan-2-yl)morpholin-3-one (<b>50a</b>)</h3><div class="NLM_p last">To a solution of <b>49</b> (300 mg, 0.761 mmol) and ethanethiol (0.225 mL, 3.04 mmol) in 0.2 mL of toluene was added cyanomethylenetributylphosphorane (0.735 mL, 3.04 mmol). The resulting solution was stirred at 110 °C overnight. After this period, the mixture was concentrated, and the crude material absorbed onto a plug of silica gel and purified by chromatography on silica gel, eluting with 20% acetone in hexanes, provided <b>50a</b> as a light yellow oil (85% yield, 283 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.21–7.34 (m, 3H), 7.11–7.18 (m, 2H), 7.07 (d, <i>J</i> = 8.41 Hz, 2H), 6.79 (d, <i>J</i> = 7.83 Hz, 1H), 4.77 (d, <i>J</i> = 9.00 Hz, 1H), 4.56 (d, <i>J</i> = 9.00 Hz, 1H), 4.44 (q, <i>J</i> = 16.43 Hz, 2H), 3.06–3.15 (m, 2H), 2.44–2.62 (m, 3H), 2.04 (td, <i>J</i> = 7.36, 14.43 Hz, 1H), 1.56–1.68 (m, 1H), 1.23–1.31 (m, 3H), 0.66 (t, <i>J</i> = 7.43 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 438.2 [M + H]<sup>+</sup></div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-3-oxo-4-((<i>S</i>)-1-(<i>N</i>-phenylcyclopropanesulfonamido)butan-2-yl)morpholin-2-yl)acetic Acid (<b>8</b>)</h3><div class="NLM_p last">Compound <b>8</b> was prepared as a single isomer from <b>49</b> (6% combined yield for the last three steps) through procedures similar to those described for the synthesis of <b>5</b>. The isomers at C2 were separated by reverse phase preparatory HPLC (Gemini Prep C<sub>18</sub> 5 μm column; Phenomenex, Torrance, CA; gradient elution of 25–75% MeCN in water, both solvents containing 0.1% TFA, 30 min method) to provide <b>8</b> as the first eluting isomer. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.43–7.54 (m, 4H), 7.33–7.43 (m, 2H), 7.31 (d, <i>J</i> = 1.37 Hz, 1H), 7.16–7.27 (m, 2H), 6.95–7.14 (m, 3H), 4.79 (d, <i>J</i> = 12.52 Hz, 2H), 4.44–4.62 (m, 1H), 4.33 (s, 1H), 3.72–3.92 (m, 1H), 2.91–3.16 (m, 3H), 2.30–2.47 (m, 1H), 1.83–2.07 (m, 1H), 1.45–1.67 (m, 1H), 1.06 (d, <i>J</i> = 4.70 Hz, 2H), 0.93 (d, <i>J</i> = 6.46 Hz, 2H), 0.51 (t, <i>J</i> = 7.53 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 631.1 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 631.1434 [M + H]<sup>+</sup>, calcd for C<sub>31</sub>H<sub>33</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>6</sub>S 631.1431.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(<i>N</i>-(2-fluorophenyl)cyclopropanesulfonamido)butan-2-yl)-3-oxomorpholin-2-yl)acetic Acid (<b>9</b>)</h3><div class="NLM_p last">Compound <b>9</b> was prepared as a single isomer from <b>49</b> (16% combined yield for the last three steps) through procedures similar to those described for the synthesis of <b>5</b>. The isomers at C2 were separated by reverse phase preparatory HPLC (Gemini Prep C<sub>18</sub> 5 μm column; Phenomenex, Torrance, CA; gradient elution of 25–75% MeCN in water, both solvents containing 0.1% TFA, 30 min method) to provide <b>9</b> as the first eluting isomer. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.52 (dt, <i>J</i> = 1.56, 7.82 Hz, 1H), 7.35–7.43 (m, 1H), 7.29–7.34 (m, 2H), 7.26–7.28 (m, 1H), 7.25 (s, 1H), 7.14–7.24 (m, 5H), 7.07 (d, <i>J</i> = 7.43 Hz, 1H), 4.90–4.98 (m, 1H), 4.82–4.89 (m, 1H), 4.44 (t, <i>J</i> = 6.36 Hz, 1H), 4.34 (dd, <i>J</i> = 8.90, 14.77 Hz, 1H), 3.81 (dd, <i>J</i> = 4.60, 14.77 Hz, 1H), 3.15 (br s, 1H), 3.04 (d, <i>J</i> = 6.46 Hz, 2H), 2.41–2.55 (m, 1H), 1.83–2.00 (m, <i>J</i> = 7.04, 8.22 Hz, 1H), 1.47–1.65 (m, <i>J</i> = 2.25, 7.14 Hz, 1H), 0.87–1.12 (m, 4H), 0.49 (t, <i>J</i> = 7.53 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 649.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 649.1349 [M + H]<sup>+</sup>, calcd for C<sub>31</sub>H<sub>32</sub>Cl<sub>2</sub>FN<sub>2</sub>O<sub>6</sub>S 649.1337.</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(<i>N</i>-(4-fluorophenyl)cyclopropanesulfonamido)butan-2-yl)-3-oxomorpholin-2-yl)acetic Acid (<b>10</b>)</h3><div class="NLM_p last">Compound <b>10</b> was prepared as a single isomer from <b>49</b> (6% combined yield for the last three steps) through procedures similar to those described for the synthesis of <b>5</b>. The isomers at C2 were separated by reverse phase preparatory HPLC (Gemini Prep C<sub>18</sub> 5 μm column; Phenomenex, Torrance, CA; gradient elution of 25–75% MeCN in water, both solvents containing 0.1% TFA, 30 min method) to provide <b>10</b> as the first eluting isomer. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.39–7.46 (m, 2H), 7.32 (d, <i>J</i> = 8.61 Hz, 2H), 7.19–7.28 (m, 3H), 7.10–7.18 (m, 4H), 7.06 (d, <i>J</i> = 7.43 Hz, 1H), 4.84 (td, <i>J</i> = 7.43, 9.19 Hz, 2H), 4.33–4.48 (m, <i>J</i> = 8.80 Hz, 2H), 3.80 (dd, <i>J</i> = 4.79, 14.38 Hz, 2H), 2.95–3.14 (m, 2H), 2.31–2.42 (m, 1H), 1.84–2.00 (m, 1H), 1.51–1.65 (m, 1H), 1.00–1.10 (m, 2H), 0.89–1.00 (m, 2H), 0.50 (t, <i>J</i> = 7.53 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 649.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 649.1336 [M + H]<sup>+</sup>, calcd for C<sub>31</sub>H<sub>32</sub>Cl<sub>2</sub>FN<sub>2</sub>O<sub>6</sub>S 649.1337.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(<i>N</i>-(2,4-difluorophenyl)cyclopropanesulfonamido)butan-2-yl)-3-oxomorpholin-2-yl)acetic Acid (<b>11</b>)</h3><div class="NLM_p last">Compound <b>11</b> (4%) was prepared as a single isomer through procedures similar to those described for the synthesis of <b>5</b>. The isomers at C2 were separated by reverse phase preparatory HPLC (Gemini Prep C<sub>18</sub> 5 μm column; Phenomenex, Torrance, CA; gradient elution of 25–75% MeCN in water, both solvents containing 0.1% TFA, 30 min method) to provide <b>11</b> as the first eluting isomer. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.38–7.54 (m, 1H), 7.13–7.37 (m, 7H), 7.03–7.13 (m, 1H), 6.90–7.03 (m, 2H), 4.96 (d, <i>J</i> = 7.09 Hz, 1H), 4.87 (d, <i>J</i> = 7.34 Hz, 1H), 4.48 (t, <i>J</i> = 6.48 Hz, 1H), 4.20–4.34 (m, 1H), 3.69–3.82 (m, 1H), 3.20 (br s, 1H), 2.97–3.15 (m, 2H), 2.42–2.53 (m, 1H), 1.85–1.94 (m, 1H), 1.48–1.64 (m, 1H), 0.87–1.09 (m, 4H), 0.49 (t, <i>J</i> = 7.46 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 667 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(<i>N</i>-(2-fluorophenyl)propan-2-ylsulfonamido)butan-2-yl)-3-oxomorpholin-2-yl)acetic Acid (<b>12</b>)</h3><div class="NLM_p last">Compound <b>12</b> was prepared as a single isomer from <b>49</b> (28% combined yield for the last three steps) through procedures similar to those described for the synthesis of <b>5</b>. The isomers at C2 were separated by reverse phase preparatory HPLC (Gemini Prep C<sub>18</sub> 5 μm column; Phenomenex, Torrance, CA; gradient elution of 25–75% MeCN in water, both solvents containing 0.1% TFA, 30 min method) to provide <b>12</b> as the first eluting isomer. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.67 (dt, <i>J</i> = 1.47, 7.97 Hz, 1H), 7.34–7.43 (m, <i>J</i> = 1.47, 4.79 Hz, 1H), 7.31 (d, <i>J</i> = 8.41 Hz, 2H), 7.26–7.28 (m, 1H), 7.13–7.25 (m, 6H), 7.04 (d, <i>J</i> = 7.63 Hz, 1H), 4.89–4.98 (m, 1H), 4.77–4.87 (m, 1H), 4.37 (t, <i>J</i> = 6.16 Hz, 2H), 3.78 (dd, <i>J</i> = 4.50, 14.87 Hz, 1H), 2.92–3.28 (m, 4H), 1.90 (quint, <i>J</i> = 7.53, 15.06 Hz, 1H), 1.47–1.63 (m, 1H), 1.39 (d, <i>J</i> = 6.85 Hz, 6H), 0.45 (t, <i>J</i> = 7.53 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 651.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(<i>N</i>-(2-fluorophenyl)methylsulfonamido)butan-2-yl)-3-oxomorpholin-2-yl)acetic Acid (<b>13</b>)</h3><div class="NLM_p last">Compound <b>13</b> was prepared as a single isomer from <b>52</b> (20% combined yield for the last two steps) through procedures similar to those described for the synthesis of <b>5</b>. The isomers at C2 were separated by reverse phase preparatory HPLC (Gemini Prep C<sub>18</sub> 5 μm column; Phenomenex, Torrance, CA; gradient elution of 25–75% MeCN in water, both solvents containing 0.1% TFA, 30 min method) to provide <b>13</b> as the first eluting isomer. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.46–7.52 (m, <i>J</i> = 1.57 Hz, 1H), 7.35–7.44 (m, 1H), 7.32 (d, <i>J</i> = 8.41 Hz, 3H), 7.14–7.26 (m, 6H), 7.05 (d, <i>J</i> = 7.63 Hz, 1H), 4.89–4.98 (m, 1H), 4.87 (s, 1H), 4.41 (d, <i>J</i> = 12.72 Hz, 1H), 4.29 (dd, <i>J</i> = 8.71, 14.77 Hz, 1H), 3.73 (dd, <i>J</i> = 4.70, 14.87 Hz, 1H), 3.03 (dd, <i>J</i> = 3.23, 6.36 Hz, 3H), 2.93 (br s, 3H), 1.80–1.98 (m, 1H), 1.49–1.64 (m, 1H), 0.48 (t, <i>J</i> = 7.53 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 623.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(ethylsulfonyl)butan-2-yl)-3-oxomorpholin-2-yl)acetic Acid (<b>14</b>)</h3><div class="NLM_p last">Compound <b>14</b> was prepared as a single isomer from <b>49</b> (14% combined yield for the last three steps) through procedures similar to those described for the synthesis of <b>5</b>. The isomers at C2 were separated by reverse phase preparatory HPLC (Gemini Prep C<sub>18</sub> 5 μm column; Phenomenex, Torrance, CA; gradient elution of 25–75% MeCN in water, both solvents containing 0.1% TFA, 30 min method) to provide <b>14</b> as the first eluting isomer. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.33–7.38 (m, 2H), 7.25 (td, <i>J</i> = 2.15, 3.91 Hz, 4H), 7.14–7.21 (m, 1H), 7.02 (d, <i>J</i> = 7.63 Hz, 1H), 5.09 (d, <i>J</i> = 7.04 Hz, 1H), 4.95 (d, <i>J</i> = 7.04 Hz, 1H), 4.79 (t, <i>J</i> = 5.87 Hz, 1H), 4.05 (br s, 1H), 3.44 (br s, 1H), 3.01–3.16 (m, 4H), 2.97 (d, <i>J</i> = 12.91 Hz, 1H), 2.14 (ddd, <i>J</i> = 7.34, 9.44, 14.13 Hz, 1H), 1.60 (ddd, <i>J</i> = 4.21, 7.53, 13.89 Hz, 1H), 1.38–1.50 (m, 3H), 0.57 (t, <i>J</i> = 7.43 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 528.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 528.1021 [M + H]<sup>+</sup>, calcd for C<sub>24</sub>H<sub>28</sub>Cl<sub>2</sub>NO<sub>6</sub>S 528.1009.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(isopropylsulfonyl)butan-2-yl)-3-oxomorpholin-2-yl)acetic Acid (<b>15</b>)</h3><div class="NLM_p last">Compound <b>15</b> was prepared as a single isomer from <b>49</b> (3% combined yield for the last three steps) through procedures similar to those described for the synthesis of <b>5</b>. The isomers at C2 were separated by reverse phase preparatory HPLC (Gemini Prep C<sub>18</sub> 5 μm column; Phenomenex, Torrance, CA; gradient elution of 25–75% MeCN in water, both solvents containing 0.1% TFA, 30 min method) to provide <b>15</b> as the first eluting isomer. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32–7.39 (m, 3H), 7.30 (s, 2H), 7.21–7.27 (m, 2H), 7.17 (s, 1H), 6.99–7.07 (m, 1H), 5.07–5.17 (m, 1H), 4.95 (s, 1H), 4.74 (s, 1H), 3.11 (d, <i>J</i> = 6.06 Hz, 3H), 2.86–2.98 (m, 1H), 2.05–2.21 (m, 1H), 1.55–1.69 (m, 1H), 1.43 (dd, <i>J</i> = 4.30, 6.85 Hz, 6H), 0.56 (t, <i>J</i> = 7.53 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 542.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 542.1177 [M + H]<sup>+</sup>, calcd for C<sub>25</sub>H<sub>30</sub>Cl<sub>2</sub>NO<sub>6</sub>S 542.1165.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(neopentylsulfonyl)butan-2-yl)-3-oxomorpholin-2-yl)acetic Acid (<b>16</b>)</h3><div class="NLM_p last">Compound <b>16</b> was prepared as a single isomer from <b>49</b> (4% combined yield for the last three steps) through procedures similar to those described for the synthesis of <b>5</b>. The isomers at C2 were separated by reverse phase preparatory HPLC (Gemini Prep C<sub>18</sub> 5 μm column; Phenomenex, Torrance, CA; gradient elution of 25–75% MeCN in water, both solvents containing 0.1% TFA, 30 min method) to provide <b>16</b> as the first eluting isomer. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.23–7.28 (m, 2H), 7.21 (s, 3H), 7.14–7.17 (m, 1H), 7.05–7.12 (m, 1H), 6.95 (d, <i>J</i> = 7.63 Hz, 1H), 5.00 (d, <i>J</i> = 6.46 Hz, 1H), 4.85 (d, <i>J</i> = 6.65 Hz, 1H), 4.60 (t, <i>J</i> = 6.06 Hz, 1H), 3.82–3.97 (m, 1H), 3.01 (d, <i>J</i> = 6.46 Hz, 2H), 2.77–2.95 (m, 3H), 1.95–2.10 (m, 1H), 1.41–1.56 (m, 1H), 1.16 (s, 10H), 0.38–0.52 (m, 3H). MS (ESI) <i>m</i>/<i>z</i> = 570.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(cyclopentylsulfonyl)butan-2-yl)-3-oxomorpholin-2-yl)acetic Acid (<b>17</b>)</h3><div class="NLM_p last">Compound <b>17</b> was prepared as a single isomer from <b>49</b> (12% combined yield for the last three steps) through similar procedures to those described for the synthesis of <b>5</b>. The isomers at C2 were separated by reverse phase preparatory HPLC (Gemini Prep C<sub>18</sub> 5 μm column; Phenomenex, Torrance, CA; gradient elution of 25–75% MeCN in water, both solvents containing 0.1% TFA, 30 min method) to provide <b>17</b> as the first eluting isomer. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.22 (ddd, <i>J</i> = 6.46, 8.61, 12.52 Hz, 5H), 7.12–7.17 (m, <i>J</i> = 1.17, 1.96 Hz, 1H), 7.08 (t, <i>J</i> = 7.82 Hz, 1H), 6.95 (d, <i>J</i> = 7.63 Hz, 1H), 5.02 (d, <i>J</i> = 6.65 Hz, 1H), 4.85 (d, <i>J</i> = 6.65 Hz, 1H), 4.62 (t, <i>J</i> = 6.06 Hz, 1H), 3.89 (dd, <i>J</i> = 9.00, 13.50 Hz, 1H), 3.19–3.39 (m, 2H), 2.98–3.04 (m, 2H), 2.84 (dd, <i>J</i> = 2.64, 13.99 Hz, 1H), 1.87–2.12 (m, 5H), 1.75 (br s, 2H), 1.60 (d, <i>J</i> = 4.11 Hz, 3H), 0.46 (t, <i>J</i> = 7.53 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 568.1 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 568.1332 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>33</sub>Cl<sub>2</sub>NO<sub>6</sub>S 568.1322.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-3-oxo-4-((<i>S</i>)-1-(phenylsulfonyl)butan-2-yl)morpholin-2-yl)acetic Acid (<b>18</b>)</h3><div class="NLM_p last">Compound <b>18</b> was prepared as a single isomer from <b>49</b> (37% combined yield for the last three steps) through procedures similar to those described for the synthesis of <b>5</b>. The isomers at C2 were separated by reverse phase preparatory HPLC (Gemini Prep C<sub>18</sub> 5 μm column; Phenomenex, Torrance, CA; gradient elution of 25–75% MeCN in water, both solvents containing 0.1% TFA, 30 min method) to provide <b>18</b> as the first eluting isomer. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.96 (d, <i>J</i> = 7.24 Hz, 2H), 7.56–7.77 (m, 3H), 7.14–7.46 (m, 7H), 7.02 (d, <i>J</i> = 7.63 Hz, 1H), 4.88–5.12 (m, 2H), 4.63 (dd, <i>J</i> = 4.89, 6.85 Hz, 1H), 4.21 (dd, <i>J</i> = 9.39, 14.28 Hz, 1H), 3.42 (br s, 1H), 2.98–3.21 (m, 3H), 2.09 (ddd, <i>J</i> = 7.43, 9.44, 14.23 Hz, 1H), 1.57 (ddd, <i>J</i> = 4.11, 7.58, 13.94 Hz, 1H), 0.48 (t, <i>J</i> = 7.43 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 576.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 576.1020 [M + H]<sup>+</sup>, calcd for C<sub>28</sub>H<sub>28</sub>Cl<sub>2</sub>NO<sub>6</sub>S 576.1009.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(<i>N</i>,<i>N</i>-dimethylsulfamoyl)butan-2-yl)-3-oxomorpholin-2-yl)acetic Acid (<b>19</b>)</h3><div class="NLM_p last">Compound <b>8</b> was prepared as a single isomer from <b>42</b> (>1% combined yield from <b>42</b>) through procedures similar to those described for the synthesis of <b>5</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.31–7.36 (m, 2H), 7.20–7.26 (m, 4H), 7.12–7.19 (m, 1H), 7.01 (d, <i>J</i> = 7.6 Hz, 1H), 5.03 (d, <i>J</i> = 7.0 Hz, 1H), 4.93 (d, <i>J</i> = 7.0 Hz, 1H), 4.77 (t, <i>J</i> = 6.0 Hz, 1H), 3.87 (dd, <i>J</i> = 13.7, 9.4 Hz, 1H), 3.29 (br s, 1H), 3.11 (d, <i>J</i> = 6.1 Hz, 2H), 2.89 (s, 3H), 2.89 (s, 3H), 2.82–2.87 (m, 1H), 2.05–2.20 (m, 1H), 1.63 (ddd, <i>J</i> = 13.9, 7.7, 4.2 Hz, 1H), 0.56 (t, <i>J</i> = 7.5 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 543.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(oxetan-3-ylsulfonyl)butan-2-yl)-3-oxomorpholin-2-yl)acetic Acid (<b>20</b>)</h3><div class="NLM_p last">Compound <b>20</b> was prepared as a single isomer from <b>39b</b> (10% combined yield for the six three steps) through procedures similar to those described for the synthesis of <b>5</b> in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The isomers at C2 were separated by reverse phase preparatory HPLC (Gemini Prep C<sub>18</sub> 5 μm column; Phenomenex, Torrance, CA; gradient elution of 25–75% MeCN in water, both solvents containing 0.1% TFA, 30 min method) to provide <b>20</b> as the first eluting isomer. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.35 (s, 2H), 7.30 (s, 2H), 7.23–7.26 (m, 2H), 7.19 (t, <i>J</i> = 7.82 Hz, 1H), 7.04 (d, <i>J</i> = 7.63 Hz, 1H), 4.86–5.13 (m, 5H), 4.74 (dd, <i>J</i> = 5.67, 6.65 Hz, 1H), 4.33–4.45 (m, 1H), 3.91–4.05 (m, 1H), 3.39–3.54 (m, 1H), 3.04–3.19 (m, 2H), 2.86 (d, <i>J</i> = 16.43 Hz, 1H), 2.04–2.17 (m, 1H), 1.50–1.70 (m, 1H), 0.58 (t, <i>J</i> = 7.43 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 556.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 556.0966 [M + H]<sup>+</sup>, calcd for C<sub>25</sub>H<sub>28</sub>Cl<sub>2</sub>NO<sub>7</sub>S 556.0958.</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (2<i>S</i>)-2-((5<i>R</i>,6<i>R</i>)-2-Allyl-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholino)butanal (<b>53</b>)</h3><div class="NLM_p last">To a solution of a 2:1.3 mixture of (2<i>R,</i>5<i>R,</i>6<i>R</i>)-2-allyl-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-hydroxybutan-2-yl)morpholin-3-one and (2<i>S,</i>5<i>R,</i>6<i>R</i>)-2-allyl-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-hydroxybutan-2-yl)morpholin-3-one (<b>52</b>) (163 mg, 0.375 mmol, synthesized from <b>48</b> through procedures similar to those described in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>) in DCM (1.8 mL) was added Dess–Martin periodinane (175 mg, 0.413 mmol) and water (7.44 μL, 0.413 mmol). After 30 min, saturated aqueous sodium thiosulfate was added. The mixture was extracted with DCM. The combined organic layers were washed with saturated aqueous NaHCO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to provide <b>53</b> (>98% yield, 159 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (1.5:1 mixture of isomers at C2) δ 9.54 (s, 1H), 9.42 (s, 1.5H), 8.27 (d, <i>J</i> = 12 Hz, 1H), 8.01 (d, <i>J</i> = 12 Hz, 1H), 7.94 (t, <i>J</i> = 6.3 Hz, 1H), 7.36 (t, <i>J</i> = 6 Hz, 1H), 7.34–7.22 (m, 10H), 7.16–7.05 (m, 7.5H), 6.71 (d, <i>J</i> = 8 Hz, 1.5H), 5.99–5.93 (m, 2.5H), 5.31–5.16 (m, 6H), 4.96 (d, <i>J</i> = 8 Hz, 1H), 4.75 (d, <i>J</i> = 12 HZ, 1.5H), 4.71 (d, <i>J</i> = 8 Hz, 1H), 4.70–4.68 (M, 1H), 4.57 (d, <i>J</i> = 12 Hz, 1.5H), 4.37 (m, 1H), 3.80 (t, <i>J</i> = 8 Hz, 1.5H), 3.59 (m, <i>J</i> = 8 Hz, 1H), 2.84–2.80 (m, 5H), 2.23–2.15 (m, 2.5H), 0.84–0.79 (m, 7.5H). MS (ESI) <i>m</i>/<i>z</i> = 432.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (5<i>R</i>,6<i>R</i>)-2-Allyl-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(methylamino)butan-2-yl)morpholin-3-one (<b>54</b>)</h3><div class="NLM_p last">To a solution of (2<i>S</i>)-2-((5<i>R</i>,6<i>R</i>)-2-allyl-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholino)butanal (<b>53</b>) (188 mg, 0.435 mmol) in DCE (4 mL) were added methanamine (1.305 mL, 2.61 mmol) 2.0 M solution in THF, sodium triacetoxyborohydride (276 mg, 1.305 mmol), and 3 drops of HOAc. After being stirred overnight, the reaction mixture was quenched with water and saturated aqueous NaHCO<sub>3</sub>. The reaction mixture was extracted with ethyl acetate. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to provide (5<i>R</i>,6<i>R</i>)-2-allyl-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(methylamino)butan-2-yl)morpholin-3-one (<b>54</b>) (83% yield, 162 mg), used without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (1.5:1 mixture of isomers at C2) δ 7.34–7.22 (m, 8H), 7.13–7.09 (m, 4H), 6.71 (d, <i>J</i> = 12 Hz, 1H), 6.05–5.87 (m, 1.5H), 5.31–5.15 (m, 4H), 4.90–4.88 (m, 1H), 4.61 (d, <i>J</i> = 8 Hz, 1.5H), 4.50 (t, <i>J</i> = 8 Hz, 1H), 3.74 (s, 1H), 2.83–2.79 (m, 3H), 2.42 (m, <i>J</i> = 12 Hz, 6H), 1.89–1.75 (m, 2H), 1.66–1.52 (m, 3H), 0.71–0.64 (m, 7.5H). MS (ESI) <i>m</i>/<i>z</i> = 447.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>N</i>-((2<i>S</i>)-2-((5<i>R</i>,6<i>R</i>)-2-Allyl-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholino)butyl)-<i>N</i>-methylcyclopropanesulfonamide (<b>55</b>)</h3><div class="NLM_p last">To a solution of (2<i>R</i>,5<i>R</i>,6<i>R</i>)-2-allyl-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(methylamino)butan-2-yl)morpholin-3-one and (2<i>S,</i>5<i>R,</i>6<i>R</i>)-2-allyl-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(methylamino)butan-2-yl)morpholin-3-one (<b>54</b>) (162 mg, 0.362 mmol) and pyridine (0.070 mL, 0.869 mmol) in DCM (4 mL) was added cyclopropanesulfonyl chloride (0.044 mL, 0.435 mmol). After 90 min, DMAP (5.0 mg, 0.041 mmol) was added. After 1 h, cyclopropanesulfonyl chloride (0.044 mL, 0.435 mmol) and pyridine (0.070 mL, 0.869 mmol) were added. After being stirred for 3 days, the mixture was quenched with water and extracted with DCM (2×), and saturated aqueous NH<sub>4</sub>Cl was added. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude residue was purified by flash chromatography on silica gel (12 g column, gradient elution with 5–70% ethyl acetate in hexanes) to provide <b>55</b> (38% yield, 75 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (1.5:1 mixture of isomers at C2) δ 7.33–7.19 (m, 5.5H), 7.10–7.02 (m, 5.5H), 6.82 (d, <i>J</i> = 8 Hz, 1H), 5.98–5.93 (m, 2H), 5.24–5.11 (m, 4H), 4.72 (m, <i>J</i> = 12H, 1H), 4.61 (m, <i>J</i> = 12 Hz, 2H), 4.40–4.36 (m, 2H), 2.97 (s, 4.5H), 2.93 (s, 3H), 2.40–2.22 (m, 2H), 1.96–1.94 (m, 2H), 1.69–1.61 (m, 1.5H), 1.27–1.10 (m, 3.5H), 0.99–0.96 (m, 3.5H), 0.67–0.57 (m, 5H). MS (ESI) <i>m</i>/<i>z</i> = 551.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-6-(3-Chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-(<i>N</i>-methylcyclopropanesulfonamido)butan-2-yl)-3-oxomorpholin-2-yl)acetic Acid (<b>7</b>)</h3><div class="NLM_p last">Compound <b>7</b> was prepared as a single isomer from <b>55</b> (39% yield) through a procedure similar to that described for the synthesis of <b>5</b>. The isomers at C2 were separated by reverse phase preparatory HPLC (Gemini Prep C<sub>18</sub> 5 μm column; Phenomenex, Torrance, CA; gradient elution of 25–75% MeCN in water, where both solvents contain 0.1% TFA, 30 min method) to provide <b>7</b> as the faster eluting isomer. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.28–7.38 (m, 4H), 7.14–7.27 (m, 4H), 4.82–4.98 (m, 2H), 4.71 (t, <i>J</i> = 6.16 Hz, 1H), 3.11 (dd, <i>J</i> = 6.26, 9.00 Hz, 3H), 2.88 (s, 3H), 2.33 (s, 1H), 1.77–1.96 (m, 1H), 1.53–1.73 (m, 1H), 1.08–1.29 (m, 2H), 0.85–1.07 (m, 4H), 0.57 (t, <i>J</i> = 7.53 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 569.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 569.1279 [M + H]<sup>+</sup>, calcd for C<sub>26</sub>H<sub>31</sub>Cl<sub>2</sub>NO<sub>6</sub>S 569.1274.</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 2-((2<i>R</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-1-(<i>tert</i>-Butylsulfonyl)butan-2-yl)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-2-methyl-3-oxomorpholin-2-yl)acetic Acid (<b>6</b>)</h3><div class="NLM_p last">Compound <b>6</b> was prepared from <b>42b</b> (10% combined yield for the last three steps) as a single isomer through procedures similar to those described for the synthesis of <b>5</b>. The isomers at C2 were separated by reverse phase preparatory HPLC (Gemini Prep C<sub>18</sub> 5 μm column; Phenomenex, Torrance, CA; gradient elution of 25–75% MeCN in water, where both solvents contain 0.1% TFA, 30 min method) to provide <b>6</b> as the faster eluting isomer. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.27–7.34 (m, 2H), 7.08 (d, <i>J</i> = 16.43 Hz, 5H), 6.81 (d, <i>J</i> = 7.83 Hz, 1H), 5.07 (q, <i>J</i> = 9.59 Hz, 2H), 4.01 (dd, <i>J</i> = 10.56, 13.30 Hz, 1H), 3.32 (dd, <i>J</i> = 7.24, 9.39 Hz, 2H), 3.18 (d, <i>J</i> = 15.85 Hz, 1H), 3.01 (d, <i>J</i> = 15.65 Hz, 1H), 2.80 (d, <i>J</i> = 12.32 Hz, 1H), 2.12–2.33 (m, 1H), 1.69–1.78 (m, 3H), 1.43 (s, 9H), 0.53 (t, <i>J</i> = 7.43 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 570.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 570.1479 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>34</sub>Cl<sub>2</sub>NO<sub>6</sub>S 570.1478.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61"><a href="/doi/suppl/10.1021/jm401767k">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78717" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78717" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">(i) In vitro biological assays, (ii) in vivo protocols, and (iii) determination of cocrystal structures of <b>4</b> bound to MDM2. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401767k/suppl_file/jm401767k_si_001.pdf">jm401767k_si_001.pdf (187.29 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm401767k" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Z. Gonzalez</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5a3b343b3d3534203b1a3b373d3f3474393537"><span class="__cf_email__" data-cfemail="62030c03050d0c180322030f05070c4c010d0f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Eksterowicz</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael D. Bartberger</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hilary P. Beck</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jude Canon</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ada Chen</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Chow</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason Duquette</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian M. Fox</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiasheng Fu</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Huang</span> - <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan B. Houze</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lixia Jin</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yihong Li</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhihong Li</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yun Ling</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mei-Chu Lo</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander M. Long</span> - <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawrence R. McGee</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel McIntosh</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dustin L. McMinn</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan D. Oliner</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tao Osgood</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yosup Rew</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne Y. Saiki</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Shaffer</span> - <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah Wortman</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Yakowec</span> - <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xuelei Yan</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiuping Ye</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dongyin Yu</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoning Zhao</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing Zhou</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven H. Olson</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julio C. Medina</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daqing Sun</span> - <span class="hlFld-Affiliation affiliation">Departments of †Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ∥Therapeutic Discovery and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i62" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i62"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i63" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i63"> Abbreviations Used</h2><tr><td class="NLM_term">AcCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">BrdU</td><td class="NLM_def"><p class="first last">5-bromo-2-deoxyuridine</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CYP3A4</td><td class="NLM_def"><p class="first last">cytochrome P450 3A4</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMBCl</td><td class="NLM_def"><p class="first last">2,4-dimethoxybenzyl chloride</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diemethylformamide</p></td></tr><tr><td class="NLM_term">DMP</td><td class="NLM_def"><p class="first last">Dess–Martin periodinane</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">dr</td><td class="NLM_def"><p class="first last">diastereoselectivity ratio</p></td></tr><tr><td class="NLM_term">EdU</td><td class="NLM_def"><p class="first last">5-ethynyl-2′-deoxyuridine</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">FACS</td><td class="NLM_def"><p class="first last">fluorescence-activated cell sorting</p></td></tr><tr><td class="NLM_term">hPXR</td><td class="NLM_def"><p class="first last">human pregnane X receptor</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time-resolved fluorescence</p></td></tr><tr><td class="NLM_term">LiHMDS</td><td class="NLM_def"><p class="first last">lithium bis(trimethylsilyl)amide</p></td></tr><tr><td class="NLM_term">MDM2</td><td class="NLM_def"><p class="first last">murine double minute 2</p></td></tr><tr><td class="NLM_term">MsCl</td><td class="NLM_def"><p class="first last">methanesulfonyl chloride</p></td></tr><tr><td class="NLM_term">NaHMDS</td><td class="NLM_def"><p class="first last">sodium bis(trimethylsilyl)amide</p></td></tr><tr><td class="NLM_term">NMO</td><td class="NLM_def"><p class="first last"><i>N</i>-methylmorpholinine <i>N</i>-oxide</p></td></tr><tr><td class="NLM_term">q.d.</td><td class="NLM_def"><p class="first last">once a day dosing</p></td></tr><tr><td class="NLM_term">qRT-PCR</td><td class="NLM_def"><p class="first last">quantitative reverse transcription polymerase chain reaction</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of mean</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetrabutylammonium fluoride</p></td></tr><tr><td class="NLM_term">TDI</td><td class="NLM_def"><p class="first last">time dependent inhibition</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TES</td><td class="NLM_def"><p class="first last">triethylsilyl</p></td></tr><tr><td class="NLM_term">TESCl</td><td class="NLM_def"><p class="first last">triethylsilyl chloride</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10577" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10577" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">p53, the cellular gatekeeper for growth and division</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401767k&amp;key=10.1016%2FS0092-8674%2800%2981871-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401767k&amp;key=9039259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADyaK2sXhtFahtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1997&pages=323-331&author=A.+J.+Levine&title=p53%2C+the+cellular+gatekeeper+for+growth+and+division"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">p53, The cellular gatekeeper for growth and division</span></div><div class="casAuthors">Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-331</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 55 refs., of p53 transcription factor protein structure, function, and roles in cell cycle regulation, apoptosis, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou4CgTSWvZVbVg90H21EOLACvtfcHk0lgVprfczY0ZKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtFahtLg%253D&md5=bfbec429d10b9718fe9e9ea5dce9109b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981871-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981871-1%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3Dp53%252C%2520the%2520cellular%2520gatekeeper%2520for%2520growth%2520and%2520division%26jtitle%3DCell%26date%3D1997%26volume%3D88%26spage%3D323%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lane, D. P.</span><span> </span><span class="NLM_article-title">p53, guardian of the genome</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=1992&pages=15-16&author=D.+P.+Lane&title=p53%2C+guardian+of+the+genome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DD.%2BP.%26atitle%3Dp53%252C%2520guardian%2520of%2520the%2520genome%26jtitle%3DNature%26date%3D1992%26volume%3D358%26spage%3D15%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Toledo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, G. M.</span><span> </span><span class="NLM_article-title">Regulating the p53 pathway: in vitro hypotheses, in vivo veritas</span> <span class="citation_source-journal">Nat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">923</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401767k&amp;key=10.1038%2Fnrc2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Clsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=909-923&author=F.+Toledoauthor=G.+M.+Wahl&title=Regulating+the+p53+pathway%3A+in+vitro+hypotheses%2C+in+vivo+veritas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Regulating the p53 pathway: in vitro hypotheses, in vivo veritas</span></div><div class="casAuthors">Toledo, Franck; Wahl, Geoffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">909-923</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mutations in TP53, the gene that encodes the tumor suppressor p53, are found in 50% of human cancers, and increased levels of its neg. regulators MDM2 and MDM4 (also known as MDMX) down-regulate p53 function in many of the rest.  Understanding p53 regulation remains a crucial goal to design broadly applicable anticancer strategies based on this pathway.  This review of in vitro studies, human tumor data and recent mouse models shows that p53 post-translational modifications have modulatory roles, and MDM2 and MDM4 have more profound roles for regulating p53.  Importantly, MDM4 emerges as an independent target for drug development, as its inactivation is crucial for full p53 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqN3wMkB-VB7Vg90H21EOLACvtfcHk0lgPCSA9vTyK5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Clsr3E&md5=0f87a2342dd6dcd4ab3de2a0245eabd6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2012%26sid%3Dliteratum%253Aachs%26aulast%3DToledo%26aufirst%3DF.%26aulast%3DWahl%26aufirst%3DG.%2BM.%26atitle%3DRegulating%2520the%2520p53%2520pathway%253A%2520in%2520vitro%2520hypotheses%252C%2520in%2520vivo%2520veritas%26jtitle%3DNat.%2520Rev.%26date%3D2006%26spage%3D909%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Hainaut, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollstein, M.</span><span> </span><span class="NLM_article-title">p53 and human cancers: the first ten thousand mutations</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2000&pages=81-137&author=P.+Hainautauthor=M.+Hollstein&title=p53+and+human+cancers%3A+the+first+ten+thousand+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHainaut%26aufirst%3DP.%26aulast%3DHollstein%26aufirst%3DM.%26atitle%3Dp53%2520and%2520human%2520cancers%253A%2520the%2520first%2520ten%2520thousand%2520mutations%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2000%26volume%3D77%26spage%3D81%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Riedinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnel, J. M.</span><span> </span><span class="NLM_article-title">Inhibitors of MDM2 and MDMX: a structural perspective</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1075</span><span class="NLM_x">–</span> <span class="NLM_lpage">1094</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401767k&amp;key=10.4155%2Ffmc.09.75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm401767k&amp;key=21425995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVChs7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1075-1094&author=C.+Riedingerauthor=J.+M.+McDonnel&title=Inhibitors+of+MDM2+and+MDMX%3A+a+structural+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of MDM2 and MDMX: a structural perspective</span></div><div class="casAuthors">Riedinger, Christiane; McDonnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1075-1094</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  P53 is a potent tumor suppressor with a crucial role in preventing uncontrolled cell proliferation and is therefore frequently deleted or mutated in cancer.  For tumors with wild-type p53, its function can be overcome by overactive cellular antagonists, such as the ubiquitin ligase murine double minute clone 2 (MDM2).  Restoring p53 activity by inhibiting MDM2 in such cancers can eradicate tumors.  Consequently, the MDM2-p53 interaction has been extensively targeted for inhibition by small mols.  In recent years, MDM2-like protein (MDMX), another key downregulator of p53, has gained increasing importance as an addnl. target for drug development, in order to provide a complementary approach to MDM2 inhibition.  In this review, we describe how detailed structural knowledge of the MDM2-p53 interface and, more recently, of the MDMX-p53 interaction have helped advance the development of inhibitors against the two targets.  We present a summary of the functional biochem. of MDM2, MDMX and p53 as well as their interactions and examine recent progress in the development of inhibitors of MDM2 and MDMX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQfRNKqaLAzbVg90H21EOLACvtfcHk0lgPCSA9vTyK5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVChs7%252FJ&md5=4b334f634d8b7346f0b5900a95523ce1</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.75%26sid%3Dliteratum%253Aachs%26aulast%3DRiedinger%26aufirst%3DC.%26aulast%3DMcDonnel%26aufirst%3DJ.%2BM.%26atitle%3DInhibitors%2520of%2520MDM2%2520and%2520MDMX%253A%2520a%2520structural%2520perspective%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D1075%26epage%3D1094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Oliner%2C+J.+D.%3B+Kinzler%2C+K.+W.%3B+Meltzer%2C+P.+S.%3B+George%2C+D.+L.%3B+Vogelstein%2C+B.Nature+1992%2C+358%2C+80%E2%80%9383"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DMeltzer%26aufirst%3DP.%2BS.%26aulast%3DGeorge%26aufirst%3DD.%2BL.%26aulast%3DVogelstein%26aufirst%3DB.%26jtitle%3DNature%26date%3D1992%26volume%3D358%26spage%3D80%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Chene, P.</span><span> </span><span class="NLM_article-title">Inhibiting the p53-MDM2 interaction: an important target for cancer therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401767k&amp;key=10.1038%2Fnrc991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401767k&amp;key=12563309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVCru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=102-109&author=P.+Chene&title=Inhibiting+the+p53-MDM2+interaction%3A+an+important+target+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting the p53-MDM2 interaction: An important target for cancer therapy</span></div><div class="casAuthors">Chene, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">102-109</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  P53 is an attractive therapeutic target in oncol. because its tumor-suppressor activity can be stimulated to eradicate tumor cells.  Inhibiting the p53-MDM2 interaction is a promising approach for activating p53, because this assocn. is well characterized at the structural and biol. levels.  MDM2 inhibits p53 transcriptional activity, favors its nuclear export and stimulates its degrdn., so inhibiting the p53-MDM2 interaction with synthetic mols. should lead to p53-mediated cell-cycle arrest or apoptosis in p53-pos. stressed cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC1Ihu0XrL47Vg90H21EOLACvtfcHk0lgPCSA9vTyK5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVCru7k%253D&md5=a66dab38cd424a4ca6f8b349aa72fd0e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc991%26sid%3Dliteratum%253Aachs%26aulast%3DChene%26aufirst%3DP.%26atitle%3DInhibiting%2520the%2520p53-MDM2%2520interaction%253A%2520an%2520important%2520target%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D102%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">Surfing the p53 network</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401767k&amp;key=10.1038%2F35042675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401767k&amp;key=11099028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVemtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=307-310&author=B.+Vogelsteinauthor=D.+Laneauthor=A.+J.+Levine&title=Surfing+the+p53+network"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Surfing the p53 network</span></div><div class="casAuthors">Vogelstein, Bert; Lane, David; Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6810</span>),
    <span class="NLM_cas:pages">307-310</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUz4RWc7xOzrVg90H21EOLACvtfcHk0lg9hh4RI8Bd3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVemtrY%253D&md5=136728653fb9e30f8ac0c48bf7701a08</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F35042675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35042675%26sid%3Dliteratum%253Aachs%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DLane%26aufirst%3DD.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3DSurfing%2520the%2520p53%2520network%26jtitle%3DNature%2520%2528London%2529%26date%3D2000%26volume%3D408%26spage%3D307%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">MDM2 inhibits the G1 arrest and apoptosis function of the p53 tumor suppressor protein</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2445</span><span class="NLM_x">–</span> <span class="NLM_lpage">2452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401767k&amp;key=8628312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADyaK28XisFektL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=2445-2452&author=J.+Chenauthor=X.+Wuauthor=J.+Linauthor=A.+J.+Levine&title=MDM2+inhibits+the+G1+arrest+and+apoptosis+function+of+the+p53+tumor+suppressor+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein</span></div><div class="casAuthors">Chen, Jiandong; Wu, Xiangwei; Lin, Jiayuh; Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2445-52</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The mdm-2 gene encodes a 90-kDa polypeptide that binds specifically to the p53 tumor suppressor protein.  This phys. interaction results in the inhibition of the transcriptional functions of p53 (J. Chen, J. Lin, and A. J. Levine, Mol. Med. 1:142-152, 1995, and J. Mommand, G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine, Cell 69:1237-1245, 1992).  Expts. are described that demonstrate the ability of mdm-2 to abrogate both the p53-mediated cell cycle arrest and the apoptosis functions.  In addn., the results presented here suggest that mdm-2 binding to p53 and the resultant inhibition of p53 transcription functions are crit. for reversing p53-mediated cell cycle arrest.  The N-terminal half or domain of the mdm-2 protein is sufficient to regulate these biol. activities of p53, consistent with the possibility that the highly conserved central acidic region and the C-terminal putative zinc fingers of mdm-2 may encode other functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaGAP335nGprVg90H21EOLACvtfcHk0lg9hh4RI8Bd3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisFektL0%253D&md5=d0d7d755abcb42e69858df1bf4b5726a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3DMDM2%2520inhibits%2520the%2520G1%2520arrest%2520and%2520apoptosis%2520function%2520of%2520the%2520p53%2520tumor%2520suppressor%2520protein%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D2445%26epage%3D2452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Wells, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClendon, C. L.</span><span> </span><span class="NLM_article-title">Reaching for high-hanging fruit in drug discovery at protein–protein interfaces</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2007&pages=1001-1009&author=J.+A.+Wellsauthor=C.+L.+McClendon&title=Reaching+for+high-hanging+fruit+in+drug+discovery+at+protein%E2%80%93protein+interfaces"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DMcClendon%26aufirst%3DC.%2BL.%26atitle%3DReaching%2520for%2520high-hanging%2520fruit%2520in%2520drug%2520discovery%2520at%2520protein%25E2%2580%2593protein%2520interfaces%26jtitle%3DNature%26date%3D2007%26volume%3D450%26spage%3D1001%26epage%3D1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kussie, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorina, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcchal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elenbaas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">948</span><span class="NLM_x">–</span> <span class="NLM_lpage">953</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401767k&amp;key=10.1126%2Fscience.274.5289.948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401767k&amp;key=8875929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADyaK28XmslKnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=948-953&author=P.+H.+Kussieauthor=S.+Gorinaauthor=V.+Marcchalauthor=B.+Elenbaasauthor=J.+Moreauauthor=A.+J.+Levineauthor=N.+P.+Pavletich&title=Structure+of+the+MDM2+oncoprotein+bound+to+the+p53+tumor+suppressor+transactivation+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain</span></div><div class="casAuthors">Kussie, Paul H.; Gorina, Svetlana; Marechal, Vincent; Elenbaas, Brian; Moreau, Jacque; Levine, Arnold J.; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">5289</span>),
    <span class="NLM_cas:pages">948-953</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The MDM2 oncoprotein is a cellular inhibitor of the p53 tumor suppressor in that it can bind the transactivation domain of p53 and downregulate its ability to activate transcription.  In certain cancers, MDM2 amplification is a common event and contributes to the inactivation of p53.  The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic α helix.  The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the p53 α helix and, in particular, on a triad of p53 amino acids - Phe19, Trp23, and Leu26 - which insert deep into the MDM2 cleft.  These same p53 residues are also involved in transactivation, supporting the hypothesis that MDM2 inactivates p53 by concealing its transactivation domain.  The structure also suggests that the amphipathic α helix may be a common structural motif in the binding of a diverse family of transactivation factors to the TATA-binding protein-assocd. factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotkRIRDnQnX7Vg90H21EOLACvtfcHk0lhfHLsHRFHyog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmslKnt7k%253D&md5=3702422b0a761617cff1498f47f30eeb</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.274.5289.948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.274.5289.948%26sid%3Dliteratum%253Aachs%26aulast%3DKussie%26aufirst%3DP.%2BH.%26aulast%3DGorina%26aufirst%3DS.%26aulast%3DMarcchal%26aufirst%3DV.%26aulast%3DElenbaas%26aufirst%3DB.%26aulast%3DMoreau%26aufirst%3DJ.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520the%2520MDM2%2520oncoprotein%2520bound%2520to%2520the%2520p53%2520tumor%2520suppressor%2520transactivation%2520domain%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D948%26epage%3D953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Garcia-Echevarria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blommers, M. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span> </span><span class="NLM_article-title">Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3205</span><span class="NLM_x">–</span> <span class="NLM_lpage">3208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3205-3208&author=C.+Garcia-Echevarriaauthor=P.+Cheneauthor=M.+J.+J.+Blommersauthor=P.+Furet&title=Discovery+of+potent+antagonists+of+the+interaction+between+human+double+minute+2+and+tumor+suppressor+p53"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echevarria%26aufirst%3DC.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DBlommers%26aufirst%3DM.%2BJ.%2BJ.%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520potent%2520antagonists%2520of%2520the%2520interaction%2520between%2520human%2520double%2520minute%25202%2520and%2520tumor%2520suppressor%2520p53%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3205%26epage%3D3208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Arkin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. A.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of protein–protein interactions: progressing towards the dream</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=301-317&author=M.+R.+Arkinauthor=J.+A.+Wells&title=Small-molecule+inhibitors+of+protein%E2%80%93protein+interactions%3A+progressing+towards+the+dream"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520protein%25E2%2580%2593protein%2520interactions%253A%2520progressing%2520towards%2520the%2520dream%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D301%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="note"><p class="first last">For other small molecule MDM2-inhibitor scaffolds see the following. Imidazolines:</p></div><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvajal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kammlott, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotouhi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. A.</span><span> </span><span class="NLM_article-title">In vivo activation of the p53 pathway by small molecule antagonists of MDM2</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=844-848&author=L.+T.+Vassilevauthor=B.+T.+Vuauthor=B.+Gravesauthor=D.+Carvajalauthor=F.+Podlaskiauthor=Z.+Filipovicauthor=N.+Kongauthor=U.+Kammlottauthor=C.+Lukacsauthor=C.+Kleinauthor=N.+Fotouhiauthor=E.+A.+Liu&title=In+vivo+activation+of+the+p53+pathway+by+small+molecule+antagonists+of+MDM2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DVu%26aufirst%3DB.%2BT.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DCarvajal%26aufirst%3DD.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DFilipovic%26aufirst%3DZ.%26aulast%3DKong%26aufirst%3DN.%26aulast%3DKammlott%26aufirst%3DU.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DFotouhi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DE.%2BA.%26atitle%3DIn%2520vivo%2520activation%2520of%2520the%2520p53%2520pathway%2520by%2520small%2520molecule%2520antagonists%2520of%2520MDM2%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D844%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of the p53-MDM2 interaction</span> <span class="citation_source-journal">Curr. Top. Microbiol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2011&pages=151-172&author=B.+T.+Vuauthor=L.+Vassilev&title=Small-molecule+inhibitors+of+the+p53-MDM2+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DB.%2BT.%26aulast%3DVassilev%26aufirst%3DL.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520p53-MDM2%2520interaction%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2011%26volume%3D348%26spage%3D151%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> Benzodiazepinediones:</p></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Parks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattance, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasberger, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span> </span><span class="NLM_article-title">1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: discovery and SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">765</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=765-770&author=D.+J.+Parksauthor=L.+V.+LaFranceauthor=R.+R.+Calvoauthor=K.+L.+Milkiewiczauthor=V.+Guptaauthor=J.+Lattanceauthor=K.+Ramachandrenauthor=T.+E.+Carverauthor=E.+C.+Petrellaauthor=M.+D.+Cummingsauthor=D.+Maguireauthor=B.+L.+Grasbergerauthor=T.+Lu&title=1%2C4-Benzodiazepine-2%2C5-diones+as+small+molecule+antagonists+of+the+HDM2-p53+interaction%3A+discovery+and+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DCalvo%26aufirst%3DR.%2BR.%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DGupta%26aufirst%3DV.%26aulast%3DLattance%26aufirst%3DJ.%26aulast%3DRamachandren%26aufirst%3DK.%26aulast%3DCarver%26aufirst%3DT.%2BE.%26aulast%3DPetrella%26aufirst%3DE.%2BC.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DMaguire%26aufirst%3DD.%26aulast%3DGrasberger%26aufirst%3DB.%2BL.%26aulast%3DLu%26aufirst%3DT.%26atitle%3D1%252C4-Benzodiazepine-2%252C5-diones%2520as%2520small%2520molecule%2520antagonists%2520of%2520the%2520HDM2-p53%2520interaction%253A%2520discovery%2520and%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D765%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Parks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marugan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblish, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franks, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattanze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasberger, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span> </span><span class="NLM_article-title">Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein–protein interaction through structure-based drug design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3310</span><span class="NLM_x">–</span> <span class="NLM_lpage">3314</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3310-3314&author=D.+J.+Parksauthor=L.+V.+LaFranceauthor=R.+R.+Calvoauthor=K.+L.+Milkiewiczauthor=J.+L.+Maruganauthor=P.+Raboissonauthor=C.+Schubertauthor=H.+K.+Koblishauthor=S.+Zhaoauthor=C.+F.+Franksauthor=J.+Lattanzeauthor=T.+E.+Carverauthor=M.+D.+Cummingsauthor=D.+Maguireauthor=B.+L.+Grasbergerauthor=A.+C.+Maroneyauthor=T.+Lu&title=Enhanced+pharmacokinetic+properties+of+1%2C4-benzodiazepine-2%2C5-dione+antagonists+of+the+HDM2-p53+protein%E2%80%93protein+interaction+through+structure-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DCalvo%26aufirst%3DR.%2BR.%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DMarugan%26aufirst%3DJ.%2BL.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DFranks%26aufirst%3DC.%2BF.%26aulast%3DLattanze%26aufirst%3DJ.%26aulast%3DCarver%26aufirst%3DT.%2BE.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DMaguire%26aufirst%3DD.%26aulast%3DGrasberger%26aufirst%3DB.%2BL.%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DLu%26aufirst%3DT.%26atitle%3DEnhanced%2520pharmacokinetic%2520properties%2520of%25201%252C4-benzodiazepine-2%252C5-dione%2520antagonists%2520of%2520the%2520HDM2-p53%2520protein%25E2%2580%2593protein%2520interaction%2520through%2520structure-based%2520drug%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3310%26epage%3D3314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Grasberger, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblish, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattanze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franks, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bylebyl, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manthey, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantoliano, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckman, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomczuk, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molloy, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bone, R. F.</span><span> </span><span class="NLM_article-title">Discovery and co-crystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049137g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=909-912&author=B.+L.+Grasbergerauthor=T.+Luauthor=C.+Schubertauthor=D.+J.+Parksauthor=T.+E.+Carverauthor=H.+K.+Koblishauthor=M.+D.+Cummingsauthor=L.+V.+LaFranceauthor=K.+L.+Milkiewiczauthor=R.+R.+Calvoauthor=D.+Maguireauthor=J.+Lattanzeauthor=C.+F.+Franksauthor=S.+Zhaoauthor=K.+Ramachandrenauthor=G.+R.+Bylebylauthor=M.+Zhangauthor=C.+L.+Mantheyauthor=E.+C.+Petrellaauthor=M.+W.+Pantolianoauthor=I.+C.+Deckmanauthor=J.+C.+Spurlinoauthor=A.+C.+Maroneyauthor=B.+E.+Tomczukauthor=C.+J.+Molloyauthor=R.+F.+Bone&title=Discovery+and+co-crystal+structure+of+benzodiazepinedione+HDM2+antagonists+that+activate+p53+in+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=10.1021%2Fjm049137g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049137g%26sid%3Dliteratum%253Aachs%26aulast%3DGrasberger%26aufirst%3DB.%2BL.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DCarver%26aufirst%3DT.%2BE.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DCalvo%26aufirst%3DR.%2BR.%26aulast%3DMaguire%26aufirst%3DD.%26aulast%3DLattanze%26aufirst%3DJ.%26aulast%3DFranks%26aufirst%3DC.%2BF.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DRamachandren%26aufirst%3DK.%26aulast%3DBylebyl%26aufirst%3DG.%2BR.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26aulast%3DPetrella%26aufirst%3DE.%2BC.%26aulast%3DPantoliano%26aufirst%3DM.%2BW.%26aulast%3DDeckman%26aufirst%3DI.%2BC.%26aulast%3DSpurlino%26aufirst%3DJ.%2BC.%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DTomczuk%26aufirst%3DB.%2BE.%26aulast%3DMolloy%26aufirst%3DC.%2BJ.%26aulast%3DBone%26aufirst%3DR.%2BF.%26atitle%3DDiscovery%2520and%2520co-crystal%2520structure%2520of%2520benzodiazepinedione%2520HDM2%2520antagonists%2520that%2520activate%2520p53%2520in%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D909%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bista, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meireles, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camacho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holak, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domling, A.</span><span> </span><span class="NLM_article-title">1,4-Thienodiazepine-2,5-diones via MCR (I): synthesis, virtual space and p53-Mdm2 activity</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=16&amp;doi=10.1021%2Fjm401767k&amp;key=10.1111%2Fj.1747-0285.2010.00989.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=8&amp;doi=10.1021%2Fjm401767k&amp;key=20492448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptleqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2010&pages=116-129&author=Y.+Huangauthor=S.+Wolfauthor=M.+Bistaauthor=L.+Meirelesauthor=C.+Camachoauthor=T.+A.+Holakauthor=A.+Domling&title=1%2C4-Thienodiazepine-2%2C5-diones+via+MCR+%28I%29%3A+synthesis%2C+virtual+space+and+p53-Mdm2+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14fR"><div class="casContent"><span class="casTitleNuber">14f</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Thienodiazepine-2,5-diones via MCR (I): Synthesis, virtual space and p53-Mdm2 activity</span></div><div class="casAuthors">Huang, Yijun; Wolf, Siglinde; Bista, Michal; Meireles, Lidio; Camacho, Carlos; Holak, Tad A.; Domling, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">116-129</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">1,4-Thienodiazepine-2,5-diones have been synthesized via the Ugi-Deprotection-Cyclization (UDC) approach starting from Gewald 2-aminothiophenes, e.g. I, in a convergent and versatile manner.  The resulting scaffold is unprecedented, cyclic, and peptidomimetic with four points of diversity introduced from readily available starting materials.  In addn. to eighteen synthesized and characterized compds., a virtual compd. library was generated and evaluated for chem. space distribution and drug-like properties.  A small focused compd. library of 1,4-thienodiazepine-2,5-diones, e.g. II, has been screened for the activity against p53-Mdm2 interaction.  Biol. evaluations demonstrated that some compds. exhibited promising antagonistic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK0Ctp2sc40rVg90H21EOLACvtfcHk0liagMQhYlAQyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptleqs7s%253D&md5=030992e421fc773c9de45306758dcef0</span></div><a href="/servlet/linkout?suffix=cit14f&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2010.00989.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2010.00989.x%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DWolf%26aufirst%3DS.%26aulast%3DBista%26aufirst%3DM.%26aulast%3DMeireles%26aufirst%3DL.%26aulast%3DCamacho%26aufirst%3DC.%26aulast%3DHolak%26aufirst%3DT.%2BA.%26aulast%3DDomling%26aufirst%3DA.%26atitle%3D1%252C4-Thienodiazepine-2%252C5-diones%2520via%2520MCR%2520%2528I%2529%253A%2520synthesis%252C%2520virtual%2520space%2520and%2520p53-Mdm2%2520activity%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2010%26volume%3D76%26spage%3D116%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">Spiro-oxoindoles:</p></div><div class="NLM_citation" id="cit14g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3432</span><span class="NLM_x">–</span> <span class="NLM_lpage">3435</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051122a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14g&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFKksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3432-3435&author=K.+Dingauthor=Y.+Luauthor=Z.+Nikolovska-Coleskaauthor=G.+Wangauthor=S.+Qiuauthor=S.+Shangaryauthor=W.+Gaoauthor=D.+Qinauthor=J.+Stuckeyauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=S.+Wang&title=Structure-based+design+of+spiro-oxindoles+as+potent%2C+specific+small-molecule+inhibitors+of+the+MDM2-p53+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14gR"><div class="casContent"><span class="casTitleNuber">14g</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2-p53 Interaction</span></div><div class="casAuthors">Ding, Ke; Lu, Yipin; Nikolovska-Coleska, Zaneta; Wang, Guoping; Qiu, Su; Shangary, Sanjeev; Gao, Wei; Qin, Dongguang; Stuckey, Jeanne; Krajewski, Krzysztof; Roller, Peter P.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3432-3435</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent, specific, non-peptide small-mol. inhibitors of the MDM2-p53 interaction were successfully designed.  The most potent inhibitor (MI-63) has a Ki value of 3 nM binding to MDM2 and greater than 10,000-fold selectivity over Bcl-2/Bcl-xL proteins.  MI-63 is highly effective in activation of p53 function and in inhibition of cell growth in cancer cells with wild-type p53 status.  MI-63 has excellent specificity over cancer cells with deleted p53 and shows a minimal toxicity to normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptppiErNrFXrVg90H21EOLACvtfcHk0lgVYxht8hbdjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFKksrc%253D&md5=186a2ba028ad9b8f71107aa1c2555421</span></div><a href="/servlet/linkout?suffix=cit14g&amp;dbid=16384&amp;doi=10.1021%2Fjm051122a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051122a%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520of%2520spiro-oxindoles%2520as%2520potent%252C%2520specific%2520small-molecule%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3432%26epage%3D3435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Potent and orally active small molecule inhibitors of the MDM2-p53 interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7970</span><span class="NLM_x">–</span> <span class="NLM_lpage">7973</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901400z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7970-7973&author=S.+Yuauthor=D.+Qinauthor=S.+Shangaryauthor=J.+Chenauthor=G.+Wangauthor=K.+Dingauthor=D.+McEachernauthor=S.+Qiuauthor=Z.+Nikolovska-Coleskaauthor=R.+Millerauthor=S.+Kangauthor=D.+Yangauthor=S.+Wang&title=Potent+and+orally+active+small+molecule+inhibitors+of+the+MDM2-p53+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14h&amp;dbid=16384&amp;doi=10.1021%2Fjm901400z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901400z%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DS.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPotent%2520and%2520orally%2520active%2520small%2520molecule%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7970%26epage%3D7973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Wang, S.; Yu, S.; Sun, W.; Shangary, S. K.; Sun, D.; Zou, P.; McEachern, D.; Zhao, Y.</span><span> </span><span class="NLM_article-title">Preparation of Spiro-oxindole Derivatives as MDM2 Antagonists</span>. US2011/0112052A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Wang&author=S.+Yu&author=W.+Sun&author=S.+K.+Shangary&author=D.+Sun&author=P.+Zou&author=D.+McEachern&author=Y.+Zhao&title=Preparation+of+Spiro-oxindole+Derivatives+as+MDM2+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520Spiro-oxindole%2520Derivatives%2520as%2520MDM2%2520Antagonists%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">3-Imidazolyndole:</p></div><div class="NLM_citation" id="cit14j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chène, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachyra Valat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hergovich Lisztwan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuya, K.</span><span> </span><span class="NLM_article-title">The central valine concept provides an entry in a class of non-peptide inhibitors of the p53-MDM2 interaction</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3498&author=P.+Furetauthor=P.+Ch%C3%A8neauthor=A.+De+Poverauthor=T.+Stachyra+Valatauthor=J.+Hergovich+Lisztwanauthor=J.+Kallenauthor=K.+Masuya&title=The+central+valine+concept+provides+an+entry+in+a+class+of+non-peptide+inhibitors+of+the+p53-MDM2+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DCh%25C3%25A8ne%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DStachyra%2BValat%26aufirst%3DT.%26aulast%3DHergovich%2BLisztwan%26aufirst%3DJ.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DMasuya%26aufirst%3DK.%26atitle%3DThe%2520central%2520valine%2520concept%2520provides%2520an%2520entry%2520in%2520a%2520class%2520of%2520non-peptide%2520inhibitors%2520of%2520the%2520p53-MDM2%2520interaction%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">Information from <a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a>.</p></div><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">RG7112 (Hoffmann-La Roche).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=RG7112+%28Hoffmann-La+Roche%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">RO5503781 (Hoffmann-La Roche).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=RO5503781+%28Hoffmann-La+Roche%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">MK-8242 (Merck).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MK-8242+%28Merck%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15d"><span><span class="NLM_label">(d) </span><div class="note"><p class="first last">SAR405838 (Sanofi).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SAR405838+%28Sanofi%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15e"><span><span class="NLM_label">(e) </span><div class="note"><p class="first last">AMG 232 (Amgen).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=AMG+232+%28Amgen%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azhar Mohammed, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaik, T. B.</span><span> </span><span class="NLM_article-title">p-53-MDM2 inhibitors: patent review (2009–2010)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm401767k&amp;key=10.1517%2F13543776.2012.656593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BC38Xit1yntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=95-105&author=A.+Kamalauthor=A.+Azhar+Mohammedauthor=T.+B.+Shaik&title=p-53-MDM2+inhibitors%3A+patent+review+%282009%E2%80%932010%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">p53-Mdm2 inhibitors: patent review (2009 - 2010)</span></div><div class="casAuthors">Kamal, Ahmed; Mohammed, Ameruddin Azhar; Shaik, Thokhir B.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-105</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: p53 plays a central role in protecting the integrity of the genome.  Its activity is ubiquitously lost in cancers, either by inactivation of its protein (p53 pathway) or by mutation in the p53 gene, thereby indicating its importance in understanding cancer and as a therapeutic target.  Activated p53 is known to induce cell cycle arrest thereby leading to apoptosis and has been the subject of intensive research in the area of medicinal chem.  Efforts are in progress to synthesize a variety of scaffolds that could inhibit the p53-Mdm2 interaction by binding to Mdm2 in the region where p53 is likely to bind.  These mols. have the potential to be developed as anticancer drug candidates and have been largely explored by both academia and industry.  Interestingly, some of these mols. are in the early stage of clin. trials.Areas covered: Areas covered in this review include patents relating to p53-Mdm2 inhibitors during the time period 2009 - 2010.  The focus of the review was on small-mol. inhibitors.Expert opinion: Inducing apoptosis in cancerous cells by the activation of p53 is an area that is being actively explored.  There are strong indications that it could become a therapeutic method for the treatment of cancer.  As a result, extensive research is being performed by both academia and industry.  It is obsd. that small mols. that are present in early clin. trials are expected to be developed as potential drugs for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIGmUfa-aEL7Vg90H21EOLACvtfcHk0ljCFNKXJOWAxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xit1yntLw%253D&md5=26fe3be7f8d25e3a5e4913b306003b09</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.656593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.656593%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DAzhar%2BMohammed%26aufirst%3DA.%26aulast%3DShaik%26aufirst%3DT.%2BB.%26atitle%3Dp-53-MDM2%2520inhibitors%253A%2520patent%2520review%2520%25282009%25E2%2580%25932010%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D95%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolinsky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">To, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wovkulich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span> </span><span class="NLM_article-title">MDM2 Small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">2587</span><span class="NLM_x">–</span> <span class="NLM_lpage">2597</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=2587-2597&author=C.+Tovarauthor=B.+Gravesauthor=K.+Packmanauthor=Z.+Filipovicauthor=B.+Higginsauthor=M.+Xiaauthor=C.+Tardellauthor=R.+Garridoauthor=E.+Leeauthor=K.+Kolinskyauthor=K.-H.+Toauthor=M.+Linnauthor=F.+Podlaskiauthor=P.+Wovkulichauthor=B.+Vuauthor=L.+T.+Vassilev&title=MDM2+Small-molecule+antagonist+RG7112+activates+p53+signaling+and+regresses+human+tumors+in+preclinical+cancer+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DFilipovic%26aufirst%3DZ.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DTardell%26aufirst%3DC.%26aulast%3DGarrido%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DKolinsky%26aufirst%3DK.%26aulast%3DTo%26aufirst%3DK.-H.%26aulast%3DLinn%26aufirst%3DM.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DWovkulich%26aufirst%3DP.%26aulast%3DVu%26aufirst%3DB.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26atitle%3DMDM2%2520Small-molecule%2520antagonist%2520RG7112%2520activates%2520p53%2520signaling%2520and%2520regresses%2520human%2520tumors%2520in%2520preclinical%2520cancer%2520models%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D2587%26epage%3D2597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartkovitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span> </span><span class="NLM_article-title">Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5979</span><span class="NLM_x">–</span> <span class="NLM_lpage">5983</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400487c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5979-5983&author=Q.+Dingauthor=Z.+Zhangauthor=J.-J.+Liuauthor=N.+Jiangauthor=J.+Zhangauthor=T.+M.+Rossauthor=X.-J.+Chuauthor=D.+Bartkovitzauthor=F.+Podlaskiauthor=C.+Jansonauthor=C.+Tovarauthor=Z.+M.+Filipovicauthor=B.+Higginsauthor=K.+Glennauthor=K.+Packmanauthor=L.+T.+Vassilevauthor=B.+Graves&title=Discovery+of+RG7388%2C+a+potent+and+selective+p53-MDM2+inhibitor+in+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm400487c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400487c%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.-J.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DRoss%26aufirst%3DT.%2BM.%26aulast%3DChu%26aufirst%3DX.-J.%26aulast%3DBartkovitz%26aufirst%3DD.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DJanson%26aufirst%3DC.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DFilipovic%26aufirst%3DZ.%2BM.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DGraves%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520RG7388%252C%2520a%2520potent%2520and%2520selective%2520p53-MDM2%2520inhibitor%2520in%2520clinical%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5979%26epage%3D5983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez Lopez De Turiso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deignan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopecky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragains, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toteva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span> </span><span class="NLM_article-title">Structure-based design of novel inhibitors of the MDM2-p53 interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4936</span><span class="NLM_x">–</span> <span class="NLM_lpage">4954</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300354j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvV2ktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4936-4954&author=Y.+Rewauthor=D.+Sunauthor=F.+Gonzalez+Lopez+De+Turisoauthor=M.+D.+Bartbergerauthor=H.+P.+Beckauthor=J.+Canonauthor=A.+Chenauthor=D.+Chowauthor=J.+Deignanauthor=B.+M.+Foxauthor=D.+Gustinauthor=X.+Huangauthor=M.+Jiangauthor=X.+Jiaoauthor=L.+Jinauthor=F.+Kayserauthor=D.+J.+Kopeckyauthor=Y.+Liauthor=M.+Loauthor=A.+M.+Longauthor=K.+Michelsenauthor=J.+D.+Olinerauthor=T.+Osgoodauthor=M.+Ragainsauthor=A.+Y.+Saikiauthor=S.+Schneiderauthor=M.+Totevaauthor=P.+Yakowecauthor=X.+Yanauthor=Q.+Yeauthor=D.+Yuauthor=X.+Zhaoauthor=J.+Zhouauthor=J.+C.+Medinaauthor=S.+H.+Olson&title=Structure-based+design+of+novel+inhibitors+of+the+MDM2-p53+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Novel Inhibitors of the MDM2-p53 Interaction</span></div><div class="casAuthors">Rew, Yosup; Sun, Daqing; Gonzalez-Lopez De Turiso, Felix; Bartberger, Michael D.; Beck, Hilary P.; Canon, Jude; Chen, Ada; Chow, David; Deignan, Jeffrey; Fox, Brian M.; Gustin, Darin; Huang, Xin; Jiang, Min; Jiao, Xianyun; Jin, Lixia; Kayser, Frank; Kopecky, David J.; Li, Yihong; Lo, Mei-Chu; Long, Alexander M.; Michelsen, Klaus; Oliner, Jonathan D.; Osgood, Tao; Ragains, Mark; Saiki, Anne Y.; Schneider, Steve; Toteva, Maria; Yakowec, Peter; Yan, Xuelei; Ye, Qiuping; Yu, Dongyin; Zhao, Xiaoning; Zhou, Jing; Medina, Julio C.; Olson, Steven H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4936-4954</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based rational design led to the discovery of novel inhibitors of the MDM2-p53 protein-protein interaction.  The affinity of these compds. for MDM2 was improved through conformational control of both the piperidinone ring and the appended N-alkyl substituent.  Optimization afforded bis(chlorophenyl)piperidinylacetic acid deriv. I (AM-8553), a potent and selective MDM2 inhibitor with excellent pharmacokinetic properties and in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPKe8WW2Cuh7Vg90H21EOLACvtfcHk0ljWka91_qBwJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvV2ktbs%253D&md5=88ba0795dfab1b5e2dc1cd5977b9f335</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm300354j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300354j%26sid%3Dliteratum%253Aachs%26aulast%3DRew%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DGonzalez%2BLopez%2BDe%2BTuriso%26aufirst%3DF.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DDeignan%26aufirst%3DJ.%26aulast%3DFox%26aufirst%3DB.%2BM.%26aulast%3DGustin%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DJiao%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DKopecky%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLo%26aufirst%3DM.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DRagains%26aufirst%3DM.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DToteva%26aufirst%3DM.%26aulast%3DYakowec%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4936%26epage%3D4954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Lucas, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, E.</span><span> </span><span class="NLM_article-title">An expeditious synthesis of the MDM2-p53 inhibitor AM-8553</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">12855</span><span class="NLM_x">–</span> <span class="NLM_lpage">12860</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja305123v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpt1Cit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=12855-12860&author=B.+S.+Lucasauthor=B.+Fisherauthor=L.+R.+McGeeauthor=S.+H.+Olsonauthor=J.+C.+Medinaauthor=E.+Cheung&title=An+expeditious+synthesis+of+the+MDM2-p53+inhibitor+AM-8553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">An Expeditious Synthesis of the MDM2-p53 Inhibitor AM-8553</span></div><div class="casAuthors">Lucas, Brian S.; Fisher, Benjamin; McGee, Lawrence R.; Olson, Steven H.; Medina, Julio C.; Cheung, Eugene</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">12855-12860</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of the structurally complex MDM2/p53 inhibitor AM-8553 was impeded by the low yield of the initial synthesis.  A second generation synthesis is described that features a Noyori dynamic kinetic resoln. (DKR), a highly diastereoselective allylation, and a novel oxazoline-assisted piperidinone forming reaction to provide AM-8553 (I) in 35.6% yield and 11 steps.  Safety: significant exotherm obsd. in ketone α-arylation reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQFB669tWQ2LVg90H21EOLACvtfcHk0ljWka91_qBwJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpt1Cit7Y%253D&md5=c32444e3c74dbe8916e41011ca11930b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja305123v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja305123v%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DB.%2BS.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DCheung%26aufirst%3DE.%26atitle%3DAn%2520expeditious%2520synthesis%2520of%2520the%2520MDM2-p53%2520inhibitor%2520AM-8553%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D12855%26epage%3D12860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Sun, D.; Li, Z.; Rew, Y.; Bartberger, M. D.; Beck, H. P.; Canon, J.; Chen, A.; Chen, X.; Chow, D.; Deignan, J.; Duquette, J.; Eksterowicz, J.; Fisher, B.; Fox, B. M.; Fu, J.; Gonzalez, A. Z.; Gonzalez-Lopez De Turiso, F.; Gribble, M.; Houze, J.; Huang, X.; Jiang, M.; Jin, L.; Kayser, F.; Liu, J.; Lo, M.-C.; Long, A. M.; Lucas, B.; McGee, L. R.; McIntosh, J.; Mihalic, J.; Oliner, J. D.; Osgood, T.; Peterson, M. L.; Roveto, P.; Saiki, A. Y.; Shaffer, P.; Toteva, M.; Wang, Y.; Wang, Y. C.; Wortman, S.; Yakowec, P.; Yan, X.; Ye, Q.; Yu, D.; Yu, M.; Zhao, X.; Zhou, X.; Zhu, J.; Olson, S. H.; Medina, J. C.</span><span> </span><span class="NLM_article-title">Discovery of AMG 232, a potent, selective, and orally bioavailable inhibitor of the MDM2-p53 interaction</span>.  <span class="citation_source-journal">J. Med. Chem.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1021/jm401753e</span> . Published Online: Jan 23,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm401753e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+Sun&author=Z.+Li&author=Y.+Rew&author=M.+D.+Bartberger&author=H.+P.+Beck&author=J.+Canon&author=A.+Chen&author=X.+Chen&author=D.+Chow&author=J.+Deignan&author=J.+Duquette&author=J.+Eksterowicz&author=B.+Fisher&author=B.+M.+Fox&author=J.+Fu&author=A.+Z.+Gonzalez&author=F.+Gonzalez-Lopez+De+Turiso&author=M.+Gribble&author=J.+Houze&author=X.+Huang&author=M.+Jiang&author=L.+Jin&author=F.+Kayser&author=J.+Liu&author=M.-C.+Lo&author=A.+M.+Long&author=B.+Lucas&author=L.+R.+McGee&author=J.+McIntosh&author=J.+Mihalic&author=J.+D.+Oliner&author=T.+Osgood&author=M.+L.+Peterson&author=P.+Roveto&author=A.+Y.+Saiki&author=P.+Shaffer&author=M.+Toteva&author=Y.+Wang&author=Y.+C.+Wang&author=S.+Wortman&author=P.+Yakowec&author=X.+Yan&author=Q.+Ye&author=D.+Yu&author=M.+Yu&author=X.+Zhao&author=X.+Zhou&author=J.+Zhu&author=S.+H.+Olson&author=J.+C.+Medina&title=Discovery+of+AMG+232%2C+a+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+the+MDM2-p53+interaction&doi=10.1021%2Fjm401753e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm401753e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401753e%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520AMG%2520232%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm401753e%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">For initial efforts from our team see the following:</p></div><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Allen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbeau, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlhieter, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadwood, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaston, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matison, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichelt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span> </span><span class="NLM_article-title">Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein–protein interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7044</span><span class="NLM_x">–</span> <span class="NLM_lpage">7053</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900681h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7044-7053&author=J.+G.+Allenauthor=M.+P.+Bourbeauauthor=G.+E.+Wohlhieterauthor=M.+D.+Bartbergerauthor=K.+Michelsenauthor=R.+Hungateauthor=R.+C.+Gadwoodauthor=R.+D.+Gastonauthor=B.+Evansauthor=L.+W.+Mannauthor=M.+E.+Matisonauthor=S.+Schneiderauthor=X.+Huangauthor=D.+Yuauthor=P.+S.+Andrewsauthor=A.+Reicheltauthor=A.+M.+Longauthor=P.+Yakowecauthor=E.+Y.+Yangauthor=T.+A.+Leeauthor=J.+D.+Oliner&title=Discovery+and+optimization+of+chromenotriazolopyrimidines+as+potent+inhibitors+of+the+mouse+double+minute+2-tumor+protein+53+protein%E2%80%93protein+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm900681h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900681h%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BG.%26aulast%3DBourbeau%26aufirst%3DM.%2BP.%26aulast%3DWohlhieter%26aufirst%3DG.%2BE.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DGadwood%26aufirst%3DR.%2BC.%26aulast%3DGaston%26aufirst%3DR.%2BD.%26aulast%3DEvans%26aufirst%3DB.%26aulast%3DMann%26aufirst%3DL.%2BW.%26aulast%3DMatison%26aufirst%3DM.%2BE.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DYakowec%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DE.%2BY.%26aulast%3DLee%26aufirst%3DT.%2BA.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520chromenotriazolopyrimidines%2520as%2520potent%2520inhibitors%2520of%2520the%2520mouse%2520double%2520minute%25202-tumor%2520protein%252053%2520protein%25E2%2580%2593protein%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7044%26epage%3D7053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGraffenreid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salyers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S.</span><span> </span><span class="NLM_article-title">Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein–protein inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2752</span><span class="NLM_x">–</span> <span class="NLM_lpage">2755</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2752-2755&author=H.+P.+Beckauthor=M.+DeGraffenreidauthor=B.+Foxauthor=J.+G.+Allenauthor=Y.+Rewauthor=S.+Schneiderauthor=A.+Y.+Saikiauthor=D.+Yuauthor=J.+D.+Olinerauthor=K.+Salyersauthor=Q.+Yeauthor=S.+Olson&title=Improvement+of+the+synthesis+and+pharmacokinetic+properties+of+chromenotriazolopyrimidine+MDM2-p53+protein%E2%80%93protein+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DDeGraffenreid%26aufirst%3DM.%26aulast%3DFox%26aufirst%3DB.%26aulast%3DAllen%26aufirst%3DJ.%2BG.%26aulast%3DRew%26aufirst%3DY.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DSalyers%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DOlson%26aufirst%3DS.%26atitle%3DImprovement%2520of%2520the%2520synthesis%2520and%2520pharmacokinetic%2520properties%2520of%2520chromenotriazolopyrimidine%2520MDM2-p53%2520protein%25E2%2580%2593protein%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2752%26epage%3D2755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="note"><p class="first last">Experimental details of the in vitro biological assays can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">For a complete discussion on the effect of the C3-Me on both potency and conformation of the piperidinone analogues, see ref <a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">19</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Gonzalez-Lopez de Turiso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correll, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julian, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMinn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span> </span><span class="NLM_article-title">Rational design and binding mode of MDM2-p53 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4053</span><span class="NLM_x">–</span> <span class="NLM_lpage">4070</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400293z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4053-4070&author=F.+Gonzalez-Lopez+de+Turisoauthor=D.+Sunauthor=Y.+Rewauthor=M.+D.+Bartbergerauthor=H.+P.+Beckauthor=J.+Canonauthor=A.+Chenauthor=D.+Chowauthor=T.+L.+Correllauthor=X.+Huangauthor=L.+D.+Julianauthor=F.+Kayserauthor=M.-C.+Loauthor=A.+M.+Longauthor=D.+McMinnauthor=J.+D.+Olinerauthor=T.+Osgoodauthor=J.+P.+Powersauthor=A.+Y.+Saikiauthor=S.+Schneiderauthor=P.+Shafferauthor=S.-H.+Xiaoauthor=P.+Yakowekauthor=X.+Yanauthor=Q.+Yeauthor=D.+Yuauthor=X.+Zhaoauthor=J.+Zhouauthor=J.+C.+Medinaauthor=S.+H.+Olson&title=Rational+design+and+binding+mode+of+MDM2-p53+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm400293z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400293z%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Lopez%2Bde%2BTuriso%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DRew%26aufirst%3DY.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DCorrell%26aufirst%3DT.%2BL.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DJulian%26aufirst%3DL.%2BD.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DLo%26aufirst%3DM.-C.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DMcMinn%26aufirst%3DD.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DShaffer%26aufirst%3DP.%26aulast%3DXiao%26aufirst%3DS.-H.%26aulast%3DYakowek%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26atitle%3DRational%2520design%2520and%2520binding%2520mode%2520of%2520MDM2-p53%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4053%26epage%3D4070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">Experimental details of the human hepatocyte intrinsic clearance assay can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="note"><p class="first last">Time-dependent inhibition, % remaining of CYP3A4 over positive control, rifampin, after 30 min at 10 μM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">Experimental details of the BrdU proliferation and HCT116 p21 TaqMan assays can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">Experimental details of in vivo studies can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note"><p class="first last">Metabolites structures determined by analogy with previous results; see ref  <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">The atomic coordinates have been deposited in the Protein Data Bank under accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=40BA">40BA</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><div class="note"><p class="first last">Intermediate <b>39e</b> was synthesized through a procedure similar to that published in the following:</p></div><span class="NLM_contrib-group">Bae, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. K.</span><span> </span><span class="NLM_article-title">Preparation of cysteinol derivatives by highly regioselective ring opening of non-activated chiral aziridines by thiols</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10041</span><span class="NLM_x">–</span> <span class="NLM_lpage">10046</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=10041-10046&author=J.+H.+Baeauthor=S.-H.+Shinauthor=C.+S.+Parkauthor=W.+K.+Lee&title=Preparation+of+cysteinol+derivatives+by+highly+regioselective+ring+opening+of+non-activated+chiral+aziridines+by+thiols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBae%26aufirst%3DJ.%2BH.%26aulast%3DShin%26aufirst%3DS.-H.%26aulast%3DPark%26aufirst%3DC.%2BS.%26aulast%3DLee%26aufirst%3DW.%2BK.%26atitle%3DPreparation%2520of%2520cysteinol%2520derivatives%2520by%2520highly%2520regioselective%2520ring%2520opening%2520of%2520non-activated%2520chiral%2520aziridines%2520by%2520thiols%26jtitle%3DTetrahedron%26date%3D1999%26volume%3D55%26spage%3D10041%26epage%3D10046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Peruncheralathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henze, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, C.</span><span> </span><span class="NLM_article-title">Indium(III) chloride-catalyzed thiolysis of meso-aziridines</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6743</span><span class="NLM_x">–</span> <span class="NLM_lpage">6746</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=6743-6746&author=S.+Peruncheralathanauthor=M.+Henzeauthor=C.+Schneider&title=Indium%28III%29+chloride-catalyzed+thiolysis+of+meso-aziridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeruncheralathan%26aufirst%3DS.%26aulast%3DHenze%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DC.%26atitle%3DIndium%2528III%2529%2520chloride-catalyzed%2520thiolysis%2520of%2520meso-aziridines%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D6743%26epage%3D6746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Tsunoda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itô, S.</span><span> </span><span class="NLM_article-title">Novel reactivity of stabilized methylenetributylphosphorane: a new Mitsunobu reagent</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">5081</span><span class="NLM_x">–</span> <span class="NLM_lpage">5082</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1994&pages=5081-5082&author=T.+Tsunodaauthor=F.+Ozakiauthor=S.+It%C3%B4&title=Novel+reactivity+of+stabilized+methylenetributylphosphorane%3A+a+new+Mitsunobu+reagent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsunoda%26aufirst%3DT.%26aulast%3DOzaki%26aufirst%3DF.%26aulast%3DIt%25C3%25B4%26aufirst%3DS.%26atitle%3DNovel%2520reactivity%2520of%2520stabilized%2520methylenetributylphosphorane%253A%2520a%2520new%2520Mitsunobu%2520reagent%26jtitle%3DTetrahedron%2520Lett.%26date%3D1994%26volume%3D35%26spage%3D5081%26epage%3D5082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="note"><p class="first last">The MDMX assay is performed exactly as the MDM2 HTRF assay (in the absence of human serum) described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> with the exception that MDMX (10 μL) was dispensed to the reaction plate and incubated with the inhibitor for 20 min before p53 (20 μL, 1.25 nM) was added.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c','cit14d','cit14e','cit14f','cit14g','cit14h','cit14i','cit14j'],'ref15':['cit15a','cit15b','cit15c','cit15d','cit15e'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':[],'ref24':[],'ref25':['cit25'],'ref26':[],'ref27':[],'ref28':[],'ref29':[],'ref30':[],'ref31':[],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 41 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Taichiro Touge, Hideki Nara, Michio Kida, Kazuhiko Matsumura, <span class="NLM_string-name hlFld-ContribAuthor">Yoshihito Kayaki</span>. </span><span class="cited-content_cbyCitation_article-title">Convincing Catalytic Performance of Oxo-Tethered Ruthenium Complexes for Asymmetric Transfer Hydrogenation of Cyclic α-Halogenated Ketones through Dynamic Kinetic Resolution. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (8)
                                     , 3070-3075. <a href="https://doi.org/10.1021/acs.orglett.1c00739" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00739</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00739%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DConvincing%252BCatalytic%252BPerformance%252Bof%252BOxo-Tethered%252BRuthenium%252BComplexes%252Bfor%252BAsymmetric%252BTransfer%252BHydrogenation%252Bof%252BCyclic%252B%2525CE%2525B1-Halogenated%252BKetones%252Bthrough%252BDynamic%252BKinetic%252BResolution%26aulast%3DTouge%26aufirst%3DTaichiro%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D03032021%26date%3D29032021%26volume%3D23%26issue%3D8%26spage%3D3070%26epage%3D3075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Harikesh Kumar, Gurudayal Prajapati, Atul Dubey, Ravi Sankar Ampapathi, <span class="NLM_string-name hlFld-ContribAuthor">Pintu Kumar Mandal</span>. </span><span class="cited-content_cbyCitation_article-title">Intramolecular 6-exo-dig Post-Ugi Cyclization of N-Substituted 2-Alkynamides: Direct Access to Functionalized Morpholinone Glycoconjugates. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (23)
                                     , 9258-9262. <a href="https://doi.org/10.1021/acs.orglett.0c03486" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03486</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03486%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DIntramolecular%252B6-exo-dig%252BPost-Ugi%252BCyclization%252Bof%252BN-Substituted%252B2-Alkynamides%25253A%252BDirect%252BAccess%252Bto%252BFunctionalized%252BMorpholinone%252BGlycoconjugates%26aulast%3DKumar%26aufirst%3DHarikesh%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19102020%26date%3D17112020%26volume%3D22%26issue%3D23%26spage%3D9258%26epage%3D9262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shweta K. Gediya, Guy J. Clarkson, <span class="NLM_string-name hlFld-ContribAuthor">Martin Wills</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Transfer Hydrogenation: Dynamic Kinetic Resolution of α-Amino Ketones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (17)
                                     , 11309-11330. <a href="https://doi.org/10.1021/acs.joc.0c01438" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01438</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01438%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAsymmetric%252BTransfer%252BHydrogenation%25253A%252BDynamic%252BKinetic%252BResolution%252Bof%252B%2525CE%2525B1-Amino%252BKetones%26aulast%3DGediya%26aufirst%3DShweta%2BK.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17062020%26date%3D19082020%26date%3D07082020%26volume%3D85%26issue%3D17%26spage%3D11309%26epage%3D11330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pravin  Patil</span>, <span class="hlFld-ContribAuthor ">Rudrakshula  Madhavachary</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kurpiewska</span>, <span class="hlFld-ContribAuthor ">Justyna  Kalinowska-Tłuścik</span>, and <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>  . </span><span class="cited-content_cbyCitation_article-title">De Novo Assembly of Highly Substituted Morpholines and Piperazines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (3)
                                     , 642-645. <a href="https://doi.org/10.1021/acs.orglett.6b03807" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b03807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b03807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b03807%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDe%252BNovo%252BAssembly%252Bof%252BHighly%252BSubstituted%252BMorpholines%252Band%252BPiperazines%26aulast%3DPatil%26aufirst%3DPravin%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D21122016%26date%3D19012017%26date%3D03022017%26volume%3D19%26issue%3D3%26spage%3D642%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James A.  Bull</span>, <span class="hlFld-ContribAuthor ">Rosemary A.  Croft</span>, <span class="hlFld-ContribAuthor ">Owen A.  Davis</span>, <span class="hlFld-ContribAuthor ">Robert  Doran</span>, and <span class="hlFld-ContribAuthor ">Kate F.  Morgan</span>  . </span><span class="cited-content_cbyCitation_article-title">Oxetanes: Recent Advances in Synthesis, Reactivity, and Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (19)
                                     , 12150-12233. <a href="https://doi.org/10.1021/acs.chemrev.6b00274" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00274%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DOxetanes%25253A%252BRecent%252BAdvances%252Bin%252BSynthesis%25252C%252BReactivity%25252C%252Band%252BMedicinal%252BChemistry%26aulast%3DBull%26aufirst%3DJames%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D28042016%26date%3D15092016%26date%3D12102016%26volume%3D116%26issue%3D19%26spage%3D12150%26epage%3D12233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stéphane L.  Bogen</span>, <span class="hlFld-ContribAuthor ">Weidong  Pan</span>, <span class="hlFld-ContribAuthor ">Craig R.  Gibeau</span>, <span class="hlFld-ContribAuthor ">Brian R.  Lahue</span>, <span class="hlFld-ContribAuthor ">Yao  Ma</span>, <span class="hlFld-ContribAuthor ">Latha G.  Nair</span>, <span class="hlFld-ContribAuthor ">Elise  Seigel</span>, <span class="hlFld-ContribAuthor ">Gerald W.  Shipps, Jr.</span>, <span class="hlFld-ContribAuthor ">Yuan  Tian</span>, <span class="hlFld-ContribAuthor ">Yaolin  Wang</span>, <span class="hlFld-ContribAuthor ">Yinghui  Lin</span>, <span class="hlFld-ContribAuthor ">Ming  Liu</span>, <span class="hlFld-ContribAuthor ">Suxing  Liu</span>, <span class="hlFld-ContribAuthor ">Asra  Mirza</span>, <span class="hlFld-ContribAuthor ">Xiaoying  Wang</span>, <span class="hlFld-ContribAuthor ">Philip  Lipari</span>, <span class="hlFld-ContribAuthor ">Cynthia  Seidel-Dugan</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Hicklin</span>, <span class="hlFld-ContribAuthor ">W. Robert  Bishop</span>, <span class="hlFld-ContribAuthor ">Diane  Rindgen</span>, <span class="hlFld-ContribAuthor ">Amin  Nomeir</span>, <span class="hlFld-ContribAuthor ">Winifred  Prosise</span>, <span class="hlFld-ContribAuthor ">Paul  Reichert</span>, <span class="hlFld-ContribAuthor ">Giovanna  Scapin</span>, <span class="hlFld-ContribAuthor ">Corey  Strickland</span>, and <span class="hlFld-ContribAuthor ">Ronald J.  Doll</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (3)
                                     , 324-329. <a href="https://doi.org/10.1021/acsmedchemlett.5b00472" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00472%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BNovel%252B3%25252C3-Disubstituted%252BPiperidines%252Bas%252BOrally%252BBioavailable%25252C%252BPotent%25252C%252Band%252BEfficacious%252BHDM2-p53%252BInhibitors%26aulast%3DBogen%26aufirst%3DSt%25C3%25A9phane%2BL.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D08122015%26date%3D20012016%26date%3D25012016%26date%3D10032016%26date%3D20012016%26volume%3D7%26issue%3D3%26spage%3D324%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujun  Zhao</span>, <span class="hlFld-ContribAuthor ">Angelo  Aguilar</span>, <span class="hlFld-ContribAuthor ">Denzil  Bernard</span>, and <span class="hlFld-ContribAuthor ">Shaomeng  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors of the MDM2–p53 Protein–Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (3)
                                     , 1038-1052. <a href="https://doi.org/10.1021/jm501092z" title="DOI URL">https://doi.org/10.1021/jm501092z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501092z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501092z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BInhibitors%252Bof%252Bthe%252BMDM2%2525E2%252580%252593p53%252BProtein%2525E2%252580%252593Protein%252BInteraction%252B%252528MDM2%252BInhibitors%252529%252Bin%252BClinical%252BTrials%252Bfor%252BCancer%252BTreatment%26aulast%3DZhao%26aufirst%3DYujun%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D18072014%26date%3D14112014%26date%3D12022015%26volume%3D58%26issue%3D3%26spage%3D1038%26epage%3D1052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tzu-Chi  Chen</span>, <span class="hlFld-ContribAuthor ">Kuan-Ting  Lin</span>, <span class="hlFld-ContribAuthor ">Chun-Houh  Chen</span>, <span class="hlFld-ContribAuthor ">Sheng-An  Lee</span>, <span class="hlFld-ContribAuthor ">Pei-Ying  Lee</span>, <span class="hlFld-ContribAuthor ">Yu-Wen  Liu</span>, <span class="hlFld-ContribAuthor ">Yu-Lun  Kuo</span>, <span class="hlFld-ContribAuthor ">Feng-Sheng  Wang</span>, <span class="hlFld-ContribAuthor ">Jin-Mei  Lai</span>, and <span class="hlFld-ContribAuthor ">Chi-Ying F.  Huang</span>  . </span><span class="cited-content_cbyCitation_article-title">Using an in Situ Proximity Ligation Assay to Systematically Profile Endogenous Protein–Protein Interactions in a Pathway Network. </span><span class="cited-content_cbyCitation_journal-name">Journal of Proteome Research</span><span> <strong>2014,</strong> <em>13 </em>
                                    (12)
                                     , 5339-5346. <a href="https://doi.org/10.1021/pr5002737" title="DOI URL">https://doi.org/10.1021/pr5002737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/pr5002737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fpr5002737%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Proteome%2520Research%26atitle%3DUsing%252Ban%252Bin%252BSitu%252BProximity%252BLigation%252BAssay%252Bto%252BSystematically%252BProfile%252BEndogenous%252BProtein%2525E2%252580%252593Protein%252BInteractions%252Bin%252Ba%252BPathway%252BNetwork%26aulast%3DChen%26aufirst%3DTzu-Chi%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D17012013%26date%3D09102014%26date%3D05122014%26date%3D22092014%26volume%3D13%26issue%3D12%26spage%3D5339%26epage%3D5346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prosper Obed  Chukwuemeka</span>, <span class="hlFld-ContribAuthor ">Haruna Isiyaku  Umar</span>, <span class="hlFld-ContribAuthor ">Opeyemi  Iwaloye</span>, <span class="hlFld-ContribAuthor ">Oluwaseyi Matthew  Oretade</span>, <span class="hlFld-ContribAuthor ">Christopher Busayo  Olowosoke</span>, <span class="hlFld-ContribAuthor ">Michael Omoniyi  Elabiyi</span>, <span class="hlFld-ContribAuthor ">Festus Omotere  Igbe</span>, <span class="hlFld-ContribAuthor ">Oyeyemi Janet  Oretade</span>, <span class="hlFld-ContribAuthor ">Joy Oseme  Eigbe</span>, <span class="hlFld-ContribAuthor ">Funmilayo Janet  Adeojo</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting p53-MDM2 interactions to identify small molecule inhibitors for cancer therapy: beyond “Failure to rescue”. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>4 </em>, 1-19. <a href="https://doi.org/10.1080/07391102.2021.1924267" title="DOI URL">https://doi.org/10.1080/07391102.2021.1924267</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1924267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1924267%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DTargeting%252Bp53-MDM2%252Binteractions%252Bto%252Bidentify%252Bsmall%252Bmolecule%252Binhibitors%252Bfor%252Bcancer%252Btherapy%25253A%252Bbeyond%252B%2525E2%252580%25259CFailure%252Bto%252Brescue%2525E2%252580%25259D%26aulast%3DChukwuemeka%26aufirst%3DProsper%2BObed%26date%3D2021%26date%3D2021%26volume%3D4%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sergio  Algar</span>, <span class="hlFld-ContribAuthor ">Mercedes  Martín-Martínez</span>, <span class="hlFld-ContribAuthor ">Rosario  González-Muñiz</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution in non-peptide α-helix mimetics on the road to effective protein-protein interaction modulators. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113015. <a href="https://doi.org/10.1016/j.ejmech.2020.113015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEvolution%252Bin%252Bnon-peptide%252B%2525CE%2525B1-helix%252Bmimetics%252Bon%252Bthe%252Broad%252Bto%252Beffective%252Bprotein-protein%252Binteraction%252Bmodulators%26aulast%3DAlgar%26aufirst%3DSergio%26date%3D2021%26volume%3D211%26spage%3D113015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaori  Fukuzawa</span>, <span class="hlFld-ContribAuthor ">Shigenori  Tanaka</span>, <span class="hlFld-ContribAuthor ">Yoichiro  Yagi</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Kurita</span>, <span class="hlFld-ContribAuthor ">Norihito  Kawashita</span>, <span class="hlFld-ContribAuthor ">Kenichiro  Takaba</span>, <span class="hlFld-ContribAuthor ">Teruki  Honma</span>. </span><span class="cited-content_cbyCitation_article-title">FMO Drug Design Consortium. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 127-181. <a href="https://doi.org/10.1007/978-981-15-9235-5_8" title="DOI URL">https://doi.org/10.1007/978-981-15-9235-5_8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-15-9235-5_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-15-9235-5_8%26sid%3Dliteratum%253Aachs%26atitle%3DFMO%252BDrug%252BDesign%252BConsortium%26aulast%3DFukuzawa%26aufirst%3DKaori%26date%3D2021%26date%3D2021%26spage%3D127%26epage%3D181%26pub%3DSpringer%2520Singapore%26atitle%3DRecent%252BAdvances%252Bof%252Bthe%252BFragment%252BMolecular%252BOrbital%252BMethod%26aulast%3DMochizuki%26aufirst%3DYuji%26date%3D2021%26volume%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam I.  Green</span>, <span class="hlFld-ContribAuthor ">Fruzsina  Hobor</span>, <span class="hlFld-ContribAuthor ">Christopher P.  Tinworth</span>, <span class="hlFld-ContribAuthor ">Stuart  Warriner</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Wilson</span>, <span class="hlFld-ContribAuthor ">Adam  Nelson</span>. </span><span class="cited-content_cbyCitation_article-title">Activity‐Directed Synthesis of Inhibitors of the p53/
              h
              DM2 Protein–Protein Interaction. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (47)
                                     , 10682-10689. <a href="https://doi.org/10.1002/chem.202002153" title="DOI URL">https://doi.org/10.1002/chem.202002153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202002153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202002153%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DActivity%2525E2%252580%252590Directed%252BSynthesis%252Bof%252BInhibitors%252Bof%252Bthe%252Bp53%25252F%252Bh%252BDM2%252BProtein%2525E2%252580%252593Protein%252BInteraction%26aulast%3DGreen%26aufirst%3DAdam%2BI.%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D47%26spage%3D10682%26epage%3D10689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eun Chae  Son</span>, <span class="hlFld-ContribAuthor ">Jiseon  Lee</span>, <span class="hlFld-ContribAuthor ">Sung-Gon  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Base-Promoted Cycloaddition of γ-Hydroxy- and δ-Hydroxy-α,β-Unsaturated Carbonyls with Azaoxyallyl Cations: Rapid Synthesis of
              N,O
              -Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (20)
                                     , 3090-3100. <a href="https://doi.org/10.1002/ejoc.202000368" title="DOI URL">https://doi.org/10.1002/ejoc.202000368</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202000368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202000368%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DBase-Promoted%252BCycloaddition%252Bof%252B%2525CE%2525B3-Hydroxy-%252Band%252B%2525CE%2525B4-Hydroxy-%2525CE%2525B1%25252C%2525CE%2525B2-Unsaturated%252BCarbonyls%252Bwith%252BAzaoxyallyl%252BCations%25253A%252BRapid%252BSynthesis%252Bof%252BN%25252CO%252B-Heterocycles%26aulast%3DSon%26aufirst%3DEun%2BChae%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D20%26spage%3D3090%26epage%3D3100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jerson L.  Silva</span>, <span class="hlFld-ContribAuthor ">Carolina G. S.  Lima</span>, <span class="hlFld-ContribAuthor ">Luciana P.  Rangel</span>, <span class="hlFld-ContribAuthor ">Giulia D. S.  Ferretti</span>, <span class="hlFld-ContribAuthor ">Fernanda P.  Pauli</span>, <span class="hlFld-ContribAuthor ">Ruan C. B.  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Thais de B.  da Silva</span>, <span class="hlFld-ContribAuthor ">Fernando C.  da Silva</span>, <span class="hlFld-ContribAuthor ">Vitor F.  Ferreira</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Synthetic Approaches towards Small Molecule Reactivators of p53. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (4)
                                     , 635. <a href="https://doi.org/10.3390/biom10040635" title="DOI URL">https://doi.org/10.3390/biom10040635</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10040635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10040635%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DRecent%252BSynthetic%252BApproaches%252Btowards%252BSmall%252BMolecule%252BReactivators%252Bof%252Bp53%26aulast%3DSilva%26aufirst%3DJerson%2BL.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D4%26spage%3D635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rafał  Rusiecki</span>, <span class="hlFld-ContribAuthor ">Jakub  Witkowski</span>, <span class="hlFld-ContribAuthor ">Joanna  Jaszczewska-Adamczak</span>. </span><span class="cited-content_cbyCitation_article-title">MDM2-p53 Interaction Inhibitors: The Current State-of-Art and Updated Patent Review (2010-Present). </span><span class="cited-content_cbyCitation_journal-name">Recent Patents on Anti-Cancer Drug Discovery</span><span> <strong>2020,</strong> <em>14 </em>
                                    (4)
                                     , 324-369. <a href="https://doi.org/10.2174/1574892814666191022163540" title="DOI URL">https://doi.org/10.2174/1574892814666191022163540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1574892814666191022163540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1574892814666191022163540%26sid%3Dliteratum%253Aachs%26jtitle%3DRecent%2520Patents%2520on%2520Anti-Cancer%2520Drug%2520Discovery%26atitle%3DMDM2-p53%252BInteraction%252BInhibitors%25253A%252BThe%252BCurrent%252BState-of-Art%252Band%252BUpdated%252BPatent%252BReview%252B%2525282010-Present%252529%26aulast%3DRusiecki%26aufirst%3DRafa%25C5%2582%26date%3D2020%26volume%3D14%26issue%3D4%26spage%3D324%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Su Kyung  Hong</span>, <span class="hlFld-ContribAuthor ">Wongi  Park</span>, <span class="hlFld-ContribAuthor ">Yong Sun  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric synthesis of 4-aryl dihydroisoquinolin-3-ones and 2-aryl morpholin-3-ones using AgOTf-activated α-bromo arylacetate. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (4)
                                     , 130841. <a href="https://doi.org/10.1016/j.tet.2019.130841" title="DOI URL">https://doi.org/10.1016/j.tet.2019.130841</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2019.130841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2019.130841%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAsymmetric%252Bsynthesis%252Bof%252B4-aryl%252Bdihydroisoquinolin-3-ones%252Band%252B2-aryl%252Bmorpholin-3-ones%252Busing%252BAgOTf-activated%252B%2525CE%2525B1-bromo%252Barylacetate%26aulast%3DHong%26aufirst%3DSu%2BKyung%26date%3D2020%26volume%3D76%26issue%3D4%26spage%3D130841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Assem  Barakat</span>, <span class="hlFld-ContribAuthor ">Mohammad Shahidul  Islam</span>, <span class="hlFld-ContribAuthor ">Hussien Mansur  Ghawas</span>, <span class="hlFld-ContribAuthor ">Abdullah Mohammed  Al-Majid</span>, <span class="hlFld-ContribAuthor ">Fardous F.  El-Senduny</span>, <span class="hlFld-ContribAuthor ">Farid A.  Badria</span>, <span class="hlFld-ContribAuthor ">Yaseen A.M.M.  Elshaier</span>, <span class="hlFld-ContribAuthor ">Hazem A.  Ghabbour</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of new substituted spirooxindoles as potential inhibitors of the MDM2–p53 interaction. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>86 </em>, 598-608. <a href="https://doi.org/10.1016/j.bioorg.2019.01.053" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.01.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.01.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.01.053%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnew%252Bsubstituted%252Bspirooxindoles%252Bas%252Bpotential%252Binhibitors%252Bof%252Bthe%252BMDM2%2525E2%252580%252593p53%252Binteraction%26aulast%3DBarakat%26aufirst%3DAssem%26date%3D2019%26volume%3D86%26spage%3D598%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lukasz  Skalniak</span>, <span class="hlFld-ContribAuthor ">Ewa  Surmiak</span>, <span class="hlFld-ContribAuthor ">Tad A.  Holak</span>. </span><span class="cited-content_cbyCitation_article-title">A therapeutic patent overview of MDM2/X-targeted therapies (2014–2018). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2019,</strong> <em>29 </em>
                                    (3)
                                     , 151-170. <a href="https://doi.org/10.1080/13543776.2019.1582645" title="DOI URL">https://doi.org/10.1080/13543776.2019.1582645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2019.1582645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2019.1582645%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Btherapeutic%252Bpatent%252Boverview%252Bof%252BMDM2%25252FX-targeted%252Btherapies%252B%2525282014%2525E2%252580%2525932018%252529%26aulast%3DSkalniak%26aufirst%3DLukasz%26date%3D2019%26date%3D2019%26volume%3D29%26issue%3D3%26spage%3D151%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad Shahidul  Islam</span>, <span class="hlFld-ContribAuthor ">Hussien Mansur  Ghawas</span>, <span class="hlFld-ContribAuthor ">Fardous F.  El-Senduny</span>, <span class="hlFld-ContribAuthor ">Abdullah Mohammed  Al-Majid</span>, <span class="hlFld-ContribAuthor ">Yaseen A.M.M.  Elshaier</span>, <span class="hlFld-ContribAuthor ">Farid A.  Badria</span>, <span class="hlFld-ContribAuthor ">Assem  Barakat</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of new thiazolo-pyrrolidine–(spirooxindole) tethered to 3-acylindole as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>82 </em>, 423-430. <a href="https://doi.org/10.1016/j.bioorg.2018.10.036" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.10.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.10.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.10.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bnew%252Bthiazolo-pyrrolidine%2525E2%252580%252593%252528spirooxindole%252529%252Btethered%252Bto%252B3-acylindole%252Bas%252Banticancer%252Bagents%26aulast%3DIslam%26aufirst%3DMohammad%2BShahidul%26date%3D2019%26volume%3D82%26spage%3D423%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gustavo  Fuertes</span>, <span class="hlFld-ContribAuthor ">Laura  Nevola</span>, <span class="hlFld-ContribAuthor ">Santiago  Esteban-Martín</span>. </span><span class="cited-content_cbyCitation_article-title">Perspectives on drug discovery strategies based on IDPs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 275-327. <a href="https://doi.org/10.1016/B978-0-12-816348-1.00009-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-816348-1.00009-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816348-1.00009-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816348-1.00009-0%26sid%3Dliteratum%253Aachs%26atitle%3DPerspectives%252Bon%252Bdrug%252Bdiscovery%252Bstrategies%252Bbased%252Bon%252BIDPs%26aulast%3DFuertes%26aufirst%3DGustavo%26date%3D2019%26spage%3D275%26epage%3D327%26pub%3DElsevier%26atitle%3DIntrinsically%252BDisordered%252BProteins%26date%3D2019%26volume%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guochao  Liao</span>, <span class="hlFld-ContribAuthor ">Deying  Yang</span>, <span class="hlFld-ContribAuthor ">Leilei  Ma</span>, <span class="hlFld-ContribAuthor ">Wenwei  Li</span>, <span class="hlFld-ContribAuthor ">Liqin  Hu</span>, <span class="hlFld-ContribAuthor ">Liming  Zeng</span>, <span class="hlFld-ContribAuthor ">Peng  Wu</span>, <span class="hlFld-ContribAuthor ">Lixin  Duan</span>, <span class="hlFld-ContribAuthor ">Zhongqiu  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">The development of piperidinones as potent MDM2-P53 protein-protein interaction inhibitors for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>159 </em>, 1-9. <a href="https://doi.org/10.1016/j.ejmech.2018.09.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdevelopment%252Bof%252Bpiperidinones%252Bas%252Bpotent%252BMDM2-P53%252Bprotein-protein%252Binteraction%252Binhibitors%252Bfor%252Bcancer%252Btherapy%26aulast%3DLiao%26aufirst%3DGuochao%26date%3D2018%26volume%3D159%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lukasz  Skalniak</span>, <span class="hlFld-ContribAuthor ">Justyna  Kocik</span>, <span class="hlFld-ContribAuthor ">Justyna  Polak</span>, <span class="hlFld-ContribAuthor ">Anna  Skalniak</span>, <span class="hlFld-ContribAuthor ">Monika  Rak</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Wolnicka-Glubisz</span>, <span class="hlFld-ContribAuthor ">Tad  Holak</span>. </span><span class="cited-content_cbyCitation_article-title">Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53-Mutated Cells. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2018,</strong> <em>10 </em>
                                    (11)
                                     , 396. <a href="https://doi.org/10.3390/cancers10110396" title="DOI URL">https://doi.org/10.3390/cancers10110396</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers10110396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers10110396%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DProlonged%252BIdasanutlin%252B%252528RG7388%252529%252BTreatment%252BLeads%252Bto%252Bthe%252BGeneration%252Bof%252Bp53-Mutated%252BCells%26aulast%3DSkalniak%26aufirst%3DLukasz%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D11%26spage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarfaraj  Niazi</span>, <span class="hlFld-ContribAuthor ">Madhusudan  Purohit</span>, <span class="hlFld-ContribAuthor ">Javed H.  Niazi</span>. </span><span class="cited-content_cbyCitation_article-title">Role of p53 circuitry in tumorigenesis: A brief review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 7-24. <a href="https://doi.org/10.1016/j.ejmech.2018.08.099" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.099%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRole%252Bof%252Bp53%252Bcircuitry%252Bin%252Btumorigenesis%25253A%252BA%252Bbrief%252Breview%26aulast%3DNiazi%26aufirst%3DSarfaraj%26date%3D2018%26volume%3D158%26spage%3D7%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mélanie  Lambert</span>, <span class="hlFld-ContribAuthor ">Samy  Jambon</span>, <span class="hlFld-ContribAuthor ">Sabine  Depauw</span>, <span class="hlFld-ContribAuthor ">Marie-Hélène  David-Cordonnier</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Transcription Factors for Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (6)
                                     , 1479. <a href="https://doi.org/10.3390/molecules23061479" title="DOI URL">https://doi.org/10.3390/molecules23061479</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23061479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23061479%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DTargeting%252BTranscription%252BFactors%252Bfor%252BCancer%252BTreatment%26aulast%3DLambert%26aufirst%3DM%25C3%25A9lanie%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D6%26spage%3D1479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mikhail  Krasavin</span>, <span class="hlFld-ContribAuthor ">Maxim A.  Gureyev</span>, <span class="hlFld-ContribAuthor ">Dmitry  Dar'in</span>, <span class="hlFld-ContribAuthor ">Olga  Bakulina</span>, <span class="hlFld-ContribAuthor ">Maria  Chizhova</span>, <span class="hlFld-ContribAuthor ">Anastasia  Lepikhina</span>, <span class="hlFld-ContribAuthor ">Daria  Novikova</span>, <span class="hlFld-ContribAuthor ">Tatyana  Grigoreva</span>, <span class="hlFld-ContribAuthor ">Gleb  Ivanov</span>, <span class="hlFld-ContribAuthor ">Aisulu  Zhumagalieva</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Garabadzhiu</span>, <span class="hlFld-ContribAuthor ">Vyacheslav G.  Tribulovich</span>. </span><span class="cited-content_cbyCitation_article-title">Design, in silico prioritization and biological profiling of apoptosis-inducing lactams amenable by the Castagnoli-Cushman reaction. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (9)
                                     , 2651-2673. <a href="https://doi.org/10.1016/j.bmc.2018.04.036" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bin%252Bsilico%252Bprioritization%252Band%252Bbiological%252Bprofiling%252Bof%252Bapoptosis-inducing%252Blactams%252Bamenable%252Bby%252Bthe%252BCastagnoli-Cushman%252Breaction%26aulast%3DKrasavin%26aufirst%3DMikhail%26date%3D2018%26volume%3D26%26issue%3D9%26spage%3D2651%26epage%3D2673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gehad  Lotfy</span>, <span class="hlFld-ContribAuthor ">El Sayed H.  El Ashry</span>, <span class="hlFld-ContribAuthor ">Mohamed M.  Said</span>, <span class="hlFld-ContribAuthor ">El Sayed  El Tamany</span>, <span class="hlFld-ContribAuthor ">Yasmine M.  Abdel Aziz</span>, <span class="hlFld-ContribAuthor ">Abdullah  Al-Dhfyan</span>, <span class="hlFld-ContribAuthor ">Abdullah M.  Al-Majid</span>, <span class="hlFld-ContribAuthor ">Assem  Barakat</span>. </span><span class="cited-content_cbyCitation_article-title">Regio- and stereoselective synthesis of new spirooxindoles via 1,3-dipolar cycloaddition reaction: Anticancer and molecular docking studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Photochemistry and Photobiology B: Biology</span><span> <strong>2018,</strong> <em>180 </em>, 98-108. <a href="https://doi.org/10.1016/j.jphotobiol.2018.01.026" title="DOI URL">https://doi.org/10.1016/j.jphotobiol.2018.01.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jphotobiol.2018.01.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jphotobiol.2018.01.026%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Photochemistry%2520and%2520Photobiology%2520B%253A%2520Biology%26atitle%3DRegio-%252Band%252Bstereoselective%252Bsynthesis%252Bof%252Bnew%252Bspirooxindoles%252Bvia%252B1%25252C3-dipolar%252Bcycloaddition%252Breaction%25253A%252BAnticancer%252Band%252Bmolecular%252Bdocking%252Bstudies%26aulast%3DLotfy%26aufirst%3DGehad%26date%3D2018%26volume%3D180%26spage%3D98%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oleksandr O.  Grygorenko</span>, <span class="hlFld-ContribAuthor ">Angelina V.  Biitseva</span>, <span class="hlFld-ContribAuthor ">Serhii  Zhersh</span>. </span><span class="cited-content_cbyCitation_article-title">Amino sulfonic acids, peptidosulfonamides and other related compounds. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (13)
                                     , 1355-1421. <a href="https://doi.org/10.1016/j.tet.2018.01.033" title="DOI URL">https://doi.org/10.1016/j.tet.2018.01.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.01.033%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAmino%252Bsulfonic%252Bacids%25252C%252Bpeptidosulfonamides%252Band%252Bother%252Brelated%252Bcompounds%26aulast%3DGrygorenko%26aufirst%3DOleksandr%2BO.%26date%3D2018%26volume%3D74%26issue%3D13%26spage%3D1355%26epage%3D1421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mi  Zhou</span>, <span class="hlFld-ContribAuthor ">Qing  Li</span>, <span class="hlFld-ContribAuthor ">Wenna  Kong</span>, <span class="hlFld-ContribAuthor ">Renxiao  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Experimental Methods Used for Identifying Small-Molecule Inhibitors of Protein-Protein Interaction. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 95-133. <a href="https://doi.org/10.1007/978-981-13-0773-7_5" title="DOI URL">https://doi.org/10.1007/978-981-13-0773-7_5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-13-0773-7_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-13-0773-7_5%26sid%3Dliteratum%253Aachs%26atitle%3DExperimental%252BMethods%252BUsed%252Bfor%252BIdentifying%252BSmall-Molecule%252BInhibitors%252Bof%252BProtein-Protein%252BInteraction%26aulast%3DZhou%26aufirst%3DMi%26date%3D2018%26date%3D2018%26spage%3D95%26epage%3D133%26pub%3DSpringer%2520Singapore%26atitle%3DTargeting%252BProtein-Protein%252BInteractions%252Bby%252BSmall%252BMolecules%26aulast%3DSheng%26aufirst%3DChunquan%26date%3D2018%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Zhou</span>, <span class="hlFld-ContribAuthor ">Shuke  Wu</span>, <span class="hlFld-ContribAuthor ">Zhi  Li</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot Enantioselective Synthesis of
              d
              -Phenylglycines from Racemic Mandelic Acids, Styrenes, or Biobased
              l
              -Phenylalanine
              via
              Cascade Biocatalysis. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2017,</strong> <em>359 </em>
                                    (24)
                                     , 4305-4316. <a href="https://doi.org/10.1002/adsc.201700956" title="DOI URL">https://doi.org/10.1002/adsc.201700956</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201700956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201700956%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DOne-Pot%252BEnantioselective%252BSynthesis%252Bof%252Bd%252B-Phenylglycines%252Bfrom%252BRacemic%252BMandelic%252BAcids%25252C%252BStyrenes%25252C%252Bor%252BBiobased%252Bl%252B-Phenylalanine%252Bvia%252BCascade%252BBiocatalysis%26aulast%3DZhou%26aufirst%3DYi%26date%3D2017%26date%3D2017%26volume%3D359%26issue%3D24%26spage%3D4305%26epage%3D4316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Nguyen</span>, <span class="hlFld-ContribAuthor ">Wenjuan  Liao</span>, <span class="hlFld-ContribAuthor ">Shelya X.  Zeng</span>, <span class="hlFld-ContribAuthor ">Hua  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Reviving the guardian of the genome: Small molecule activators of p53. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2017,</strong> <em>178 </em>, 92-108. <a href="https://doi.org/10.1016/j.pharmthera.2017.03.013" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2017.03.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2017.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2017.03.013%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DReviving%252Bthe%252Bguardian%252Bof%252Bthe%252Bgenome%25253A%252BSmall%252Bmolecule%252Bactivators%252Bof%252Bp53%26aulast%3DNguyen%26aufirst%3DDaniel%26date%3D2017%26volume%3D178%26spage%3D92%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I.R.  Hardcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Protein–Protein Interaction Inhibitors in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 154-201. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12392-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12392-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12392-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12392-3%26sid%3Dliteratum%253Aachs%26atitle%3DProtein%2525E2%252580%252593Protein%252BInteraction%252BInhibitors%252Bin%252BCancer%26aulast%3DHardcastle%26aufirst%3DI.R.%26date%3D2017%26spage%3D154%26epage%3D201%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anup Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Shikha S.  Chauhan</span>, <span class="hlFld-ContribAuthor ">Sudhir Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Ved Vrat  Verma</span>, <span class="hlFld-ContribAuthor ">Akhilesh  Singh</span>, <span class="hlFld-ContribAuthor ">Rakesh Kumar  Arya</span>, <span class="hlFld-ContribAuthor ">Shrankhla  Maheshwari</span>, <span class="hlFld-ContribAuthor ">Md. Sohail  Akhtar</span>, <span class="hlFld-ContribAuthor ">Jayanta  Sarkar</span>, <span class="hlFld-ContribAuthor ">Vivek M.  Rangnekar</span>, <span class="hlFld-ContribAuthor ">Prem M.S.  Chauhan</span>, <span class="hlFld-ContribAuthor ">Dipak  Datta</span>. </span><span class="cited-content_cbyCitation_article-title">Dual targeting of MDM2 with a novel small-molecule inhibitor overcomes TRAIL resistance in cancer. </span><span class="cited-content_cbyCitation_journal-name">Carcinogenesis</span><span> <strong>2016,</strong> <em>37 </em>
                                    (11)
                                     , 1027-1040. <a href="https://doi.org/10.1093/carcin/bgw088" title="DOI URL">https://doi.org/10.1093/carcin/bgw088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/carcin/bgw088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fcarcin%2Fbgw088%26sid%3Dliteratum%253Aachs%26jtitle%3DCarcinogenesis%26atitle%3DDual%252Btargeting%252Bof%252BMDM2%252Bwith%252Ba%252Bnovel%252Bsmall-molecule%252Binhibitor%252Bovercomes%252BTRAIL%252Bresistance%252Bin%252Bcancer%26aulast%3DSingh%26aufirst%3DAnup%2BKumar%26date%3D2016%26date%3D2016%26volume%3D37%26issue%3D11%26spage%3D1027%26epage%3D1040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agostinho  Lemos</span>, <span class="hlFld-ContribAuthor ">Mariana  Leão</span>, <span class="hlFld-ContribAuthor ">Joana  Soares</span>, <span class="hlFld-ContribAuthor ">Andreia  Palmeira</span>, <span class="hlFld-ContribAuthor ">Madalena  Pinto</span>, <span class="hlFld-ContribAuthor ">Lucília  Saraiva</span>, <span class="hlFld-ContribAuthor ">Maria Emília  Sousa</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2016,</strong> <em>36 </em>
                                    (5)
                                     , 789-844. <a href="https://doi.org/10.1002/med.21393" title="DOI URL">https://doi.org/10.1002/med.21393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21393%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMedicinal%252BChemistry%252BStrategies%252Bto%252BDisrupt%252Bthe%252Bp53-MDM2%25252FMDMX%252BInteraction%26aulast%3DLemos%26aufirst%3DAgostinho%26date%3D2016%26date%3D2016%26volume%3D36%26issue%3D5%26spage%3D789%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia  Estrada-Ortiz</span>, <span class="hlFld-ContribAuthor ">Constantinos G.  Neochoritis</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">How To Design a Successful p53-MDM2/X Interaction Inhibitor: A Thorough Overview Based on Crystal Structures. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (8)
                                     , 757-772. <a href="https://doi.org/10.1002/cmdc.201500487" title="DOI URL">https://doi.org/10.1002/cmdc.201500487</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500487%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DHow%252BTo%252BDesign%252Ba%252BSuccessful%252Bp53-MDM2%25252FX%252BInteraction%252BInhibitor%25253A%252BA%252BThorough%252BOverview%252BBased%252Bon%252BCrystal%252BStructures%26aulast%3DEstrada-Ortiz%26aufirst%3DNatalia%26date%3D2016%26date%3D2015%26volume%3D11%26issue%3D8%26spage%3D757%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Belkis  Atasever-Arslan</span>, <span class="hlFld-ContribAuthor ">Kaan  Yilancioglu</span>, <span class="hlFld-ContribAuthor ">Zeynep  Kalkan</span>, <span class="hlFld-ContribAuthor ">Ahmet Can  Timucin</span>, <span class="hlFld-ContribAuthor ">Hazal  Gür</span>, <span class="hlFld-ContribAuthor ">Fatma Busra  Isik</span>, <span class="hlFld-ContribAuthor ">Emre  Deniz</span>, <span class="hlFld-ContribAuthor ">Batu  Erman</span>, <span class="hlFld-ContribAuthor ">Selim  Cetiner</span>. </span><span class="cited-content_cbyCitation_article-title">Screening of new antileukemic agents from essential oils of algae extracts and computational modeling of their interactions with intracellular signaling nodes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2016,</strong> <em>83 </em>, 120-131. <a href="https://doi.org/10.1016/j.ejps.2015.12.001" title="DOI URL">https://doi.org/10.1016/j.ejps.2015.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2015.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2015.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DScreening%252Bof%252Bnew%252Bantileukemic%252Bagents%252Bfrom%252Bessential%252Boils%252Bof%252Balgae%252Bextracts%252Band%252Bcomputational%252Bmodeling%252Bof%252Btheir%252Binteractions%252Bwith%252Bintracellular%252Bsignaling%252Bnodes%26aulast%3DAtasever-Arslan%26aufirst%3DBelkis%26date%3D2016%26volume%3D83%26spage%3D120%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiyuan  Cheng</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Liang</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Changhong  Yi</span>, <span class="hlFld-ContribAuthor ">Hongyun  Li</span>, <span class="hlFld-ContribAuthor ">Shaolong  Zhang</span>, <span class="hlFld-ContribAuthor ">Qinggang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Insight into binding modes of p53 and inhibitors to MDM2 based on molecular dynamic simulations and principal component analysis. </span><span class="cited-content_cbyCitation_journal-name">Molecular Physics</span><span> <strong>2016,</strong> <em>114 </em>
                                    (1)
                                     , 128-140. <a href="https://doi.org/10.1080/00268976.2015.1087598" title="DOI URL">https://doi.org/10.1080/00268976.2015.1087598</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00268976.2015.1087598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00268976.2015.1087598%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Physics%26atitle%3DInsight%252Binto%252Bbinding%252Bmodes%252Bof%252Bp53%252Band%252Binhibitors%252Bto%252BMDM2%252Bbased%252Bon%252Bmolecular%252Bdynamic%252Bsimulations%252Band%252Bprincipal%252Bcomponent%252Banalysis%26aulast%3DCheng%26aufirst%3DWeiyuan%26date%3D2016%26date%3D2015%26volume%3D114%26issue%3D1%26spage%3D128%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eman M M  Abdelraheem</span>, <span class="hlFld-ContribAuthor ">Carlos J  Camacho</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">Focusing on shared subpockets – new developments in fragment-based drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2015,</strong> <em>10 </em>
                                    (11)
                                     , 1179-1187. <a href="https://doi.org/10.1517/17460441.2015.1080684" title="DOI URL">https://doi.org/10.1517/17460441.2015.1080684</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2015.1080684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2015.1080684%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DFocusing%252Bon%252Bshared%252Bsubpockets%252B%2525E2%252580%252593%252Bnew%252Bdevelopments%252Bin%252Bfragment-based%252Bdrug%252Bdiscovery%26aulast%3DAbdelraheem%26aufirst%3DEman%2BM%2BM%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D11%26spage%3D1179%26epage%3D1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George A.  Pantelopulos</span>, <span class="hlFld-ContribAuthor ">Sudipto  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Vincent A.  Voelz</span>. </span><span class="cited-content_cbyCitation_article-title">Microsecond simulations of mdm2 and its complex with p53 yield insight into force field accuracy and conformational dynamics. </span><span class="cited-content_cbyCitation_journal-name">Proteins: Structure, Function, and Bioinformatics</span><span> <strong>2015,</strong> <em>83 </em>
                                    (9)
                                     , 1665-1676. <a href="https://doi.org/10.1002/prot.24852" title="DOI URL">https://doi.org/10.1002/prot.24852</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prot.24852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprot.24852%26sid%3Dliteratum%253Aachs%26jtitle%3DProteins%253A%2520Structure%252C%2520Function%252C%2520and%2520Bioinformatics%26atitle%3DMicrosecond%252Bsimulations%252Bof%252Bmdm2%252Band%252Bits%252Bcomplex%252Bwith%252Bp53%252Byield%252Binsight%252Binto%252Bforce%252Bfield%252Baccuracy%252Band%252Bconformational%252Bdynamics%26aulast%3DPantelopulos%26aufirst%3DGeorge%2BA.%26date%3D2015%26date%3D2015%26volume%3D83%26issue%3D9%26spage%3D1665%26epage%3D1676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bian  Zhang</span>, <span class="hlFld-ContribAuthor ">Bernard T  Golding</span>, <span class="hlFld-ContribAuthor ">Ian R  Hardcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule MDM2-p53 inhibitors: recent advances. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2015,</strong> <em>7 </em>
                                    (5)
                                     , 631-645. <a href="https://doi.org/10.4155/fmc.15.13" title="DOI URL">https://doi.org/10.4155/fmc.15.13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.15.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.15.13%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSmall-molecule%252BMDM2-p53%252Binhibitors%25253A%252Brecent%252Badvances%26aulast%3DZhang%26aufirst%3DBian%26date%3D2015%26volume%3D7%26issue%3D5%26spage%3D631%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atul  Kumar</span>, <span class="hlFld-ContribAuthor ">Garima  Gupta</span>, <span class="hlFld-ContribAuthor ">Ajay Kumar  Bishnoi</span>, <span class="hlFld-ContribAuthor ">Ruchi  Saxena</span>, <span class="hlFld-ContribAuthor ">Karan Singh  Saini</span>, <span class="hlFld-ContribAuthor ">Rituraj  Konwar</span>, <span class="hlFld-ContribAuthor ">Sandeep  Kumar</span>, <span class="hlFld-ContribAuthor ">Anila  Dwivedi</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of new bioisosteres of spirooxindoles (MI-63/219) as anti-breast cancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (4)
                                     , 839-848. <a href="https://doi.org/10.1016/j.bmc.2014.12.037" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.12.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.12.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnew%252Bbioisosteres%252Bof%252Bspirooxindoles%252B%252528MI-63%25252F219%252529%252Bas%252Banti-breast%252Bcancer%252Bagents%26aulast%3DKumar%26aufirst%3DAtul%26date%3D2015%26volume%3D23%26issue%3D4%26spage%3D839%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lydia  Mata-Cantero</span>, <span class="hlFld-ContribAuthor ">Sofía  Lobato-Gil</span>, <span class="hlFld-ContribAuthor ">Fabienne  Aillet</span>, <span class="hlFld-ContribAuthor ">Valérie  Lang</span>, <span class="hlFld-ContribAuthor ">Manuel S.  Rodriguez</span>. </span><span class="cited-content_cbyCitation_article-title">The Ubiquitin-Proteasome System (UPS) as a Cancer Drug Target: Emerging Mechanisms and Therapeutics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 225-264. <a href="https://doi.org/10.1007/978-94-017-9421-3_11" title="DOI URL">https://doi.org/10.1007/978-94-017-9421-3_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-94-017-9421-3_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-94-017-9421-3_11%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BUbiquitin-Proteasome%252BSystem%252B%252528UPS%252529%252Bas%252Ba%252BCancer%252BDrug%252BTarget%25253A%252BEmerging%252BMechanisms%252Band%252BTherapeutics%26aulast%3DMata-Cantero%26aufirst%3DLydia%26date%3D2015%26date%3D2014%26spage%3D225%26epage%3D264%26pub%3DSpringer%2520Netherlands%26atitle%3DStress%252BResponse%252BPathways%252Bin%252BCancer%26aulast%3DWondrak%26aufirst%3DGeorg%2BT.%26date%3D2015%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0022.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Potent morpholinone and piperidinone inhibitors of the MDM2–p53 interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cocrystal structure of <b>3</b> bound to human MDM2 (17–111) at 1.7 Å resolution. White labels indicate positions normally occupied by key p53 residues. MDM2 residues His96 and Gly58 are labeled in yellow. The coordinates of <b>3</b> with MDM2 have been deposited in the PDB with accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OAS">4OAS</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. B3LYP/6-31G* structures and relative energies (kcal/mol) for model mono- and disubstituted piperidinone and morpholinone inhibitors of the MDM2–p53 interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. C2-Me-substituted morpholinone <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cell activity of <b>4</b> is p53 dependent. (a) In HCT116 p53<sup>wt</sup> and p53<sup>–/–</sup> cells, the percentage of BrdU positive cells was measured 16 h after compound treatment by flow cytometry. DMSO control was designated as 0% inhibition. (b) In HCT116 p53<sup>wt</sup> and p53 −/– cells, total RNA was extracted 7 h after compound treatment and p21 mRNA was measured by quantitative RT-PCR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. PD study results of <b>4</b> in SJSA-1 tumor xenograft: (∗) <i>p</i> < 0.05. Female athymic nude mice (<i>n</i> = 5/group) were implanted subcutaneously with 5 × 10<sup>6</sup> SJSA-1 cells. When tumors reached ∼175 mm<sup>3</sup>, 25 mg/kg <b>4</b> or vehicle was administered orally once daily (q.d.) for 4 days. Mice were sacrificed on day 4 at 1, 2, 4, 8, and 24 h postdose. Tumors were immediately removed and snap-frozen. p21 mRNA levels were measured by quantitative RT-PCR. Tumors treated with vehicle served as a negative control and indicated the baseline p21 mRNA level. Data are represented as mean p21 fold induction over vehicle (blue bars) + SEM of data from five mice. Concentrations in plasma were analyzed by LC/MS/MS and plotted as red dots against the right <i>y</i>-axis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. SJSA-1 cells (5 × 10<sup>6</sup>) were implanted subcutaneously into female athymic nude mice. Treatment with vehicle or <b>4</b> at 5, 25, 50, or 100 mg/kg q.d. by oral gavage began on day 9 when tumors had reached ∼200 mm<sup>3</sup> (<i>n</i> = 10/group). Tumor sizes and body weights were measured twice per week. Data are represented as mean tumor volumes, and the error bars represent SEM of data from 10 mice. No significant (>5%) body weight loss was observed in any of the groups: (∗) <i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Metabolite profiles of <b>4</b> (a) and <b>25</b> (b) from hepatocyte incubation at 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Cocrystal structure of <b>4</b> bound to human MDM2 (17–111). White labels indicate positions normally occupied by key p53 residues. MDM2 residues His96 and Gly58 are labeled in yellow. The coordinates of <b>4</b> with MDM2 have been deposited in the PDB with accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OBA">4OBA</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LiAlH<sub>4</sub>, THF, reflux, 3 h, quant; (b) Boc<sub>2</sub>O, TEA, DCM, 12 h, 73%; (c) DMP, DCM, rt, 2 h, 95%; (d) 3-chlorophenylmagnesium bromide, THF, rt, 12 h, 47%; (e) HCl/dioxane, 2 h, quant.</p></p></figure><figure data-id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) AgNO<sub>2</sub>, Et<sub>2</sub>O, 0 °C, 62%; (b) 3-chlorobenzaldehyde, pyridine, alumina, TESCl, 55 °C, 12 h; (c) Zn/HCl, 40 °C, 2 h, 20% over two steps; (d) (+)-di-<i>p</i>-toluoyl-<span class="smallcaps smallerCapital">d</span>-tartaric acid, EtOH/water, 38% (97% ee).</p></p></figure><figure data-id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TBSCl, imidazole, DCM 25 °C, 90%; (b) Yb(OTf)<sub>3,</sub> CH<sub>3</sub>CN, 6 h, 130 °C, 79–93%; (c) DEAD, PPh<sub>3</sub>, THF, 40 °C, 12 h, 69–82% (d) <i>t</i>-BuSH, InCl<sub>3</sub>, DCM, 25 °C, 12 h, 88–98%; (e) MsCl, TEA, DCM, −78 °C to rt, 12 h, 31%; (f) TBAF, THF, 15 min, 25 °C, 73–95%; (g) bromoacetic acid, NaH, THF, 25 °C, 12 h, 100% conversion; (h) HATU, DMF, DIPEA, 25 °C, 1 h, 61–90% (last two steps); (i) LiHMDS, allyl bromide, −78 °C, 1 h, 85%, 2:1 mixture of isomers; (j) NaIO<sub>4</sub>, RuCl<sub>3</sub>, CH<sub>3</sub>CN/CCl<sub>4</sub>/H<sub>2</sub>O, 32–75% combined yield for both isomers.</p></p></figure><figure data-id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) chloroacetyl chloride, TEA, 0 °C, THF, 2 h; then NaH, rt, 12 h, 86%; (b) ethyl 2-bromo-2-cyclopropylacetate, NaH, DMF, rt, 12 h, 82%; (c) NaOEt/EtOH, rt, 4 h, 57%; (d) LiEt<sub>3</sub>BH, THF, rt, 30 min, 90%; (e) <i>t</i>-BuSH, cyanomethyltributylphosphorane, toluene, 110 °C, 12 h, 43%. (f) LiHMDS, allyl bromide, −78 °C, 1 h, 85%, 2:1 mixture of isomers; (g) NaIO<sub>4</sub>, RuCl<sub>3</sub>, CH<sub>3</sub>CN/CCl<sub>4</sub>/H<sub>2</sub>O, 32–75% combined yield for both isomers.</p></p></figure><figure data-id="sch5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3,4-dimethoxybenzyl alcohol, NaH, DMF, 60 °C, 2 h, 44%; (b) 4-bromobenzenesulfonyl chloride, DMAP, DCM, rt, 78%; (c) <b>47</b>, NaO<sup>t</sup>Bu, DMF, 85 °C, 12 h, 66%; (d) DDQ, CH<sub>2</sub>Cl<sub>2</sub>/H<sub>2</sub>O, 0 °C, 2 h, 87%; (e) cyanomethyltributylphosphorane, toluene, 110 °C, 12 h, 10–85%; (f) LiHMDS, allyl bromide, −78 °C, 1 h, 85%, 2:1 mixture of isomers; (g) NaIO<sub>4</sub>, RuCl<sub>3</sub>, CH<sub>3</sub>CN/CCl<sub>4</sub>/H<sub>2</sub>O, 32–75% combined yield for both isomers.</p></p></figure><figure data-id="sch6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LHMDS, allyl bromide, −78 °C, 1 h, 85%, 2:1 mixture of isomers; (b) DDQ, CH<sub>2</sub>Cl<sub>2</sub>/H<sub>2</sub>O, 0 °C, 2 h, 87%; (c) DMP, DCM, 1 h, rt, quant; (d) MeNH<sub>2</sub>, Na(OEt)<sub>3</sub>BH, DCE, 12 h, 83%; (e) cyclopropanesulfonyl chloride, TEA, DCM, rt, 24 h, 38% (three steps); (f) NaIO<sub>4</sub>, RuCl<sub>3</sub>, CH<sub>3</sub>CN/CCl<sub>4</sub>/H<sub>2</sub>O, 65%, combined yield for both isomers.</p></p></figure><figure data-id="sch7" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/medium/jm-2013-01767k_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401767k/production/images/large/jm-2013-01767k_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401767k&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LiHMDS, MeI, −78 °C, 1 h, 85%, ∼1.5:1 mixture of isomers; (b) LiHMDS, allyl bromide, −30 °C, 12 h, 45%, ∼1.5:1 mixture of isomers; (c) NaIO<sub>4</sub>, RuCl<sub>3</sub>, CH<sub>3</sub>CN/CCl<sub>4</sub>/H<sub>2</sub>O, 49%, combined yield for both isomers.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i64">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53677" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53677" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">p53, the cellular gatekeeper for growth and division</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401767k&amp;key=10.1016%2FS0092-8674%2800%2981871-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401767k&amp;key=9039259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADyaK2sXhtFahtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1997&pages=323-331&author=A.+J.+Levine&title=p53%2C+the+cellular+gatekeeper+for+growth+and+division"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">p53, The cellular gatekeeper for growth and division</span></div><div class="casAuthors">Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-331</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 55 refs., of p53 transcription factor protein structure, function, and roles in cell cycle regulation, apoptosis, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou4CgTSWvZVbVg90H21EOLACvtfcHk0lgHNAZHkIKJZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtFahtLg%253D&md5=bfbec429d10b9718fe9e9ea5dce9109b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981871-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981871-1%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3Dp53%252C%2520the%2520cellular%2520gatekeeper%2520for%2520growth%2520and%2520division%26jtitle%3DCell%26date%3D1997%26volume%3D88%26spage%3D323%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lane, D. P.</span><span> </span><span class="NLM_article-title">p53, guardian of the genome</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=1992&pages=15-16&author=D.+P.+Lane&title=p53%2C+guardian+of+the+genome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DD.%2BP.%26atitle%3Dp53%252C%2520guardian%2520of%2520the%2520genome%26jtitle%3DNature%26date%3D1992%26volume%3D358%26spage%3D15%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Toledo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, G. M.</span><span> </span><span class="NLM_article-title">Regulating the p53 pathway: in vitro hypotheses, in vivo veritas</span> <span class="citation_source-journal">Nat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">923</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401767k&amp;key=10.1038%2Fnrc2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Clsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=909-923&author=F.+Toledoauthor=G.+M.+Wahl&title=Regulating+the+p53+pathway%3A+in+vitro+hypotheses%2C+in+vivo+veritas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Regulating the p53 pathway: in vitro hypotheses, in vivo veritas</span></div><div class="casAuthors">Toledo, Franck; Wahl, Geoffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">909-923</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mutations in TP53, the gene that encodes the tumor suppressor p53, are found in 50% of human cancers, and increased levels of its neg. regulators MDM2 and MDM4 (also known as MDMX) down-regulate p53 function in many of the rest.  Understanding p53 regulation remains a crucial goal to design broadly applicable anticancer strategies based on this pathway.  This review of in vitro studies, human tumor data and recent mouse models shows that p53 post-translational modifications have modulatory roles, and MDM2 and MDM4 have more profound roles for regulating p53.  Importantly, MDM4 emerges as an independent target for drug development, as its inactivation is crucial for full p53 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqN3wMkB-VB7Vg90H21EOLACvtfcHk0lgk8pcFUIk2zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Clsr3E&md5=0f87a2342dd6dcd4ab3de2a0245eabd6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2012%26sid%3Dliteratum%253Aachs%26aulast%3DToledo%26aufirst%3DF.%26aulast%3DWahl%26aufirst%3DG.%2BM.%26atitle%3DRegulating%2520the%2520p53%2520pathway%253A%2520in%2520vitro%2520hypotheses%252C%2520in%2520vivo%2520veritas%26jtitle%3DNat.%2520Rev.%26date%3D2006%26spage%3D909%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Hainaut, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollstein, M.</span><span> </span><span class="NLM_article-title">p53 and human cancers: the first ten thousand mutations</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2000&pages=81-137&author=P.+Hainautauthor=M.+Hollstein&title=p53+and+human+cancers%3A+the+first+ten+thousand+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHainaut%26aufirst%3DP.%26aulast%3DHollstein%26aufirst%3DM.%26atitle%3Dp53%2520and%2520human%2520cancers%253A%2520the%2520first%2520ten%2520thousand%2520mutations%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2000%26volume%3D77%26spage%3D81%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Riedinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnel, J. M.</span><span> </span><span class="NLM_article-title">Inhibitors of MDM2 and MDMX: a structural perspective</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1075</span><span class="NLM_x">–</span> <span class="NLM_lpage">1094</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401767k&amp;key=10.4155%2Ffmc.09.75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm401767k&amp;key=21425995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVChs7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1075-1094&author=C.+Riedingerauthor=J.+M.+McDonnel&title=Inhibitors+of+MDM2+and+MDMX%3A+a+structural+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of MDM2 and MDMX: a structural perspective</span></div><div class="casAuthors">Riedinger, Christiane; McDonnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1075-1094</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  P53 is a potent tumor suppressor with a crucial role in preventing uncontrolled cell proliferation and is therefore frequently deleted or mutated in cancer.  For tumors with wild-type p53, its function can be overcome by overactive cellular antagonists, such as the ubiquitin ligase murine double minute clone 2 (MDM2).  Restoring p53 activity by inhibiting MDM2 in such cancers can eradicate tumors.  Consequently, the MDM2-p53 interaction has been extensively targeted for inhibition by small mols.  In recent years, MDM2-like protein (MDMX), another key downregulator of p53, has gained increasing importance as an addnl. target for drug development, in order to provide a complementary approach to MDM2 inhibition.  In this review, we describe how detailed structural knowledge of the MDM2-p53 interface and, more recently, of the MDMX-p53 interaction have helped advance the development of inhibitors against the two targets.  We present a summary of the functional biochem. of MDM2, MDMX and p53 as well as their interactions and examine recent progress in the development of inhibitors of MDM2 and MDMX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQfRNKqaLAzbVg90H21EOLACvtfcHk0lgk8pcFUIk2zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVChs7%252FJ&md5=4b334f634d8b7346f0b5900a95523ce1</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.75%26sid%3Dliteratum%253Aachs%26aulast%3DRiedinger%26aufirst%3DC.%26aulast%3DMcDonnel%26aufirst%3DJ.%2BM.%26atitle%3DInhibitors%2520of%2520MDM2%2520and%2520MDMX%253A%2520a%2520structural%2520perspective%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D1075%26epage%3D1094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Oliner%2C+J.+D.%3B+Kinzler%2C+K.+W.%3B+Meltzer%2C+P.+S.%3B+George%2C+D.+L.%3B+Vogelstein%2C+B.Nature+1992%2C+358%2C+80%E2%80%9383"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DMeltzer%26aufirst%3DP.%2BS.%26aulast%3DGeorge%26aufirst%3DD.%2BL.%26aulast%3DVogelstein%26aufirst%3DB.%26jtitle%3DNature%26date%3D1992%26volume%3D358%26spage%3D80%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Chene, P.</span><span> </span><span class="NLM_article-title">Inhibiting the p53-MDM2 interaction: an important target for cancer therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401767k&amp;key=10.1038%2Fnrc991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401767k&amp;key=12563309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVCru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=102-109&author=P.+Chene&title=Inhibiting+the+p53-MDM2+interaction%3A+an+important+target+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting the p53-MDM2 interaction: An important target for cancer therapy</span></div><div class="casAuthors">Chene, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">102-109</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  P53 is an attractive therapeutic target in oncol. because its tumor-suppressor activity can be stimulated to eradicate tumor cells.  Inhibiting the p53-MDM2 interaction is a promising approach for activating p53, because this assocn. is well characterized at the structural and biol. levels.  MDM2 inhibits p53 transcriptional activity, favors its nuclear export and stimulates its degrdn., so inhibiting the p53-MDM2 interaction with synthetic mols. should lead to p53-mediated cell-cycle arrest or apoptosis in p53-pos. stressed cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC1Ihu0XrL47Vg90H21EOLACvtfcHk0lgk8pcFUIk2zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVCru7k%253D&md5=a66dab38cd424a4ca6f8b349aa72fd0e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc991%26sid%3Dliteratum%253Aachs%26aulast%3DChene%26aufirst%3DP.%26atitle%3DInhibiting%2520the%2520p53-MDM2%2520interaction%253A%2520an%2520important%2520target%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D102%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">Surfing the p53 network</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401767k&amp;key=10.1038%2F35042675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401767k&amp;key=11099028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVemtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=307-310&author=B.+Vogelsteinauthor=D.+Laneauthor=A.+J.+Levine&title=Surfing+the+p53+network"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Surfing the p53 network</span></div><div class="casAuthors">Vogelstein, Bert; Lane, David; Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6810</span>),
    <span class="NLM_cas:pages">307-310</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUz4RWc7xOzrVg90H21EOLACvtfcHk0li2NyE2hWLPIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVemtrY%253D&md5=136728653fb9e30f8ac0c48bf7701a08</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F35042675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35042675%26sid%3Dliteratum%253Aachs%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DLane%26aufirst%3DD.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3DSurfing%2520the%2520p53%2520network%26jtitle%3DNature%2520%2528London%2529%26date%3D2000%26volume%3D408%26spage%3D307%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">MDM2 inhibits the G1 arrest and apoptosis function of the p53 tumor suppressor protein</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2445</span><span class="NLM_x">–</span> <span class="NLM_lpage">2452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401767k&amp;key=8628312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADyaK28XisFektL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=2445-2452&author=J.+Chenauthor=X.+Wuauthor=J.+Linauthor=A.+J.+Levine&title=MDM2+inhibits+the+G1+arrest+and+apoptosis+function+of+the+p53+tumor+suppressor+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein</span></div><div class="casAuthors">Chen, Jiandong; Wu, Xiangwei; Lin, Jiayuh; Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2445-52</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The mdm-2 gene encodes a 90-kDa polypeptide that binds specifically to the p53 tumor suppressor protein.  This phys. interaction results in the inhibition of the transcriptional functions of p53 (J. Chen, J. Lin, and A. J. Levine, Mol. Med. 1:142-152, 1995, and J. Mommand, G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine, Cell 69:1237-1245, 1992).  Expts. are described that demonstrate the ability of mdm-2 to abrogate both the p53-mediated cell cycle arrest and the apoptosis functions.  In addn., the results presented here suggest that mdm-2 binding to p53 and the resultant inhibition of p53 transcription functions are crit. for reversing p53-mediated cell cycle arrest.  The N-terminal half or domain of the mdm-2 protein is sufficient to regulate these biol. activities of p53, consistent with the possibility that the highly conserved central acidic region and the C-terminal putative zinc fingers of mdm-2 may encode other functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaGAP335nGprVg90H21EOLACvtfcHk0li2NyE2hWLPIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisFektL0%253D&md5=d0d7d755abcb42e69858df1bf4b5726a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3DMDM2%2520inhibits%2520the%2520G1%2520arrest%2520and%2520apoptosis%2520function%2520of%2520the%2520p53%2520tumor%2520suppressor%2520protein%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D2445%26epage%3D2452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Wells, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClendon, C. L.</span><span> </span><span class="NLM_article-title">Reaching for high-hanging fruit in drug discovery at protein–protein interfaces</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2007&pages=1001-1009&author=J.+A.+Wellsauthor=C.+L.+McClendon&title=Reaching+for+high-hanging+fruit+in+drug+discovery+at+protein%E2%80%93protein+interfaces"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DMcClendon%26aufirst%3DC.%2BL.%26atitle%3DReaching%2520for%2520high-hanging%2520fruit%2520in%2520drug%2520discovery%2520at%2520protein%25E2%2580%2593protein%2520interfaces%26jtitle%3DNature%26date%3D2007%26volume%3D450%26spage%3D1001%26epage%3D1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kussie, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorina, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcchal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elenbaas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">948</span><span class="NLM_x">–</span> <span class="NLM_lpage">953</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401767k&amp;key=10.1126%2Fscience.274.5289.948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401767k&amp;key=8875929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADyaK28XmslKnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=948-953&author=P.+H.+Kussieauthor=S.+Gorinaauthor=V.+Marcchalauthor=B.+Elenbaasauthor=J.+Moreauauthor=A.+J.+Levineauthor=N.+P.+Pavletich&title=Structure+of+the+MDM2+oncoprotein+bound+to+the+p53+tumor+suppressor+transactivation+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain</span></div><div class="casAuthors">Kussie, Paul H.; Gorina, Svetlana; Marechal, Vincent; Elenbaas, Brian; Moreau, Jacque; Levine, Arnold J.; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">5289</span>),
    <span class="NLM_cas:pages">948-953</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The MDM2 oncoprotein is a cellular inhibitor of the p53 tumor suppressor in that it can bind the transactivation domain of p53 and downregulate its ability to activate transcription.  In certain cancers, MDM2 amplification is a common event and contributes to the inactivation of p53.  The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic α helix.  The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the p53 α helix and, in particular, on a triad of p53 amino acids - Phe19, Trp23, and Leu26 - which insert deep into the MDM2 cleft.  These same p53 residues are also involved in transactivation, supporting the hypothesis that MDM2 inactivates p53 by concealing its transactivation domain.  The structure also suggests that the amphipathic α helix may be a common structural motif in the binding of a diverse family of transactivation factors to the TATA-binding protein-assocd. factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotkRIRDnQnX7Vg90H21EOLACvtfcHk0li2NyE2hWLPIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmslKnt7k%253D&md5=3702422b0a761617cff1498f47f30eeb</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.274.5289.948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.274.5289.948%26sid%3Dliteratum%253Aachs%26aulast%3DKussie%26aufirst%3DP.%2BH.%26aulast%3DGorina%26aufirst%3DS.%26aulast%3DMarcchal%26aufirst%3DV.%26aulast%3DElenbaas%26aufirst%3DB.%26aulast%3DMoreau%26aufirst%3DJ.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520the%2520MDM2%2520oncoprotein%2520bound%2520to%2520the%2520p53%2520tumor%2520suppressor%2520transactivation%2520domain%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D948%26epage%3D953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Garcia-Echevarria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blommers, M. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span> </span><span class="NLM_article-title">Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3205</span><span class="NLM_x">–</span> <span class="NLM_lpage">3208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3205-3208&author=C.+Garcia-Echevarriaauthor=P.+Cheneauthor=M.+J.+J.+Blommersauthor=P.+Furet&title=Discovery+of+potent+antagonists+of+the+interaction+between+human+double+minute+2+and+tumor+suppressor+p53"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echevarria%26aufirst%3DC.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DBlommers%26aufirst%3DM.%2BJ.%2BJ.%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520potent%2520antagonists%2520of%2520the%2520interaction%2520between%2520human%2520double%2520minute%25202%2520and%2520tumor%2520suppressor%2520p53%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3205%26epage%3D3208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Arkin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. A.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of protein–protein interactions: progressing towards the dream</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=301-317&author=M.+R.+Arkinauthor=J.+A.+Wells&title=Small-molecule+inhibitors+of+protein%E2%80%93protein+interactions%3A+progressing+towards+the+dream"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520protein%25E2%2580%2593protein%2520interactions%253A%2520progressing%2520towards%2520the%2520dream%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D301%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="note"><p class="first last">For other small molecule MDM2-inhibitor scaffolds see the following. Imidazolines:</p></div><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvajal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kammlott, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotouhi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. A.</span><span> </span><span class="NLM_article-title">In vivo activation of the p53 pathway by small molecule antagonists of MDM2</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=844-848&author=L.+T.+Vassilevauthor=B.+T.+Vuauthor=B.+Gravesauthor=D.+Carvajalauthor=F.+Podlaskiauthor=Z.+Filipovicauthor=N.+Kongauthor=U.+Kammlottauthor=C.+Lukacsauthor=C.+Kleinauthor=N.+Fotouhiauthor=E.+A.+Liu&title=In+vivo+activation+of+the+p53+pathway+by+small+molecule+antagonists+of+MDM2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DVu%26aufirst%3DB.%2BT.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DCarvajal%26aufirst%3DD.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DFilipovic%26aufirst%3DZ.%26aulast%3DKong%26aufirst%3DN.%26aulast%3DKammlott%26aufirst%3DU.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DFotouhi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DE.%2BA.%26atitle%3DIn%2520vivo%2520activation%2520of%2520the%2520p53%2520pathway%2520by%2520small%2520molecule%2520antagonists%2520of%2520MDM2%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D844%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of the p53-MDM2 interaction</span> <span class="citation_source-journal">Curr. Top. Microbiol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2011&pages=151-172&author=B.+T.+Vuauthor=L.+Vassilev&title=Small-molecule+inhibitors+of+the+p53-MDM2+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DB.%2BT.%26aulast%3DVassilev%26aufirst%3DL.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520p53-MDM2%2520interaction%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2011%26volume%3D348%26spage%3D151%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> Benzodiazepinediones:</p></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Parks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattance, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasberger, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span> </span><span class="NLM_article-title">1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: discovery and SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">765</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=765-770&author=D.+J.+Parksauthor=L.+V.+LaFranceauthor=R.+R.+Calvoauthor=K.+L.+Milkiewiczauthor=V.+Guptaauthor=J.+Lattanceauthor=K.+Ramachandrenauthor=T.+E.+Carverauthor=E.+C.+Petrellaauthor=M.+D.+Cummingsauthor=D.+Maguireauthor=B.+L.+Grasbergerauthor=T.+Lu&title=1%2C4-Benzodiazepine-2%2C5-diones+as+small+molecule+antagonists+of+the+HDM2-p53+interaction%3A+discovery+and+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DCalvo%26aufirst%3DR.%2BR.%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DGupta%26aufirst%3DV.%26aulast%3DLattance%26aufirst%3DJ.%26aulast%3DRamachandren%26aufirst%3DK.%26aulast%3DCarver%26aufirst%3DT.%2BE.%26aulast%3DPetrella%26aufirst%3DE.%2BC.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DMaguire%26aufirst%3DD.%26aulast%3DGrasberger%26aufirst%3DB.%2BL.%26aulast%3DLu%26aufirst%3DT.%26atitle%3D1%252C4-Benzodiazepine-2%252C5-diones%2520as%2520small%2520molecule%2520antagonists%2520of%2520the%2520HDM2-p53%2520interaction%253A%2520discovery%2520and%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D765%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Parks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marugan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblish, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franks, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattanze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasberger, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span> </span><span class="NLM_article-title">Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein–protein interaction through structure-based drug design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3310</span><span class="NLM_x">–</span> <span class="NLM_lpage">3314</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3310-3314&author=D.+J.+Parksauthor=L.+V.+LaFranceauthor=R.+R.+Calvoauthor=K.+L.+Milkiewiczauthor=J.+L.+Maruganauthor=P.+Raboissonauthor=C.+Schubertauthor=H.+K.+Koblishauthor=S.+Zhaoauthor=C.+F.+Franksauthor=J.+Lattanzeauthor=T.+E.+Carverauthor=M.+D.+Cummingsauthor=D.+Maguireauthor=B.+L.+Grasbergerauthor=A.+C.+Maroneyauthor=T.+Lu&title=Enhanced+pharmacokinetic+properties+of+1%2C4-benzodiazepine-2%2C5-dione+antagonists+of+the+HDM2-p53+protein%E2%80%93protein+interaction+through+structure-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DCalvo%26aufirst%3DR.%2BR.%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DMarugan%26aufirst%3DJ.%2BL.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DFranks%26aufirst%3DC.%2BF.%26aulast%3DLattanze%26aufirst%3DJ.%26aulast%3DCarver%26aufirst%3DT.%2BE.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DMaguire%26aufirst%3DD.%26aulast%3DGrasberger%26aufirst%3DB.%2BL.%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DLu%26aufirst%3DT.%26atitle%3DEnhanced%2520pharmacokinetic%2520properties%2520of%25201%252C4-benzodiazepine-2%252C5-dione%2520antagonists%2520of%2520the%2520HDM2-p53%2520protein%25E2%2580%2593protein%2520interaction%2520through%2520structure-based%2520drug%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3310%26epage%3D3314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Grasberger, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblish, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattanze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franks, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bylebyl, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manthey, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantoliano, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckman, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomczuk, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molloy, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bone, R. F.</span><span> </span><span class="NLM_article-title">Discovery and co-crystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049137g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=909-912&author=B.+L.+Grasbergerauthor=T.+Luauthor=C.+Schubertauthor=D.+J.+Parksauthor=T.+E.+Carverauthor=H.+K.+Koblishauthor=M.+D.+Cummingsauthor=L.+V.+LaFranceauthor=K.+L.+Milkiewiczauthor=R.+R.+Calvoauthor=D.+Maguireauthor=J.+Lattanzeauthor=C.+F.+Franksauthor=S.+Zhaoauthor=K.+Ramachandrenauthor=G.+R.+Bylebylauthor=M.+Zhangauthor=C.+L.+Mantheyauthor=E.+C.+Petrellaauthor=M.+W.+Pantolianoauthor=I.+C.+Deckmanauthor=J.+C.+Spurlinoauthor=A.+C.+Maroneyauthor=B.+E.+Tomczukauthor=C.+J.+Molloyauthor=R.+F.+Bone&title=Discovery+and+co-crystal+structure+of+benzodiazepinedione+HDM2+antagonists+that+activate+p53+in+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=10.1021%2Fjm049137g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049137g%26sid%3Dliteratum%253Aachs%26aulast%3DGrasberger%26aufirst%3DB.%2BL.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DCarver%26aufirst%3DT.%2BE.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DCalvo%26aufirst%3DR.%2BR.%26aulast%3DMaguire%26aufirst%3DD.%26aulast%3DLattanze%26aufirst%3DJ.%26aulast%3DFranks%26aufirst%3DC.%2BF.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DRamachandren%26aufirst%3DK.%26aulast%3DBylebyl%26aufirst%3DG.%2BR.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26aulast%3DPetrella%26aufirst%3DE.%2BC.%26aulast%3DPantoliano%26aufirst%3DM.%2BW.%26aulast%3DDeckman%26aufirst%3DI.%2BC.%26aulast%3DSpurlino%26aufirst%3DJ.%2BC.%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DTomczuk%26aufirst%3DB.%2BE.%26aulast%3DMolloy%26aufirst%3DC.%2BJ.%26aulast%3DBone%26aufirst%3DR.%2BF.%26atitle%3DDiscovery%2520and%2520co-crystal%2520structure%2520of%2520benzodiazepinedione%2520HDM2%2520antagonists%2520that%2520activate%2520p53%2520in%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D909%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bista, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meireles, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camacho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holak, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domling, A.</span><span> </span><span class="NLM_article-title">1,4-Thienodiazepine-2,5-diones via MCR (I): synthesis, virtual space and p53-Mdm2 activity</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=16&amp;doi=10.1021%2Fjm401767k&amp;key=10.1111%2Fj.1747-0285.2010.00989.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=8&amp;doi=10.1021%2Fjm401767k&amp;key=20492448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptleqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2010&pages=116-129&author=Y.+Huangauthor=S.+Wolfauthor=M.+Bistaauthor=L.+Meirelesauthor=C.+Camachoauthor=T.+A.+Holakauthor=A.+Domling&title=1%2C4-Thienodiazepine-2%2C5-diones+via+MCR+%28I%29%3A+synthesis%2C+virtual+space+and+p53-Mdm2+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14fR"><div class="casContent"><span class="casTitleNuber">14f</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Thienodiazepine-2,5-diones via MCR (I): Synthesis, virtual space and p53-Mdm2 activity</span></div><div class="casAuthors">Huang, Yijun; Wolf, Siglinde; Bista, Michal; Meireles, Lidio; Camacho, Carlos; Holak, Tad A.; Domling, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">116-129</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">1,4-Thienodiazepine-2,5-diones have been synthesized via the Ugi-Deprotection-Cyclization (UDC) approach starting from Gewald 2-aminothiophenes, e.g. I, in a convergent and versatile manner.  The resulting scaffold is unprecedented, cyclic, and peptidomimetic with four points of diversity introduced from readily available starting materials.  In addn. to eighteen synthesized and characterized compds., a virtual compd. library was generated and evaluated for chem. space distribution and drug-like properties.  A small focused compd. library of 1,4-thienodiazepine-2,5-diones, e.g. II, has been screened for the activity against p53-Mdm2 interaction.  Biol. evaluations demonstrated that some compds. exhibited promising antagonistic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK0Ctp2sc40rVg90H21EOLACvtfcHk0ljG2HGw_zQQow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptleqs7s%253D&md5=030992e421fc773c9de45306758dcef0</span></div><a href="/servlet/linkout?suffix=cit14f&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2010.00989.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2010.00989.x%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DWolf%26aufirst%3DS.%26aulast%3DBista%26aufirst%3DM.%26aulast%3DMeireles%26aufirst%3DL.%26aulast%3DCamacho%26aufirst%3DC.%26aulast%3DHolak%26aufirst%3DT.%2BA.%26aulast%3DDomling%26aufirst%3DA.%26atitle%3D1%252C4-Thienodiazepine-2%252C5-diones%2520via%2520MCR%2520%2528I%2529%253A%2520synthesis%252C%2520virtual%2520space%2520and%2520p53-Mdm2%2520activity%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2010%26volume%3D76%26spage%3D116%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">Spiro-oxoindoles:</p></div><div class="NLM_citation" id="rightTab-cit14g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3432</span><span class="NLM_x">–</span> <span class="NLM_lpage">3435</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051122a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14g&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFKksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3432-3435&author=K.+Dingauthor=Y.+Luauthor=Z.+Nikolovska-Coleskaauthor=G.+Wangauthor=S.+Qiuauthor=S.+Shangaryauthor=W.+Gaoauthor=D.+Qinauthor=J.+Stuckeyauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=S.+Wang&title=Structure-based+design+of+spiro-oxindoles+as+potent%2C+specific+small-molecule+inhibitors+of+the+MDM2-p53+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14gR"><div class="casContent"><span class="casTitleNuber">14g</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2-p53 Interaction</span></div><div class="casAuthors">Ding, Ke; Lu, Yipin; Nikolovska-Coleska, Zaneta; Wang, Guoping; Qiu, Su; Shangary, Sanjeev; Gao, Wei; Qin, Dongguang; Stuckey, Jeanne; Krajewski, Krzysztof; Roller, Peter P.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3432-3435</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent, specific, non-peptide small-mol. inhibitors of the MDM2-p53 interaction were successfully designed.  The most potent inhibitor (MI-63) has a Ki value of 3 nM binding to MDM2 and greater than 10,000-fold selectivity over Bcl-2/Bcl-xL proteins.  MI-63 is highly effective in activation of p53 function and in inhibition of cell growth in cancer cells with wild-type p53 status.  MI-63 has excellent specificity over cancer cells with deleted p53 and shows a minimal toxicity to normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptppiErNrFXrVg90H21EOLACvtfcHk0ljG2HGw_zQQow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFKksrc%253D&md5=186a2ba028ad9b8f71107aa1c2555421</span></div><a href="/servlet/linkout?suffix=cit14g&amp;dbid=16384&amp;doi=10.1021%2Fjm051122a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051122a%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520of%2520spiro-oxindoles%2520as%2520potent%252C%2520specific%2520small-molecule%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3432%26epage%3D3435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Potent and orally active small molecule inhibitors of the MDM2-p53 interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7970</span><span class="NLM_x">–</span> <span class="NLM_lpage">7973</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901400z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7970-7973&author=S.+Yuauthor=D.+Qinauthor=S.+Shangaryauthor=J.+Chenauthor=G.+Wangauthor=K.+Dingauthor=D.+McEachernauthor=S.+Qiuauthor=Z.+Nikolovska-Coleskaauthor=R.+Millerauthor=S.+Kangauthor=D.+Yangauthor=S.+Wang&title=Potent+and+orally+active+small+molecule+inhibitors+of+the+MDM2-p53+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14h&amp;dbid=16384&amp;doi=10.1021%2Fjm901400z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901400z%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DS.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPotent%2520and%2520orally%2520active%2520small%2520molecule%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7970%26epage%3D7973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Wang, S.; Yu, S.; Sun, W.; Shangary, S. K.; Sun, D.; Zou, P.; McEachern, D.; Zhao, Y.</span><span> </span><span class="NLM_article-title">Preparation of Spiro-oxindole Derivatives as MDM2 Antagonists</span>. US2011/0112052A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Wang&author=S.+Yu&author=W.+Sun&author=S.+K.+Shangary&author=D.+Sun&author=P.+Zou&author=D.+McEachern&author=Y.+Zhao&title=Preparation+of+Spiro-oxindole+Derivatives+as+MDM2+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520Spiro-oxindole%2520Derivatives%2520as%2520MDM2%2520Antagonists%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">3-Imidazolyndole:</p></div><div class="NLM_citation" id="rightTab-cit14j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chène, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachyra Valat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hergovich Lisztwan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuya, K.</span><span> </span><span class="NLM_article-title">The central valine concept provides an entry in a class of non-peptide inhibitors of the p53-MDM2 interaction</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3498&author=P.+Furetauthor=P.+Ch%C3%A8neauthor=A.+De+Poverauthor=T.+Stachyra+Valatauthor=J.+Hergovich+Lisztwanauthor=J.+Kallenauthor=K.+Masuya&title=The+central+valine+concept+provides+an+entry+in+a+class+of+non-peptide+inhibitors+of+the+p53-MDM2+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DCh%25C3%25A8ne%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DStachyra%2BValat%26aufirst%3DT.%26aulast%3DHergovich%2BLisztwan%26aufirst%3DJ.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DMasuya%26aufirst%3DK.%26atitle%3DThe%2520central%2520valine%2520concept%2520provides%2520an%2520entry%2520in%2520a%2520class%2520of%2520non-peptide%2520inhibitors%2520of%2520the%2520p53-MDM2%2520interaction%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">Information from <a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a>.</p></div><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">RG7112 (Hoffmann-La Roche).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=RG7112+%28Hoffmann-La+Roche%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">RO5503781 (Hoffmann-La Roche).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=RO5503781+%28Hoffmann-La+Roche%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">MK-8242 (Merck).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MK-8242+%28Merck%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15d"><span><span class="NLM_label">(d) </span><div class="note"><p class="first last">SAR405838 (Sanofi).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SAR405838+%28Sanofi%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15e"><span><span class="NLM_label">(e) </span><div class="note"><p class="first last">AMG 232 (Amgen).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=AMG+232+%28Amgen%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azhar Mohammed, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaik, T. B.</span><span> </span><span class="NLM_article-title">p-53-MDM2 inhibitors: patent review (2009–2010)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm401767k&amp;key=10.1517%2F13543776.2012.656593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BC38Xit1yntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=95-105&author=A.+Kamalauthor=A.+Azhar+Mohammedauthor=T.+B.+Shaik&title=p-53-MDM2+inhibitors%3A+patent+review+%282009%E2%80%932010%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">p53-Mdm2 inhibitors: patent review (2009 - 2010)</span></div><div class="casAuthors">Kamal, Ahmed; Mohammed, Ameruddin Azhar; Shaik, Thokhir B.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-105</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: p53 plays a central role in protecting the integrity of the genome.  Its activity is ubiquitously lost in cancers, either by inactivation of its protein (p53 pathway) or by mutation in the p53 gene, thereby indicating its importance in understanding cancer and as a therapeutic target.  Activated p53 is known to induce cell cycle arrest thereby leading to apoptosis and has been the subject of intensive research in the area of medicinal chem.  Efforts are in progress to synthesize a variety of scaffolds that could inhibit the p53-Mdm2 interaction by binding to Mdm2 in the region where p53 is likely to bind.  These mols. have the potential to be developed as anticancer drug candidates and have been largely explored by both academia and industry.  Interestingly, some of these mols. are in the early stage of clin. trials.Areas covered: Areas covered in this review include patents relating to p53-Mdm2 inhibitors during the time period 2009 - 2010.  The focus of the review was on small-mol. inhibitors.Expert opinion: Inducing apoptosis in cancerous cells by the activation of p53 is an area that is being actively explored.  There are strong indications that it could become a therapeutic method for the treatment of cancer.  As a result, extensive research is being performed by both academia and industry.  It is obsd. that small mols. that are present in early clin. trials are expected to be developed as potential drugs for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIGmUfa-aEL7Vg90H21EOLACvtfcHk0lioW2iSxRy7og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xit1yntLw%253D&md5=26fe3be7f8d25e3a5e4913b306003b09</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.656593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.656593%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DAzhar%2BMohammed%26aufirst%3DA.%26aulast%3DShaik%26aufirst%3DT.%2BB.%26atitle%3Dp-53-MDM2%2520inhibitors%253A%2520patent%2520review%2520%25282009%25E2%2580%25932010%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D95%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolinsky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">To, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wovkulich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span> </span><span class="NLM_article-title">MDM2 Small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">2587</span><span class="NLM_x">–</span> <span class="NLM_lpage">2597</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=2587-2597&author=C.+Tovarauthor=B.+Gravesauthor=K.+Packmanauthor=Z.+Filipovicauthor=B.+Higginsauthor=M.+Xiaauthor=C.+Tardellauthor=R.+Garridoauthor=E.+Leeauthor=K.+Kolinskyauthor=K.-H.+Toauthor=M.+Linnauthor=F.+Podlaskiauthor=P.+Wovkulichauthor=B.+Vuauthor=L.+T.+Vassilev&title=MDM2+Small-molecule+antagonist+RG7112+activates+p53+signaling+and+regresses+human+tumors+in+preclinical+cancer+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DFilipovic%26aufirst%3DZ.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DTardell%26aufirst%3DC.%26aulast%3DGarrido%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DKolinsky%26aufirst%3DK.%26aulast%3DTo%26aufirst%3DK.-H.%26aulast%3DLinn%26aufirst%3DM.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DWovkulich%26aufirst%3DP.%26aulast%3DVu%26aufirst%3DB.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26atitle%3DMDM2%2520Small-molecule%2520antagonist%2520RG7112%2520activates%2520p53%2520signaling%2520and%2520regresses%2520human%2520tumors%2520in%2520preclinical%2520cancer%2520models%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D2587%26epage%3D2597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartkovitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span> </span><span class="NLM_article-title">Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5979</span><span class="NLM_x">–</span> <span class="NLM_lpage">5983</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400487c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5979-5983&author=Q.+Dingauthor=Z.+Zhangauthor=J.-J.+Liuauthor=N.+Jiangauthor=J.+Zhangauthor=T.+M.+Rossauthor=X.-J.+Chuauthor=D.+Bartkovitzauthor=F.+Podlaskiauthor=C.+Jansonauthor=C.+Tovarauthor=Z.+M.+Filipovicauthor=B.+Higginsauthor=K.+Glennauthor=K.+Packmanauthor=L.+T.+Vassilevauthor=B.+Graves&title=Discovery+of+RG7388%2C+a+potent+and+selective+p53-MDM2+inhibitor+in+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm400487c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400487c%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.-J.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DRoss%26aufirst%3DT.%2BM.%26aulast%3DChu%26aufirst%3DX.-J.%26aulast%3DBartkovitz%26aufirst%3DD.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DJanson%26aufirst%3DC.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DFilipovic%26aufirst%3DZ.%2BM.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DGraves%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520RG7388%252C%2520a%2520potent%2520and%2520selective%2520p53-MDM2%2520inhibitor%2520in%2520clinical%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5979%26epage%3D5983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez Lopez De Turiso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deignan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopecky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragains, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toteva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span> </span><span class="NLM_article-title">Structure-based design of novel inhibitors of the MDM2-p53 interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4936</span><span class="NLM_x">–</span> <span class="NLM_lpage">4954</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300354j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvV2ktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4936-4954&author=Y.+Rewauthor=D.+Sunauthor=F.+Gonzalez+Lopez+De+Turisoauthor=M.+D.+Bartbergerauthor=H.+P.+Beckauthor=J.+Canonauthor=A.+Chenauthor=D.+Chowauthor=J.+Deignanauthor=B.+M.+Foxauthor=D.+Gustinauthor=X.+Huangauthor=M.+Jiangauthor=X.+Jiaoauthor=L.+Jinauthor=F.+Kayserauthor=D.+J.+Kopeckyauthor=Y.+Liauthor=M.+Loauthor=A.+M.+Longauthor=K.+Michelsenauthor=J.+D.+Olinerauthor=T.+Osgoodauthor=M.+Ragainsauthor=A.+Y.+Saikiauthor=S.+Schneiderauthor=M.+Totevaauthor=P.+Yakowecauthor=X.+Yanauthor=Q.+Yeauthor=D.+Yuauthor=X.+Zhaoauthor=J.+Zhouauthor=J.+C.+Medinaauthor=S.+H.+Olson&title=Structure-based+design+of+novel+inhibitors+of+the+MDM2-p53+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Novel Inhibitors of the MDM2-p53 Interaction</span></div><div class="casAuthors">Rew, Yosup; Sun, Daqing; Gonzalez-Lopez De Turiso, Felix; Bartberger, Michael D.; Beck, Hilary P.; Canon, Jude; Chen, Ada; Chow, David; Deignan, Jeffrey; Fox, Brian M.; Gustin, Darin; Huang, Xin; Jiang, Min; Jiao, Xianyun; Jin, Lixia; Kayser, Frank; Kopecky, David J.; Li, Yihong; Lo, Mei-Chu; Long, Alexander M.; Michelsen, Klaus; Oliner, Jonathan D.; Osgood, Tao; Ragains, Mark; Saiki, Anne Y.; Schneider, Steve; Toteva, Maria; Yakowec, Peter; Yan, Xuelei; Ye, Qiuping; Yu, Dongyin; Zhao, Xiaoning; Zhou, Jing; Medina, Julio C.; Olson, Steven H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4936-4954</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based rational design led to the discovery of novel inhibitors of the MDM2-p53 protein-protein interaction.  The affinity of these compds. for MDM2 was improved through conformational control of both the piperidinone ring and the appended N-alkyl substituent.  Optimization afforded bis(chlorophenyl)piperidinylacetic acid deriv. I (AM-8553), a potent and selective MDM2 inhibitor with excellent pharmacokinetic properties and in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPKe8WW2Cuh7Vg90H21EOLACvtfcHk0liqehhrKBLxlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvV2ktbs%253D&md5=88ba0795dfab1b5e2dc1cd5977b9f335</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm300354j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300354j%26sid%3Dliteratum%253Aachs%26aulast%3DRew%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DGonzalez%2BLopez%2BDe%2BTuriso%26aufirst%3DF.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DDeignan%26aufirst%3DJ.%26aulast%3DFox%26aufirst%3DB.%2BM.%26aulast%3DGustin%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DJiao%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DKopecky%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLo%26aufirst%3DM.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DRagains%26aufirst%3DM.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DToteva%26aufirst%3DM.%26aulast%3DYakowec%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4936%26epage%3D4954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Lucas, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, E.</span><span> </span><span class="NLM_article-title">An expeditious synthesis of the MDM2-p53 inhibitor AM-8553</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">12855</span><span class="NLM_x">–</span> <span class="NLM_lpage">12860</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja305123v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401767k&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpt1Cit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=12855-12860&author=B.+S.+Lucasauthor=B.+Fisherauthor=L.+R.+McGeeauthor=S.+H.+Olsonauthor=J.+C.+Medinaauthor=E.+Cheung&title=An+expeditious+synthesis+of+the+MDM2-p53+inhibitor+AM-8553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">An Expeditious Synthesis of the MDM2-p53 Inhibitor AM-8553</span></div><div class="casAuthors">Lucas, Brian S.; Fisher, Benjamin; McGee, Lawrence R.; Olson, Steven H.; Medina, Julio C.; Cheung, Eugene</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">12855-12860</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of the structurally complex MDM2/p53 inhibitor AM-8553 was impeded by the low yield of the initial synthesis.  A second generation synthesis is described that features a Noyori dynamic kinetic resoln. (DKR), a highly diastereoselective allylation, and a novel oxazoline-assisted piperidinone forming reaction to provide AM-8553 (I) in 35.6% yield and 11 steps.  Safety: significant exotherm obsd. in ketone α-arylation reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQFB669tWQ2LVg90H21EOLACvtfcHk0liqehhrKBLxlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpt1Cit7Y%253D&md5=c32444e3c74dbe8916e41011ca11930b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja305123v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja305123v%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DB.%2BS.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DCheung%26aufirst%3DE.%26atitle%3DAn%2520expeditious%2520synthesis%2520of%2520the%2520MDM2-p53%2520inhibitor%2520AM-8553%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D12855%26epage%3D12860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Sun, D.; Li, Z.; Rew, Y.; Bartberger, M. D.; Beck, H. P.; Canon, J.; Chen, A.; Chen, X.; Chow, D.; Deignan, J.; Duquette, J.; Eksterowicz, J.; Fisher, B.; Fox, B. M.; Fu, J.; Gonzalez, A. Z.; Gonzalez-Lopez De Turiso, F.; Gribble, M.; Houze, J.; Huang, X.; Jiang, M.; Jin, L.; Kayser, F.; Liu, J.; Lo, M.-C.; Long, A. M.; Lucas, B.; McGee, L. R.; McIntosh, J.; Mihalic, J.; Oliner, J. D.; Osgood, T.; Peterson, M. L.; Roveto, P.; Saiki, A. Y.; Shaffer, P.; Toteva, M.; Wang, Y.; Wang, Y. C.; Wortman, S.; Yakowec, P.; Yan, X.; Ye, Q.; Yu, D.; Yu, M.; Zhao, X.; Zhou, X.; Zhu, J.; Olson, S. H.; Medina, J. C.</span><span> </span><span class="NLM_article-title">Discovery of AMG 232, a potent, selective, and orally bioavailable inhibitor of the MDM2-p53 interaction</span>.  <span class="citation_source-journal">J. Med. Chem.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1021/jm401753e</span> . Published Online: Jan 23,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm401753e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+Sun&author=Z.+Li&author=Y.+Rew&author=M.+D.+Bartberger&author=H.+P.+Beck&author=J.+Canon&author=A.+Chen&author=X.+Chen&author=D.+Chow&author=J.+Deignan&author=J.+Duquette&author=J.+Eksterowicz&author=B.+Fisher&author=B.+M.+Fox&author=J.+Fu&author=A.+Z.+Gonzalez&author=F.+Gonzalez-Lopez+De+Turiso&author=M.+Gribble&author=J.+Houze&author=X.+Huang&author=M.+Jiang&author=L.+Jin&author=F.+Kayser&author=J.+Liu&author=M.-C.+Lo&author=A.+M.+Long&author=B.+Lucas&author=L.+R.+McGee&author=J.+McIntosh&author=J.+Mihalic&author=J.+D.+Oliner&author=T.+Osgood&author=M.+L.+Peterson&author=P.+Roveto&author=A.+Y.+Saiki&author=P.+Shaffer&author=M.+Toteva&author=Y.+Wang&author=Y.+C.+Wang&author=S.+Wortman&author=P.+Yakowec&author=X.+Yan&author=Q.+Ye&author=D.+Yu&author=M.+Yu&author=X.+Zhao&author=X.+Zhou&author=J.+Zhu&author=S.+H.+Olson&author=J.+C.+Medina&title=Discovery+of+AMG+232%2C+a+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+the+MDM2-p53+interaction&doi=10.1021%2Fjm401753e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm401753e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401753e%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520AMG%2520232%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm401753e%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">For initial efforts from our team see the following:</p></div><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Allen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbeau, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlhieter, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadwood, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaston, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matison, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichelt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span> </span><span class="NLM_article-title">Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein–protein interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7044</span><span class="NLM_x">–</span> <span class="NLM_lpage">7053</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900681h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7044-7053&author=J.+G.+Allenauthor=M.+P.+Bourbeauauthor=G.+E.+Wohlhieterauthor=M.+D.+Bartbergerauthor=K.+Michelsenauthor=R.+Hungateauthor=R.+C.+Gadwoodauthor=R.+D.+Gastonauthor=B.+Evansauthor=L.+W.+Mannauthor=M.+E.+Matisonauthor=S.+Schneiderauthor=X.+Huangauthor=D.+Yuauthor=P.+S.+Andrewsauthor=A.+Reicheltauthor=A.+M.+Longauthor=P.+Yakowecauthor=E.+Y.+Yangauthor=T.+A.+Leeauthor=J.+D.+Oliner&title=Discovery+and+optimization+of+chromenotriazolopyrimidines+as+potent+inhibitors+of+the+mouse+double+minute+2-tumor+protein+53+protein%E2%80%93protein+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm900681h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900681h%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BG.%26aulast%3DBourbeau%26aufirst%3DM.%2BP.%26aulast%3DWohlhieter%26aufirst%3DG.%2BE.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DGadwood%26aufirst%3DR.%2BC.%26aulast%3DGaston%26aufirst%3DR.%2BD.%26aulast%3DEvans%26aufirst%3DB.%26aulast%3DMann%26aufirst%3DL.%2BW.%26aulast%3DMatison%26aufirst%3DM.%2BE.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DYakowec%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DE.%2BY.%26aulast%3DLee%26aufirst%3DT.%2BA.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520chromenotriazolopyrimidines%2520as%2520potent%2520inhibitors%2520of%2520the%2520mouse%2520double%2520minute%25202-tumor%2520protein%252053%2520protein%25E2%2580%2593protein%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7044%26epage%3D7053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGraffenreid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salyers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S.</span><span> </span><span class="NLM_article-title">Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein–protein inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2752</span><span class="NLM_x">–</span> <span class="NLM_lpage">2755</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2752-2755&author=H.+P.+Beckauthor=M.+DeGraffenreidauthor=B.+Foxauthor=J.+G.+Allenauthor=Y.+Rewauthor=S.+Schneiderauthor=A.+Y.+Saikiauthor=D.+Yuauthor=J.+D.+Olinerauthor=K.+Salyersauthor=Q.+Yeauthor=S.+Olson&title=Improvement+of+the+synthesis+and+pharmacokinetic+properties+of+chromenotriazolopyrimidine+MDM2-p53+protein%E2%80%93protein+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DDeGraffenreid%26aufirst%3DM.%26aulast%3DFox%26aufirst%3DB.%26aulast%3DAllen%26aufirst%3DJ.%2BG.%26aulast%3DRew%26aufirst%3DY.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DSalyers%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DOlson%26aufirst%3DS.%26atitle%3DImprovement%2520of%2520the%2520synthesis%2520and%2520pharmacokinetic%2520properties%2520of%2520chromenotriazolopyrimidine%2520MDM2-p53%2520protein%25E2%2580%2593protein%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2752%26epage%3D2755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="note"><p class="first last">Experimental details of the in vitro biological assays can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">For a complete discussion on the effect of the C3-Me on both potency and conformation of the piperidinone analogues, see ref <a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">19</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Gonzalez-Lopez de Turiso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correll, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julian, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMinn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span> </span><span class="NLM_article-title">Rational design and binding mode of MDM2-p53 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4053</span><span class="NLM_x">–</span> <span class="NLM_lpage">4070</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400293z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4053-4070&author=F.+Gonzalez-Lopez+de+Turisoauthor=D.+Sunauthor=Y.+Rewauthor=M.+D.+Bartbergerauthor=H.+P.+Beckauthor=J.+Canonauthor=A.+Chenauthor=D.+Chowauthor=T.+L.+Correllauthor=X.+Huangauthor=L.+D.+Julianauthor=F.+Kayserauthor=M.-C.+Loauthor=A.+M.+Longauthor=D.+McMinnauthor=J.+D.+Olinerauthor=T.+Osgoodauthor=J.+P.+Powersauthor=A.+Y.+Saikiauthor=S.+Schneiderauthor=P.+Shafferauthor=S.-H.+Xiaoauthor=P.+Yakowekauthor=X.+Yanauthor=Q.+Yeauthor=D.+Yuauthor=X.+Zhaoauthor=J.+Zhouauthor=J.+C.+Medinaauthor=S.+H.+Olson&title=Rational+design+and+binding+mode+of+MDM2-p53+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm400293z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400293z%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Lopez%2Bde%2BTuriso%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DRew%26aufirst%3DY.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DCorrell%26aufirst%3DT.%2BL.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DJulian%26aufirst%3DL.%2BD.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DLo%26aufirst%3DM.-C.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DMcMinn%26aufirst%3DD.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DShaffer%26aufirst%3DP.%26aulast%3DXiao%26aufirst%3DS.-H.%26aulast%3DYakowek%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26atitle%3DRational%2520design%2520and%2520binding%2520mode%2520of%2520MDM2-p53%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4053%26epage%3D4070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">Experimental details of the human hepatocyte intrinsic clearance assay can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="note"><p class="first last">Time-dependent inhibition, % remaining of CYP3A4 over positive control, rifampin, after 30 min at 10 μM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">Experimental details of the BrdU proliferation and HCT116 p21 TaqMan assays can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">Experimental details of in vivo studies can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note"><p class="first last">Metabolites structures determined by analogy with previous results; see ref  <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">The atomic coordinates have been deposited in the Protein Data Bank under accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=40BA">40BA</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><div class="note"><p class="first last">Intermediate <b>39e</b> was synthesized through a procedure similar to that published in the following:</p></div><span class="NLM_contrib-group">Bae, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. K.</span><span> </span><span class="NLM_article-title">Preparation of cysteinol derivatives by highly regioselective ring opening of non-activated chiral aziridines by thiols</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10041</span><span class="NLM_x">–</span> <span class="NLM_lpage">10046</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=10041-10046&author=J.+H.+Baeauthor=S.-H.+Shinauthor=C.+S.+Parkauthor=W.+K.+Lee&title=Preparation+of+cysteinol+derivatives+by+highly+regioselective+ring+opening+of+non-activated+chiral+aziridines+by+thiols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBae%26aufirst%3DJ.%2BH.%26aulast%3DShin%26aufirst%3DS.-H.%26aulast%3DPark%26aufirst%3DC.%2BS.%26aulast%3DLee%26aufirst%3DW.%2BK.%26atitle%3DPreparation%2520of%2520cysteinol%2520derivatives%2520by%2520highly%2520regioselective%2520ring%2520opening%2520of%2520non-activated%2520chiral%2520aziridines%2520by%2520thiols%26jtitle%3DTetrahedron%26date%3D1999%26volume%3D55%26spage%3D10041%26epage%3D10046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Peruncheralathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henze, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, C.</span><span> </span><span class="NLM_article-title">Indium(III) chloride-catalyzed thiolysis of meso-aziridines</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6743</span><span class="NLM_x">–</span> <span class="NLM_lpage">6746</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=6743-6746&author=S.+Peruncheralathanauthor=M.+Henzeauthor=C.+Schneider&title=Indium%28III%29+chloride-catalyzed+thiolysis+of+meso-aziridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeruncheralathan%26aufirst%3DS.%26aulast%3DHenze%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DC.%26atitle%3DIndium%2528III%2529%2520chloride-catalyzed%2520thiolysis%2520of%2520meso-aziridines%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D6743%26epage%3D6746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Tsunoda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itô, S.</span><span> </span><span class="NLM_article-title">Novel reactivity of stabilized methylenetributylphosphorane: a new Mitsunobu reagent</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">5081</span><span class="NLM_x">–</span> <span class="NLM_lpage">5082</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1994&pages=5081-5082&author=T.+Tsunodaauthor=F.+Ozakiauthor=S.+It%C3%B4&title=Novel+reactivity+of+stabilized+methylenetributylphosphorane%3A+a+new+Mitsunobu+reagent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsunoda%26aufirst%3DT.%26aulast%3DOzaki%26aufirst%3DF.%26aulast%3DIt%25C3%25B4%26aufirst%3DS.%26atitle%3DNovel%2520reactivity%2520of%2520stabilized%2520methylenetributylphosphorane%253A%2520a%2520new%2520Mitsunobu%2520reagent%26jtitle%3DTetrahedron%2520Lett.%26date%3D1994%26volume%3D35%26spage%3D5081%26epage%3D5082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="note"><p class="first last">The MDMX assay is performed exactly as the MDM2 HTRF assay (in the absence of human serum) described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> with the exception that MDMX (10 μL) was dispensed to the reaction plate and incubated with the inhibitor for 20 min before p53 (20 μL, 1.25 nM) was added.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OBA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OBA','PDB','4OBA'); return false;">PDB: 4OBA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OAS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OAS','PDB','4OAS'); return false;">PDB: 4OAS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=40BA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=40BA','PDB','40BA'); return false;">PDB: 40BA</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i61"><a href="/doi/suppl/10.1021/jm401767k">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_78140"></div></div></div></div></div><hr /></hr><p class="last">(i) In vitro biological assays, (ii) in vivo protocols, and (iii) determination of cocrystal structures of <b>4</b> bound to MDM2. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401767k/suppl_file/jm401767k_si_001.pdf">jm401767k_si_001.pdf (187.29 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401767k&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-6%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm401767k%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401767k" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679914d1be27d956","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
